Skip to content

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

A PHASE 1, DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY, TOLERABILITY, IMMUNOGENICITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ESCALATING DOSAGES OF RN6G (PF-04382923) IN SUBJECTS WITH ADVANCED DRY, AGE-RELATED MACULAR DEGENERATION (AMD) INCLUDING GEOGRAPHIC ATROPHY

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01003691
Enrollment
24
Registered
2009-10-29
Start date
2010-08-05
Completion date
2013-04-19
Last updated
2022-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Maculopathies, Age-Related Maculopathy, Eye Diseases, Macular Degeneration, Retinal Degeneration

Keywords

Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G

Brief summary

The purpose of this study is to determine the safety and tolerability of multiple doses of RN6G in subjects with advanced dry, age-related macular degeneration including geographic atrophy.

Interventions

BIOLOGICALRN6G

Intravenous, multiple dose, dose ranging from 5 mg/kg up to a maximum of 15 mg/kg

BIOLOGICALPlacebo

Intravenous, multiple dose with experimental dose

Sponsors

Pfizer
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Be of non-child bearing potential * Diagnosis of dry AMD including uni- or multi-focal geographic atrophy without foveal involvement * BCVA of 20/50 or better in the study eye

Exclusion criteria

* Evidence of ocular disease other than advanced AMD or GA in the study eye * History or diagnosis of exudative (wet) AMD, with subretinal or choroidal neovascular lesions in the study eye * Presence of disease or condition that might compromise the cardiovascular, hematological, renal, hepatic, pulmonary, endocrine, central nervous immune, or gastrointestinal system * Requires ocular or systemic medications that are known to be toxic to the lens, retina or optic nerve

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Toxicity or Intolerable Dose CriteriaBaseline up to Day 304/End of Treatment (ET)The dose was considered intolerable if a participant developed either ocular toxicity or other toxicity as per Common Terminology Criteria for Adverse Events (CTCAE) or based on the investigator's discretion. Ocular toxicity included: Grade \>= 3 (retinopathy, retinal detachment, cataract formation, optic disk edema, keratitis, vitreous hemorrhage and uveitis) and acute vision loss of greater than 3 lines of vision up to and including 140 days after the first dose. Other toxicity included serious adverse event (SAE), Grade \>= 3 (increased liver transaminases, encephalopathy/leukoencephalopathy, diarrhea, enteritis or nausea, prolongation of QT interval \[Fridericia's correction\]), Grade \>=2 (central nervous system hemorrhage, decreased total leukocyte count, increased serum creatinine) and thrombocytopenia \<100\*10 9 /liter.
Number of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityBaseline up to Day 304/ETAE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. AE was assessed according to severity; Grade 1 (mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated), Grade 2 (moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental activities of daily living \[ADL\]), Grade 3 (severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL), Grade 4 (life-threatening consequences; urgent intervention indicated) and Grade 5 (death related to AE).
Number of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugBaseline up to Day 304/ETAll causalities AE was any untoward medical occurrence in participant who received study drug without regard to causal relationship. Drug-related AE was any untoward medical occurrence attributed to study drug in a participant who received study drug. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. All causalities and drug-related AEs reported wherein drug-related AEs were reported as ocular and non-ocular AEs. Ocular AEs were events which were localized in the ocular region and non-ocular AEs were systemic events which were not localized but occurred throughout the systemic circulation.
Number of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityBaseline up to Day 304/ETAE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Ocular AE were events which were localized in the ocular region and was assessed according to severity; Grade 1 (mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated), Grade 2 (moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL), Grade 3 (severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL), Grade 4 (life-threatening consequences; urgent intervention indicated) and Grade 5 (death related to AE).
Number of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugBaseline up to Day 304/ETAE was any untoward medical occurrence in participant who received study drug without regard to causal relationship and drug-related AE was any untoward medical occurrence attributed to study drug in a participant who received study drug. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Ocular AEs were events which were localized in the ocular region. Ocular AEs reported as related and non-related to study drug.
Number of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityBaseline up to Day 304/ETAE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Systemic AE were events which were not localized but occurred throughout the systemic circulation and was assessed according to severity; Grade 1 (mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated), Grade 2 (moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL), Grade 3 (severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL), Grade 4 (life-threatening consequences; urgent intervention indicated) and Grade 5 (death related to AE).
Number of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugBaseline up to Day 304/ETAE was any untoward medical occurrence in participant who received study drug without regard to causal relationship and drug-related AE was any untoward medical occurrence attributed to study drug in a participant who received study drug. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Systemic TEAEs were events which were not localized but occurred throughout the systemic circulation and reported as related and non-related to study drug.
Number of Participants With Positive Anti-Drug-Antibodies (ADA) and Neutralizing Antibodies (Nab)Baseline up to Day 304/ETThe immunogenicity of RN6G (PF-04382923) in terms of producing an antidrug antibody (ADA) and neutralizing antibody response were assessed. Neutralizing antibody response were to be assess in participants with positive ADA samples.

Secondary

MeasureTime frameDescription
Plasma Decay Half-Life (t1/2) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140Plasma decay half-life is the time measured for the plasma concentration to decrease by one half.
Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline, Day 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ETAmyloid (A) Beta (1-X) is a primary activator of complement in Alzheimer's disease (AD).
Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightBaseline, 1 and 4 H post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET
Percent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETDay 1 (1 hour , 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET
Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline, Day 1 (1 hour , 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET
Percent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETDay 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET
Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline, Day 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET
Percent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETDay 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET
Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline, 1 and 4 hour (H) post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET
Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateBaseline, 1 and 4 H post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET
Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureBaseline, 1 and 4 H post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET
Change From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, 1 and 4 H post-dose on Day 1; pre-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 168, 224 and 304/ETCriteria for changes in ECG (12-lead) were defined as: PR interval \>=220 millisecond (msec) and increase of \>=20 msec; QRS interval \>=120 msec; QT interval corrected using the Bazett's formula (QTcB) \>=500 msec; Maximum Change from Baseline in QTcF at Borderline \>=30 msec to \<60 msec and Prolonged \>=60 msec.
Change From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, 1 and 4 H post-dose on Day 1; pre-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 168, 224 and 304/ET
Change From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ETFollowing parameters were analyzed for laboratory examination: Bilirubin, Direct Bilirubin, Blood Urea Nitrogen(BUN), Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol (CL)(Fasting), Triglycerides (Fasting) (TG), Immunoglobulin G (Ig G), Immunoglobulin A (Ig A), Immunoglobulin M (Ig M)
Change From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET
Change From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ETFollowing parameters were analyzed for laboratory examination: Aspartate Aminotransferase (AMT), Creatine Kinase (CK), Alanine Aminotransferase (ALT), Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase (LD), Alkaline Phosphatase (AP).
Change From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET
Change From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ETFollowing hematology parameters were analyzed for laboratory examination: Hemoglobin, Hematocrit, Red blood cell (RBC) count, Platelet count, WBC count, Total neutrophils (Abs),Eosinophils (Abs),Monocytes (Abs),Basophils (Abs), Lymphocytes (Abs).
Change From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET
Area Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 168, 336 hours on Day 1 and 1, 2, 4, 24, 336, 672 hours on Day 140Area under the concentration-time profile from time zero to time tau (τ), the dosing interval, where tau = 672 hours.
Change From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ETFollowing hematology parameters were analyzed for laboratory examination: Prothrombin Time (PT), Partial Thromboplastin Time.
Change From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ETUrine specific gravity is a measure of the ratio of the density of urine to the density of water.
Change From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ETUrine pH is a method for evaluating urine acidity measured on a 10-point scale ranging from 0 (most acidic) to 9 (most alkaline). A lower pH means more acidity.
Change From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline, Day 28, 56, 84, 112, 140
Change From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline, Day 28, 56, 84, 112, 140
Change From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Baseline, Day 28, 56, 84, 112, 140
Change From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET
Change From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, 1 and 4 H post-dose on Day 1; pre-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 168, 224 and 304/ETQT interval corrected using the Fridericia formula (QTcF) \>=500 msec; Maximum Change from Baseline in QTcF at Borderline \>=30 msec to \<60 msec and Prolonged \>=60 msec.
Change From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET
Maximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 168, 336 hours on Day 1 and 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140
Minimum Observed Plasma Trough Concentration (Cmin) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140
Plasma Concentration (Css) at Steady State of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140Css is the concentration of the drug at the state when the amount of drug administered is equal to the amount of drug eliminated.
Time to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 168, 336 hours on Day 1 and 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140
Volume of Distribution at Steady State (Vss) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140Volume of distribution is defined as the theoretical volume in which the total amount of drug would need to be uniformly distributed to produce the desired blood concentration of a drug. Steady state volume of distribution (Vss) is the apparent volume of distribution at steady-state.
Mean Residence Time (MRT) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140The mean total time drug resides in the body.
Systemic Clearance (CL) of RN6G (PF-04382923)Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140CL is a quantitative measure of the rate at which a drug substance is removed from the body.

Countries

United States

Participant flow

Participants by arm

ArmCount
RN6G 5 mg/kg
RN6G (PF-04382923) 5 milligram/kilogram (mg/kg) of body weight, intravenous infusion over 60 minutes every 4 weeks until unacceptable toxicity, up to Month 5.
6
RN6G 10 mg/kg
RN6G (PF-04382923) 10 mg/kg of body weight, intravenous infusion over 60 minutes every 4 weeks until unacceptable toxicity, up to Month 5.
6
RN6G 15 mg/kg
RN6G (PF-04382923) 15 mg/kg of body weight, intravenous infusion over 60 minutes every 4 weeks until unacceptable toxicity, up to Month 5.
6
Placebo
Placebo intravenous infusion over 60 minutes, every 4 weeks, until unacceptable toxicity, up to Month 5.
6
Total24

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyAdverse Event0001

Baseline characteristics

CharacteristicRN6G 5 mg/kgRN6G 10 mg/kgRN6G 15 mg/kgPlaceboTotal
Age, Customized
60 to less than (<) 75 years
3 Participants3 Participants3 Participants2 Participants11 Participants
Age, Customized
Greater than or equal to (>=) 75 years
3 Participants3 Participants3 Participants4 Participants13 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants6 Participants6 Participants5 Participants23 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
6 Participants6 Participants6 Participants5 Participants23 Participants
Sex: Female, Male
Female
4 Participants1 Participants5 Participants3 Participants13 Participants
Sex: Female, Male
Male
2 Participants5 Participants1 Participants3 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 60 / 60 / 6
other
Total, other adverse events
6 / 66 / 66 / 66 / 6
serious
Total, serious adverse events
0 / 60 / 62 / 60 / 6

Outcome results

Primary

Number of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study Drug

AE was any untoward medical occurrence in participant who received study drug without regard to causal relationship and drug-related AE was any untoward medical occurrence attributed to study drug in a participant who received study drug. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Ocular AEs were events which were localized in the ocular region. Ocular AEs reported as related and non-related to study drug.

Time frame: Baseline up to Day 304/ET

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot Related4 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot Related4 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot Related3 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot Related4 Participants
Primary

Number of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by Severity

AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Ocular AE were events which were localized in the ocular region and was assessed according to severity; Grade 1 (mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated), Grade 2 (moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL), Grade 3 (severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL), Grade 4 (life-threatening consequences; urgent intervention indicated) and Grade 5 (death related to AE).

Time frame: Baseline up to Day 304/ET

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 14 Participants
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 20 Participants
RN6G 5 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 20 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 14 Participants
RN6G 10 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 23 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 10 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 15 mg/kgNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 12 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 22 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
PlaceboNumber of Participants With Ocular Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
Primary

Number of Participants With Positive Anti-Drug-Antibodies (ADA) and Neutralizing Antibodies (Nab)

The immunogenicity of RN6G (PF-04382923) in terms of producing an antidrug antibody (ADA) and neutralizing antibody response were assessed. Neutralizing antibody response were to be assess in participants with positive ADA samples.

Time frame: Baseline up to Day 304/ET

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Number Analyzed signifies number of participants evaluated for specified category. Data for Nab was not estimable as no participant was eligible for neutralizing antibody assessment, as there were no positive ADA samples.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Positive Anti-Drug-Antibodies (ADA) and Neutralizing Antibodies (Nab)Positive ADA0 Participants
RN6G 10 mg/kgNumber of Participants With Positive Anti-Drug-Antibodies (ADA) and Neutralizing Antibodies (Nab)Positive ADA0 Participants
RN6G 15 mg/kgNumber of Participants With Positive Anti-Drug-Antibodies (ADA) and Neutralizing Antibodies (Nab)Positive ADA0 Participants
PlaceboNumber of Participants With Positive Anti-Drug-Antibodies (ADA) and Neutralizing Antibodies (Nab)Positive ADA0 Participants
Primary

Number of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study Drug

AE was any untoward medical occurrence in participant who received study drug without regard to causal relationship and drug-related AE was any untoward medical occurrence attributed to study drug in a participant who received study drug. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Systemic TEAEs were events which were not localized but occurred throughout the systemic circulation and reported as related and non-related to study drug.

Time frame: Baseline up to Day 304/ET

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated2 Participants
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot related4 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot related6 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot related6 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugRelated0 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Causal Relationship to Study DrugNot related6 Participants
Primary

Number of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by Severity

AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. Systemic AE were events which were not localized but occurred throughout the systemic circulation and was assessed according to severity; Grade 1 (mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated), Grade 2 (moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL), Grade 3 (severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL), Grade 4 (life-threatening consequences; urgent intervention indicated) and Grade 5 (death related to AE).

Time frame: Baseline up to Day 304/ET

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 25 Participants
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 11 Participants
RN6G 5 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 23 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 13 Participants
RN6G 10 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 32 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 24 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 10 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 15 mg/kgNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 25 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 10 Participants
PlaceboNumber of Participants With Systemic Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 31 Participants
Primary

Number of Participants With Toxicity or Intolerable Dose Criteria

The dose was considered intolerable if a participant developed either ocular toxicity or other toxicity as per Common Terminology Criteria for Adverse Events (CTCAE) or based on the investigator's discretion. Ocular toxicity included: Grade \>= 3 (retinopathy, retinal detachment, cataract formation, optic disk edema, keratitis, vitreous hemorrhage and uveitis) and acute vision loss of greater than 3 lines of vision up to and including 140 days after the first dose. Other toxicity included serious adverse event (SAE), Grade \>= 3 (increased liver transaminases, encephalopathy/leukoencephalopathy, diarrhea, enteritis or nausea, prolongation of QT interval \[Fridericia's correction\]), Grade \>=2 (central nervous system hemorrhage, decreased total leukocyte count, increased serum creatinine) and thrombocytopenia \<100\*10 9 /liter.

Time frame: Baseline up to Day 304/End of Treatment (ET)

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureValue (NUMBER)
RN6G 5 mg/kgNumber of Participants With Toxicity or Intolerable Dose Criteria0 Participants
RN6G 10 mg/kgNumber of Participants With Toxicity or Intolerable Dose Criteria0 Participants
RN6G 15 mg/kgNumber of Participants With Toxicity or Intolerable Dose Criteria0 Participants
PlaceboNumber of Participants With Toxicity or Intolerable Dose Criteria0 Participants
Primary

Number of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study Drug

All causalities AE was any untoward medical occurrence in participant who received study drug without regard to causal relationship. Drug-related AE was any untoward medical occurrence attributed to study drug in a participant who received study drug. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. All causalities and drug-related AEs reported wherein drug-related AEs were reported as ocular and non-ocular AEs. Ocular AEs were events which were localized in the ocular region and non-ocular AEs were systemic events which were not localized but occurred throughout the systemic circulation.

Time frame: Baseline up to Day 304/ET

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugAll causalities AE6 Participants
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related non-ocular AE2 Participants
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related Ocular AE0 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugAll causalities AE6 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related non-ocular AE0 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related Ocular AE0 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related Ocular AE0 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugAll causalities AE6 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related non-ocular AE0 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugAll causalities AE6 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related non-ocular AE0 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs): All Causalities and TEAEs Categorized by Causal Relationship to Study DrugDrug-related Ocular AE0 Participants
Primary

Number of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by Severity

AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to Day 304/ET that were absent before treatment or that worsened relative to pretreatment state. AE was assessed according to severity; Grade 1 (mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated), Grade 2 (moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental activities of daily living \[ADL\]), Grade 3 (severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL), Grade 4 (life-threatening consequences; urgent intervention indicated) and Grade 5 (death related to AE).

Time frame: Baseline up to Day 304/ET

Population: Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 25 Participants
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 5 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 11 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 30 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 23 Participants
RN6G 10 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 13 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 32 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 10 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 24 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
RN6G 15 mg/kgNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 40 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 25 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 10 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 31 Participants
PlaceboNumber of Participants With Treatment Emergent Adverse Events (TEAEs) Categorized by SeverityGrade 50 Participants
Secondary

Area Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)

Area under the concentration-time profile from time zero to time tau (τ), the dosing interval, where tau = 672 hours.

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 168, 336 hours on Day 1 and 1, 2, 4, 24, 336, 672 hours on Day 140

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure and Number Analyzed signifies number of participants evaluated for specified category.

ArmMeasureGroupValue (GEOMETRIC_MEAN)Dispersion
RN6G 5 mg/kgArea Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)Day 1NA Microgram*hour per milliliter (mcg*h/mL)
RN6G 5 mg/kgArea Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)Day 14050230 Microgram*hour per milliliter (mcg*h/mL)Geometric Coefficient of Variation 20
RN6G 10 mg/kgArea Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)Day 140140300 Microgram*hour per milliliter (mcg*h/mL)Geometric Coefficient of Variation 14
RN6G 15 mg/kgArea Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)Day 1NA Microgram*hour per milliliter (mcg*h/mL)
RN6G 15 mg/kgArea Under the Curve From Time Zero to End of Dosing Interval (AUCtau) of RN6G (PF-04382923)Day 140213200 Microgram*hour per milliliter (mcg*h/mL)Geometric Coefficient of Variation 16
Secondary

Change From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ET

Criteria for changes in ECG (12-lead) were defined as: PR interval \>=220 millisecond (msec) and increase of \>=20 msec; QRS interval \>=120 msec; QT interval corrected using the Bazett's formula (QTcB) \>=500 msec; Maximum Change from Baseline in QTcF at Borderline \>=30 msec to \<60 msec and Prolonged \>=60 msec.

Time frame: Baseline, 1 and 4 H post-dose on Day 1; pre-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 168, 224 and 304/ET

Population: Safety analysis set included all randomized participants who received any amount of study drug. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: RR-36.28 MillisecondStandard Deviation 38.148
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcB-2.06 MillisecondStandard Deviation 16.679
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: PR-6.78 MillisecondStandard Deviation 9.27
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcB-0.61 MillisecondStandard Deviation 9.855
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QT-3.78 MillisecondStandard Deviation 18.493
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcB-6.39 MillisecondStandard Deviation 18.637
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcB-6.39 MillisecondStandard Deviation 17.989
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: PR0.22 MillisecondStandard Deviation 6.885
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QRS-4.44 MillisecondStandard Deviation 5.106
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: RR5.39 MillisecondStandard Deviation 61.533
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcB-2.11 MillisecondStandard Deviation 6.493
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: PR-0.78 MillisecondStandard Deviation 12.567
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QT-2.33 MillisecondStandard Deviation 11.939
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QT-1.33 MillisecondStandard Deviation 13.367
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcB4.44 MillisecondStandard Deviation 13.274
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: PR2.33 MillisecondStandard Deviation 8.892
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RR939.28 MillisecondStandard Deviation 124.486
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RR-33.11 MillisecondStandard Deviation 80.934
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcB-5.39 MillisecondStandard Deviation 11.496
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: PR-3.33 MillisecondStandard Deviation 7.76
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RR21.72 MillisecondStandard Deviation 77.289
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QRS-2.44 MillisecondStandard Deviation 6.017
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcB0.39 MillisecondStandard Deviation 4.823
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: PR-4.33 MillisecondStandard Deviation 9.177
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QRS-2.56 MillisecondStandard Deviation 3.538
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: RR-7.61 MillisecondStandard Deviation 53.735
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QT-4.67 MillisecondStandard Deviation 24.909
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PR-4.11 MillisecondStandard Deviation 8.405
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QT-1.00 MillisecondStandard Deviation 5.379
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: RR-6.78 MillisecondStandard Deviation 120.518
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcB418.56 MillisecondStandard Deviation 13.605
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PR-7.11 MillisecondStandard Deviation 14.09
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcB-6.89 MillisecondStandard Deviation 9.135
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: RR4.06 MillisecondStandard Deviation 45.449
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PR170.78 MillisecondStandard Deviation 23.268
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: RR-44.61 MillisecondStandard Deviation 76.284
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcB0.72 MillisecondStandard Deviation 9.525
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QT-3.44 MillisecondStandard Deviation 12.274
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QRS87.11 MillisecondStandard Deviation 5.036
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QT405.00 MillisecondStandard Deviation 25.174
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: RR30.56 MillisecondStandard Deviation 23.478
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QT-1.67 MillisecondStandard Deviation 6.782
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QRS-2.67 MillisecondStandard Deviation 4.881
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: PR-4.22 MillisecondStandard Deviation 13.589
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QRS-2.22 MillisecondStandard Deviation 3.202
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: RR29.56 MillisecondStandard Deviation 40.059
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QRS-1.78 MillisecondStandard Deviation 4.856
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcB-0.89 MillisecondStandard Deviation 8.516
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: PR-1.33 MillisecondStandard Deviation 9.762
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QT-13.00 MillisecondStandard Deviation 17.255
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QRS1.56 MillisecondStandard Deviation 4.375
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QRS-2.67 MillisecondStandard Deviation 4.638
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QT-2.33 MillisecondStandard Deviation 15.769
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1H post-dose Day 1: QT1.22 MillisecondStandard Deviation 14.27
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QRS-1.44 MillisecondStandard Deviation 2.083
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: PR-2.78 MillisecondStandard Deviation 11.711
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: RR-6.39 MillisecondStandard Deviation 43.272
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QT-10.22 MillisecondStandard Deviation 12.174
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QRS-2.11 MillisecondStandard Deviation 3.331
RN6G 5 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QRS-3.11 MillisecondStandard Deviation 7.101
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QRS-1.44 MillisecondStandard Deviation 3.41
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcB-14.78 MillisecondStandard Deviation 38.322
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QT-13.00 MillisecondStandard Deviation 17.006
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QRS0.22 MillisecondStandard Deviation 5.054
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: RR-39.89 MillisecondStandard Deviation 85.486
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QRS-0.11 MillisecondStandard Deviation 6.217
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QT-18.00 MillisecondStandard Deviation 35.7
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QRS1.56 MillisecondStandard Deviation 4.593
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QRS1.22 MillisecondStandard Deviation 5.439
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QT-6.00 MillisecondStandard Deviation 14.092
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QRS0.67 MillisecondStandard Deviation 6.613
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QRS-0.22 MillisecondStandard Deviation 4.456
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: RR-16.83 MillisecondStandard Deviation 58.974
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QT-9.33 MillisecondStandard Deviation 17.42
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QRS1.89 MillisecondStandard Deviation 5.34
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QRS0.22 MillisecondStandard Deviation 3.569
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcB3.17 MillisecondStandard Deviation 11.201
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QRS1.22 MillisecondStandard Deviation 6.895
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QT-11.33 MillisecondStandard Deviation 13.914
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QT422.00 MillisecondStandard Deviation 29.835
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: RR-66.17 MillisecondStandard Deviation 86.676
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1H post-dose Day 1: QT2.22 MillisecondStandard Deviation 11.713
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QT-8.67 MillisecondStandard Deviation 10.302
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QT-13.44 MillisecondStandard Deviation 19.018
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QT-11.33 MillisecondStandard Deviation 17.42
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RR-31.78 MillisecondStandard Deviation 27.507
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RR8.89 MillisecondStandard Deviation 58.224
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: RR-34.22 MillisecondStandard Deviation 82.327
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcB-4.33 MillisecondStandard Deviation 8.899
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: RR32.39 MillisecondStandard Deviation 70.6
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RR962.44 MillisecondStandard Deviation 117.246
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PR190.00 MillisecondStandard Deviation 38.006
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcB1.33 MillisecondStandard Deviation 13.471
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcB-9.33 MillisecondStandard Deviation 16.35
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: PR-4.33 MillisecondStandard Deviation 9.407
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: PR-4.89 MillisecondStandard Deviation 6.898
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: RR0.39 MillisecondStandard Deviation 53.575
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcB-4.67 MillisecondStandard Deviation 9.92
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: PR1.00 MillisecondStandard Deviation 10.673
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QTcB-9.5 MillisecondStandard Deviation 15.812
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcB-12.50 MillisecondStandard Deviation 14.442
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: PR0.33 MillisecondStandard Deviation 15.842
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: PR-8.33 MillisecondStandard Deviation 18.426
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcB-6.67 MillisecondStandard Deviation 14.188
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: PR-3.33 MillisecondStandard Deviation 18.086
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: RR-19.78 MillisecondStandard Deviation 32.654
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: PR-1.11 MillisecondStandard Deviation 14.052
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcB-12.33 MillisecondStandard Deviation 13.105
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcB-3.50 MillisecondStandard Deviation 6.483
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: PR-1.56 MillisecondStandard Deviation 11.938
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcB1.83 MillisecondStandard Deviation 9.697
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: PR2.00 MillisecondStandard Deviation 8.316
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcB430.67 MillisecondStandard Deviation 20.976
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PR-7.00 MillisecondStandard Deviation 12.994
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: RR-12.78 MillisecondStandard Deviation 56.646
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PR-1.00 MillisecondStandard Deviation 15.468
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QT-1.67 MillisecondStandard Deviation 16.896
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PR-3.00 MillisecondStandard Deviation 19.066
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QT-9.67 MillisecondStandard Deviation 12.442
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QRS91.44 MillisecondStandard Deviation 8.352
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QRS-1.56 MillisecondStandard Deviation 3.417
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: RR-24.11 MillisecondStandard Deviation 63.637
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QT-5.67 MillisecondStandard Deviation 11.939
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QRS-1.67 MillisecondStandard Deviation 2.692
RN6G 10 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: RR24.94 MillisecondStandard Deviation 70.632
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RR60.44 MillisecondStandard Deviation 122.291
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RR918.39 MillisecondStandard Deviation 101.325
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: RR79.11 MillisecondStandard Deviation 89.729
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: RR22.33 MillisecondStandard Deviation 115.576
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: RR69.44 MillisecondStandard Deviation 91.732
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: RR74.78 MillisecondStandard Deviation 98.804
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: RR57.11 MillisecondStandard Deviation 102.514
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: RR34.94 MillisecondStandard Deviation 77.744
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: RR26.56 MillisecondStandard Deviation 91.107
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: RR80.44 MillisecondStandard Deviation 104.487
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: RR52.17 MillisecondStandard Deviation 86.145
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RR-22.72 MillisecondStandard Deviation 99.733
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: RR-9.22 MillisecondStandard Deviation 80.263
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PR167.89 MillisecondStandard Deviation 25.711
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: PR-7.11 MillisecondStandard Deviation 12.261
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: PR-6.33 MillisecondStandard Deviation 7.563
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: PR28.44 MillisecondStandard Deviation 84.486
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: PR-11.47 MillisecondStandard Deviation 22.912
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: PR-0.67 MillisecondStandard Deviation 1.944
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: PR-13.56 MillisecondStandard Deviation 22.134
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: PR-4.22 MillisecondStandard Deviation 5.311
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: PR-4.67 MillisecondStandard Deviation 14.569
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: PR-7.89 MillisecondStandard Deviation 11.262
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PR-2.56 MillisecondStandard Deviation 5.154
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PR-7.89 MillisecondStandard Deviation 7.061
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PR-17.22 MillisecondStandard Deviation 21.935
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QRS97.89 MillisecondStandard Deviation 22.444
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QRS-2.33 MillisecondStandard Deviation 2.789
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QRS0.44 MillisecondStandard Deviation 2.373
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QRS-0.89 MillisecondStandard Deviation 2.656
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QRS1.78 MillisecondStandard Deviation 2.722
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QRS6.78 MillisecondStandard Deviation 22.333
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QRS5.11 MillisecondStandard Deviation 20.149
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QRS0.33 MillisecondStandard Deviation 2.883
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QRS1.22 MillisecondStandard Deviation 2.083
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QRS-0.44 MillisecondStandard Deviation 1.44
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QRS2.11 MillisecondStandard Deviation 4.53
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QRS9.78 MillisecondStandard Deviation 26.712
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QRS-2.56 MillisecondStandard Deviation 1.76
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QT408.56 MillisecondStandard Deviation 30.56
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1H post-dose Day 1: QT14.22 MillisecondStandard Deviation 14.845
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QT4.67 MillisecondStandard Deviation 29.796
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QT11.11 MillisecondStandard Deviation 14.228
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QT18.44 MillisecondStandard Deviation 31.865
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QT14.11 MillisecondStandard Deviation 26.319
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QT5.44 MillisecondStandard Deviation 13.607
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QT11.89 MillisecondStandard Deviation 18.621
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QT22.33 MillisecondStandard Deviation 22.17
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QT19.67 MillisecondStandard Deviation 14.34
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QT16.44 MillisecondStandard Deviation 36.302
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QT-1.22 MillisecondStandard Deviation 27.995
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QT-8.56 MillisecondStandard Deviation 31.792
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcB426.28 MillisecondStandard Deviation 18.37
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcB-2.67 MillisecondStandard Deviation 12.006
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcB-0.11 MillisecondStandard Deviation 6.811
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcB-2.94 MillisecondStandard Deviation 18.639
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcB1.56 MillisecondStandard Deviation 15.45
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcB2.22 MillisecondStandard Deviation 21.281
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcB-1.11 MillisecondStandard Deviation 9.66
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcB6.94 MillisecondStandard Deviation 6.641
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcB4.72 MillisecondStandard Deviation 10.794
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcB9.06 MillisecondStandard Deviation 11.144
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcB4.06 MillisecondStandard Deviation 10.81
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcB3.72 MillisecondStandard Deviation 14.188
RN6G 15 mg/kgChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QTcB-6.28 MillisecondStandard Deviation 17.655
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QRS-0.33 MillisecondStandard Deviation 2.261
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QTcB13.17 MillisecondStandard Deviation 8.813
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QT11.33 MillisecondStandard Deviation 35.308
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QRS0.78 MillisecondStandard Deviation 3.41
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QRS0.78 MillisecondStandard Deviation 1.76
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcB11.33 MillisecondStandard Deviation 18.318
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QT4.27 MillisecondStandard Deviation 26.594
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QRS100.33 MillisecondStandard Deviation 24.858
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PR16.33 MillisecondStandard Deviation 21.709
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: RR-51.67 MillisecondStandard Deviation 186.668
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QT19.22 MillisecondStandard Deviation 22.225
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PR14.13 MillisecondStandard Deviation 24.214
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: RR8.83 MillisecondStandard Deviation 65.44
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QT9.33 MillisecondStandard Deviation 36.127
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PR-1.50 MillisecondStandard Deviation 10.932
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: PR21.87 MillisecondStandard Deviation 28.757
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcB6.72 MillisecondStandard Deviation 17.425
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcB417.11 MillisecondStandard Deviation 17.539
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: PR16.27 MillisecondStandard Deviation 22.229
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: PR11.33 MillisecondStandard Deviation 23.636
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcB11.80 MillisecondStandard Deviation 20.895
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcB5.81 MillisecondStandard Deviation 17.269
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: PR16.53 MillisecondStandard Deviation 26.764
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: PR11.73 MillisecondStandard Deviation 32.392
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: RR49.00 MillisecondStandard Deviation 78.316
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcB13.50 MillisecondStandard Deviation 29.257
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: PR12.22 MillisecondStandard Deviation 23.512
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QRS0.00 MillisecondStandard Deviation 4.922
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: RR-54.11 MillisecondStandard Deviation 94.978
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcB-5.94 MillisecondStandard Deviation 5.953
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: PR3.89 MillisecondStandard Deviation 12.245
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: PR-2.89 MillisecondStandard Deviation 6.362
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RR-28.67 MillisecondStandard Deviation 70.982
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcB5.39 MillisecondStandard Deviation 19.841
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: PR-2.67 MillisecondStandard Deviation 6.902
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PR166.11 MillisecondStandard Deviation 41.177
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcB10.07 MillisecondStandard Deviation 21.177
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcB23.07 MillisecondStandard Deviation 32.116
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: RR-11.92 MillisecondStandard Deviation 122.446
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RR56.50 MillisecondStandard Deviation 78.87
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: RR-21.22 MillisecondStandard Deviation 136.555
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcB29.07 MillisecondStandard Deviation 42.361
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: RR5.13 MillisecondStandard Deviation 166.054
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QT4.89 MillisecondStandard Deviation 18.29
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QT1.56 MillisecondStandard Deviation 32.457
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1H post-dose Day 1: QT0.78 MillisecondStandard Deviation 26.346
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: RR42.60 MillisecondStandard Deviation 150.052
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QT8.22 MillisecondStandard Deviation 10.221
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QT401.78 MillisecondStandard Deviation 31.932
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QRS5.83 MillisecondStandard Deviation 4.631
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RR928.33 MillisecondStandard Deviation 117.701
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QT10.27 MillisecondStandard Deviation 28.482
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QRS1.00 MillisecondStandard Deviation 2.692
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QRS2.53 MillisecondStandard Deviation 5.586
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcB9.33 MillisecondStandard Deviation 22.955
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QT19.07 MillisecondStandard Deviation 35.345
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QRS0.40 MillisecondStandard Deviation 4.681
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QRS-0.40 MillisecondStandard Deviation 4.017
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: RR-9.60 MillisecondStandard Deviation 51.462
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QT7.47 MillisecondStandard Deviation 25.304
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QRS0.80 MillisecondStandard Deviation 4.84
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QRS1.60 MillisecondStandard Deviation 9.541
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: RR-44.87 MillisecondStandard Deviation 82.091
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QT19.33 MillisecondStandard Deviation 28.091
PlaceboChange From Baseline Electrocardiogram (ECG) 12-lead at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QRS-2.67 MillisecondStandard Deviation 6.037
Secondary

Change From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Following parameters were analyzed for laboratory examination: Bilirubin, Direct Bilirubin, Blood Urea Nitrogen(BUN), Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol (CL)(Fasting), Triglycerides (Fasting) (TG), Immunoglobulin G (Ig G), Immunoglobulin A (Ig A), Immunoglobulin M (Ig M)

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point. Categories with at least 1 non-zero data have been provided below.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.075
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Calcium0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.55
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Creatinine0.008 Milligram per deciliter (MG/DL)Standard Deviation 0.1121
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Calcium0.13 Milligram per deciliter (MG/DL)Standard Deviation 0.367
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bilirubin-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.082
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Creatinine0.020 Milligram per deciliter (MG/DL)Standard Deviation 0.1316
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Calcium-0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.638
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Glucose22.8 Milligram per deciliter (MG/DL)Standard Deviation 48.16
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Calcium0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.369
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: TG (fasting)-15.0 Milligram per deciliter (MG/DL)Standard Deviation 45.79
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: TG (fasting)4.2 Milligram per deciliter (MG/DL)Standard Deviation 63.29
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Direct Bilirubin0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.055
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Uric Acid-0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.497
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Creatinine0.053 Milligram per deciliter (MG/DL)Standard Deviation 0.0755
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Glucose93.8 Milligram per deciliter (MG/DL)Standard Deviation 11.2
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Direct Bilirubin-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.052
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Phosphate0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.417
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CL (fasting)-6.5 Milligram per deciliter (MG/DL)Standard Deviation 35.23
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Uric Acid0.62 Milligram per deciliter (MG/DL)Standard Deviation 1.072
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.063
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Uric Acid-0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.722
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CL (fasting)-9.0 Milligram per deciliter (MG/DL)Standard Deviation 13.28
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Creatinine-0.002 Milligram per deciliter (MG/DL)Standard Deviation 0.1321
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.063
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Creatinine0.918 Milligram per deciliter (MG/DL)Standard Deviation 0.2322
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: TG (fasting)-11.5 Milligram per deciliter (MG/DL)Standard Deviation 43.72
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Phosphate0.13 Milligram per deciliter (MG/DL)Standard Deviation 0.472
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.075
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CL (fasting)-2.5 Milligram per deciliter (MG/DL)Standard Deviation 17.13
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Uric Acid-0.32 Milligram per deciliter (MG/DL)Standard Deviation 0.571
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Glucose0.7 Milligram per deciliter (MG/DL)Standard Deviation 6.28
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Direct Bilirubin-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.052
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bilirubin0.48 Milligram per deciliter (MG/DL)Standard Deviation 0.147
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: TG (fasting)141.7 Milligram per deciliter (MG/DL)Standard Deviation 47.32
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Phosphate0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.459
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.041
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Uric Acid0.23 Milligram per deciliter (MG/DL)Standard Deviation 0.855
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Uric Acid-0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.641
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Creatinine0.043 Milligram per deciliter (MG/DL)Standard Deviation 0.1179
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.075
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Creatinine0.047 Milligram per deciliter (MG/DL)Standard Deviation 0.088
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: TG (fasting)-24.5 Milligram per deciliter (MG/DL)Standard Deviation 46
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Phosphate0.32 Milligram per deciliter (MG/DL)Standard Deviation 0.36
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: TG (fasting)2.2 Milligram per deciliter (MG/DL)Standard Deviation 38.57
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Calcium0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.335
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bilirubin-0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.122
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: BUN18.7 Milligram per deciliter (MG/DL)Standard Deviation 5.01
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Uric Acid4.87 Milligram per deciliter (MG/DL)Standard Deviation 1.172
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CL (fasting)0.0 Milligram per deciliter (MG/DL)Standard Deviation 8.02
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Phosphate0.27 Milligram per deciliter (MG/DL)Standard Deviation 0.308
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: BUN-0.3 Milligram per deciliter (MG/DL)Standard Deviation 3.14
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Glucose4.7 Milligram per deciliter (MG/DL)Standard Deviation 5.28
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CL (fasting)191.7 Milligram per deciliter (MG/DL)Standard Deviation 20.34
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.133
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: BUN-2.0 Milligram per deciliter (MG/DL)Standard Deviation 2.1
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CL (fasting)-4.7 Milligram per deciliter (MG/DL)Standard Deviation 19.79
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Creatinine0.055 Milligram per deciliter (MG/DL)Standard Deviation 0.171
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Phosphate0.27 Milligram per deciliter (MG/DL)Standard Deviation 0.489
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: BUN1.3 Milligram per deciliter (MG/DL)Standard Deviation 4.32
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Uric Acid-0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.539
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CL (fasting)-0.8 Milligram per deciliter (MG/DL)Standard Deviation 26.54
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bilirubin-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.082
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: BUN-0.2 Milligram per deciliter (MG/DL)Standard Deviation 5.08
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Calcium0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.279
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CL (fasting)12.3 Milligram per deciliter (MG/DL)Standard Deviation 14.19
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Phosphate-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.273
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: BUN1.0 Milligram per deciliter (MG/DL)Standard Deviation 4.6
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Glucose-2.0 Milligram per deciliter (MG/DL)Standard Deviation 1.41
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bilirubin-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.141
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Glucose6.8 Milligram per deciliter (MG/DL)Standard Deviation 4.88
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: BUN0.0 Milligram per deciliter (MG/DL)Standard Deviation 2.45
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: TG (fasting)6.0 Milligram per deciliter (MG/DL)Standard Deviation 73.16
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Calcium9.62 Milligram per deciliter (MG/DL)Standard Deviation 0.248
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Phosphate3.20 Milligram per deciliter (MG/DL)Standard Deviation 0.583
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: BUN1.2 Milligram per deciliter (MG/DL)Standard Deviation 2.14
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bilirubin-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.082
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: TG (fasting)-23.2 Milligram per deciliter (MG/DL)Standard Deviation 35.44
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Calcium-0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.361
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Glucose-1.0 Milligram per deciliter (MG/DL)Standard Deviation 6.42
RN6G 5 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Glucose1.7 Milligram per deciliter (MG/DL)Standard Deviation 6.19
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Glucose5.8 Milligram per deciliter (MG/DL)Standard Deviation 12.16
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: BUN-0.2 Milligram per deciliter (MG/DL)Standard Deviation 4.07
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CL (fasting)1.5 Milligram per deciliter (MG/DL)Standard Deviation 9.57
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Phosphate3.48 Milligram per deciliter (MG/DL)Standard Deviation 0.376
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: BUN0.5 Milligram per deciliter (MG/DL)Standard Deviation 3.51
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Glucose3.3 Milligram per deciliter (MG/DL)Standard Deviation 5.85
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: BUN1.3 Milligram per deciliter (MG/DL)Standard Deviation 2.8
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Calcium-0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.446
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: BUN1.5 Milligram per deciliter (MG/DL)Standard Deviation 2.59
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Calcium-0.27 Milligram per deciliter (MG/DL)Standard Deviation 0.393
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: TG (fasting)4.0 Milligram per deciliter (MG/DL)Standard Deviation 68.07
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Creatinine0.955 Milligram per deciliter (MG/DL)Standard Deviation 0.075
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Creatinine-0.032 Milligram per deciliter (MG/DL)Standard Deviation 0.0708
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Calcium-0.32 Milligram per deciliter (MG/DL)Standard Deviation 0.306
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Creatinine0.000 Milligram per deciliter (MG/DL)Standard Deviation 0.1163
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Glucose3.2 Milligram per deciliter (MG/DL)Standard Deviation 6.11
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Creatinine0.038 Milligram per deciliter (MG/DL)Standard Deviation 0.1196
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Calcium-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.388
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CL (fasting)0.2 Milligram per deciliter (MG/DL)Standard Deviation 10.72
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Creatinine0.008 Milligram per deciliter (MG/DL)Standard Deviation 0.0924
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Creatinine-0.020 Milligram per deciliter (MG/DL)Standard Deviation 0.1271
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CL (fasting)-2.5 Milligram per deciliter (MG/DL)Standard Deviation 8.57
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Creatinine-0.045 Milligram per deciliter (MG/DL)Standard Deviation 0.0922
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Calcium-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.344
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Creatinine0.012 Milligram per deciliter (MG/DL)Standard Deviation 0.1297
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: TG (fasting)-24.7 Milligram per deciliter (MG/DL)Standard Deviation 57.41
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Calcium-0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.264
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Creatinine0.008 Milligram per deciliter (MG/DL)Standard Deviation 0.1072
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Glucose6.3 Milligram per deciliter (MG/DL)Standard Deviation 12.04
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Uric Acid5.97 Milligram per deciliter (MG/DL)Standard Deviation 1.335
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CL (fasting)-5.8 Milligram per deciliter (MG/DL)Standard Deviation 7.99
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Calcium9.62 Milligram per deciliter (MG/DL)Standard Deviation 0.458
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Uric Acid-0.25 Milligram per deciliter (MG/DL)Standard Deviation 0.176
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Calcium-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.356
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Uric Acid0.32 Milligram per deciliter (MG/DL)Standard Deviation 0.677
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Calcium-0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.378
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CL (fasting)-10.2 Milligram per deciliter (MG/DL)Standard Deviation 15.79
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Uric Acid0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.662
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Uric Acid-0.25 Milligram per deciliter (MG/DL)Standard Deviation 0.383
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Uric Acid0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.327
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Phosphate0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.382
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Uric Acid-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.698
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Uric Acid0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.694
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Uric Acid-0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.701
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bilirubin0.58 Milligram per deciliter (MG/DL)Standard Deviation 0.422
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Glucose7.3 Milligram per deciliter (MG/DL)Standard Deviation 12.13
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bilirubin-0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.264
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: TG (fasting)-18.0 Milligram per deciliter (MG/DL)Standard Deviation 43.32
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bilirubin-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.121
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: CL (fasting)1.3 Milligram per deciliter (MG/DL)Standard Deviation 19.28
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Glucose7.2 Milligram per deciliter (MG/DL)Standard Deviation 12.56
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bilirubin-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.25
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bilirubin-0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.325
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Glucose3.7 Milligram per deciliter (MG/DL)Standard Deviation 7.42
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.343
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: TG (fasting)-16.5 Milligram per deciliter (MG/DL)Standard Deviation 32.31
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.2
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CL (fasting)0.3 Milligram per deciliter (MG/DL)Standard Deviation 15.23
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Glucose3.8 Milligram per deciliter (MG/DL)Standard Deviation 9.77
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.21
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CL (fasting)2.7 Milligram per deciliter (MG/DL)Standard Deviation 15.12
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Bilirubin0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.105
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Glucose92.5 Milligram per deciliter (MG/DL)Standard Deviation 7.84
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Direct Bilirubin0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.082
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: TG (fasting)-13.7 Milligram per deciliter (MG/DL)Standard Deviation 50.39
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Direct Bilirubin-0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.052
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Phosphate0.25 Milligram per deciliter (MG/DL)Standard Deviation 0.217
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Phosphate-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.456
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.041
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.041
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: TG (fasting)-7.3 Milligram per deciliter (MG/DL)Standard Deviation 26.3
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Phosphate-0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.331
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.041
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.041
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CL (fasting)188.7 Milligram per deciliter (MG/DL)Standard Deviation 60.01
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Phosphate0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.369
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: TG (fasting)-18.0 Milligram per deciliter (MG/DL)Standard Deviation 54.98
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Phosphate0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.197
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: BUN15.5 Milligram per deciliter (MG/DL)Standard Deviation 3.89
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: TG (fasting)138.5 Milligram per deciliter (MG/DL)Standard Deviation 58.95
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: BUN-0.2 Milligram per deciliter (MG/DL)Standard Deviation 2.64
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Phosphate0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.197
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: BUN-1.2 Milligram per deciliter (MG/DL)Standard Deviation 4.62
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: TG (fasting)-18.5 Milligram per deciliter (MG/DL)Standard Deviation 31.17
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: BUN1.3 Milligram per deciliter (MG/DL)Standard Deviation 3.78
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Phosphate0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.194
RN6G 10 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: BUN-0.5 Milligram per deciliter (MG/DL)Standard Deviation 2.74
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Creatinine0.042 Milligram per deciliter (MG/DL)Standard Deviation 0.0891
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: lg M101.0 Milligram per deciliter (MG/DL)Standard Deviation 60.79
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: lg M9.7 Milligram per deciliter (MG/DL)Standard Deviation 8.74
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: lg M4.7 Milligram per deciliter (MG/DL)Standard Deviation 7.06
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: lg M8.2 Milligram per deciliter (MG/DL)Standard Deviation 19.69
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: CL (fasting)-3.5 Milligram per deciliter (MG/DL)Standard Deviation 13.88
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: TG (fasting)110.5 Milligram per deciliter (MG/DL)Standard Deviation 41.4
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: TG (fasting)-9.3 Milligram per deciliter (MG/DL)Standard Deviation 34.91
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: TG (fasting)-8.2 Milligram per deciliter (MG/DL)Standard Deviation 23.51
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: TG (fasting)-19.7 Milligram per deciliter (MG/DL)Standard Deviation 18.22
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: TG (fasting)-2.8 Milligram per deciliter (MG/DL)Standard Deviation 23.76
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: TG (fasting)-7.5 Milligram per deciliter (MG/DL)Standard Deviation 29.13
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: TG (fasting)-4.2 Milligram per deciliter (MG/DL)Standard Deviation 24.13
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: TG (fasting)-13.8 Milligram per deciliter (MG/DL)Standard Deviation 22.68
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: TG (fasting)0.5 Milligram per deciliter (MG/DL)Standard Deviation 26.94
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: lg G840.5 Milligram per deciliter (MG/DL)Standard Deviation 171.08
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: lg G42.7 Milligram per deciliter (MG/DL)Standard Deviation 26.63
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: lg G69.7 Milligram per deciliter (MG/DL)Standard Deviation 65.83
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: lg G41.8 Milligram per deciliter (MG/DL)Standard Deviation 72.02
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: lg A257.3 Milligram per deciliter (MG/DL)Standard Deviation 108.27
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: lg A7.0 Milligram per deciliter (MG/DL)Standard Deviation 7.55
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: lg A-10.0 Milligram per deciliter (MG/DL)Standard Deviation 14.56
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: lg A-4.2 Milligram per deciliter (MG/DL)Standard Deviation 26.36
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Calcium0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.54
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bilirubin0.47 Milligram per deciliter (MG/DL)Standard Deviation 0.234
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bilirubin0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.435
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bilirubin0.25 Milligram per deciliter (MG/DL)Standard Deviation 0.409
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bilirubin0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.133
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bilirubin0.20 Milligram per deciliter (MG/DL)Standard Deviation 0.276
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bilirubin0.20 Milligram per deciliter (MG/DL)Standard Deviation 0.316
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bilirubin0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.423
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.133
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Bilirubin0.20 Milligram per deciliter (MG/DL)Standard Deviation 0.415
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Direct Bilirubin0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.055
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.082
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Direct Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.098
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.063
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.071
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.063
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Direct Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.098
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Direct Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.098
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: BUN18.8 Milligram per deciliter (MG/DL)Standard Deviation 3.87
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: BUN0.5 Milligram per deciliter (MG/DL)Standard Deviation 7.14
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: BUN2.7 Milligram per deciliter (MG/DL)Standard Deviation 1.63
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: BUN-0.2 Milligram per deciliter (MG/DL)Standard Deviation 5.98
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: BUN1.7 Milligram per deciliter (MG/DL)Standard Deviation 4.27
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: BUN1.3 Milligram per deciliter (MG/DL)Standard Deviation 2.42
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: BUN1.0 Milligram per deciliter (MG/DL)Standard Deviation 3.46
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: BUN0.8 Milligram per deciliter (MG/DL)Standard Deviation 2.93
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: BUN2.3 Milligram per deciliter (MG/DL)Standard Deviation 4.63
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Creatinine0.917 Milligram per deciliter (MG/DL)Standard Deviation 0.1657
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Creatinine0.108 Milligram per deciliter (MG/DL)Standard Deviation 0.1024
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Creatinine0.037 Milligram per deciliter (MG/DL)Standard Deviation 0.0766
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Creatinine0.082 Milligram per deciliter (MG/DL)Standard Deviation 0.1389
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Creatinine0.035 Milligram per deciliter (MG/DL)Standard Deviation 0.0742
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Creatinine0.113 Milligram per deciliter (MG/DL)Standard Deviation 0.1088
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Creatinine0.047 Milligram per deciliter (MG/DL)Standard Deviation 0.1196
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Creatinine0.092 Milligram per deciliter (MG/DL)Standard Deviation 0.0909
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Uric Acid5.77 Milligram per deciliter (MG/DL)Standard Deviation 1.039
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Calcium-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.387
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Calcium0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.488
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Calcium-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.472
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Uric Acid0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.64
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Uric Acid0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.566
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Uric Acid-0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.943
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Uric Acid0.32 Milligram per deciliter (MG/DL)Standard Deviation 0.804
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Uric Acid0.18 Milligram per deciliter (MG/DL)Standard Deviation 0.828
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Uric Acid0.28 Milligram per deciliter (MG/DL)Standard Deviation 0.422
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Uric Acid0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.836
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Uric Acid-0.07 Milligram per deciliter (MG/DL)Standard Deviation 1.143
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Calcium9.60 Milligram per deciliter (MG/DL)Standard Deviation 0.358
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Calcium-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.395
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CL (fasting)-12.5 Milligram per deciliter (MG/DL)Standard Deviation 21.68
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CL (fasting)-11.8 Milligram per deciliter (MG/DL)Standard Deviation 24.34
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Calcium-0.17 Milligram per deciliter (MG/DL)Standard Deviation 0.327
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Calcium0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.509
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Calcium0.23 Milligram per deciliter (MG/DL)Standard Deviation 0.484
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Phosphate3.62 Milligram per deciliter (MG/DL)Standard Deviation 0.637
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Phosphate0.18 Milligram per deciliter (MG/DL)Standard Deviation 0.31
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Phosphate0.25 Milligram per deciliter (MG/DL)Standard Deviation 0.539
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Phosphate0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.512
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Phosphate0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.356
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Phosphate-0.27 Milligram per deciliter (MG/DL)Standard Deviation 0.575
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Phosphate0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.418
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Phosphate0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.521
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Phosphate0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.598
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Glucose90.0 Milligram per deciliter (MG/DL)Standard Deviation 13.97
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Glucose7.0 Milligram per deciliter (MG/DL)Standard Deviation 5.48
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Glucose6.5 Milligram per deciliter (MG/DL)Standard Deviation 15.67
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Glucose7.5 Milligram per deciliter (MG/DL)Standard Deviation 11.47
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Glucose9.2 Milligram per deciliter (MG/DL)Standard Deviation 11.58
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Glucose17.7 Milligram per deciliter (MG/DL)Standard Deviation 7.69
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Glucose12.5 Milligram per deciliter (MG/DL)Standard Deviation 14.79
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Glucose8.5 Milligram per deciliter (MG/DL)Standard Deviation 12.85
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Glucose3.8 Milligram per deciliter (MG/DL)Standard Deviation 15.69
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CL (fasting)196.5 Milligram per deciliter (MG/DL)Standard Deviation 48.19
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CL (fasting)-10.8 Milligram per deciliter (MG/DL)Standard Deviation 12.63
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CL (fasting)1.7 Milligram per deciliter (MG/DL)Standard Deviation 12.89
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CL (fasting)-2.2 Milligram per deciliter (MG/DL)Standard Deviation 10.8
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CL (fasting)0.7 Milligram per deciliter (MG/DL)Standard Deviation 19.05
RN6G 15 mg/kgChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CL (fasting)4.2 Milligram per deciliter (MG/DL)Standard Deviation 10.67
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: BUN-3.5 Milligram per deciliter (MG/DL)Standard Deviation 6.35
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Glucose20.3 Milligram per deciliter (MG/DL)Standard Deviation 50.7
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Calcium-0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.512
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: BUN-0.5 Milligram per deciliter (MG/DL)Standard Deviation 8.87
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: TG (fasting)-58.0 Milligram per deciliter (MG/DL)Standard Deviation 77.36
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Calcium0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.377
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: BUN-1.2 Milligram per deciliter (MG/DL)Standard Deviation 6.76
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: BUN-1.6 Milligram per deciliter (MG/DL)Standard Deviation 5.41
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: TG (fasting)-52.2 Milligram per deciliter (MG/DL)Standard Deviation 151.28
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Phosphate3.28 Milligram per deciliter (MG/DL)Standard Deviation 0.717
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CL (fasting)-7.2 Milligram per deciliter (MG/DL)Standard Deviation 18.86
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Phosphate0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.508
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: BUN-1.0 Milligram per deciliter (MG/DL)Standard Deviation 7.62
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: BUN-3.6 Milligram per deciliter (MG/DL)Standard Deviation 7.02
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CL (fasting)194.2 Milligram per deciliter (MG/DL)Standard Deviation 33.71
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Phosphate0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.598
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: BUN0.0 Milligram per deciliter (MG/DL)Standard Deviation 4.52
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: BUN1.5 Milligram per deciliter (MG/DL)Standard Deviation 3.73
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: TG (fasting)-67.6 Milligram per deciliter (MG/DL)Standard Deviation 84.14
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Phosphate0.12 Milligram per deciliter (MG/DL)Standard Deviation 0.466
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: BUN23.3 Milligram per deciliter (MG/DL)Standard Deviation 8.33
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Direct Bilirubin0.03 Milligram per deciliter (MG/DL)Standard Deviation 0.05
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: TG (fasting)-89.0 Milligram per deciliter (MG/DL)Standard Deviation 146.53
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Phosphate0.38 Milligram per deciliter (MG/DL)Standard Deviation 0.497
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.063
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Direct Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.045
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: lg M-9.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Phosphate0.58 Milligram per deciliter (MG/DL)Standard Deviation 0.554
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Direct Bilirubin0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.045
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CL (fasting)13.3 Milligram per deciliter (MG/DL)Standard Deviation 27.09
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Phosphate0.36 Milligram per deciliter (MG/DL)Standard Deviation 0.581
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Direct Bilirubin0.00 Milligram per deciliter (MG/DL)Standard Deviation 0.071
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: TG (fasting)-98.4 Milligram per deciliter (MG/DL)Standard Deviation 140.73
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Phosphate0.30 Milligram per deciliter (MG/DL)Standard Deviation 0.863
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Direct Bilirubin-0.02 Milligram per deciliter (MG/DL)Standard Deviation 0.041
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: TG (fasting)-49.5 Milligram per deciliter (MG/DL)Standard Deviation 124.64
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Phosphate0.15 Milligram per deciliter (MG/DL)Standard Deviation 0.412
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Direct Bilirubin0.13 Milligram per deciliter (MG/DL)Standard Deviation 0.052
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Bilirubin-0.05 Milligram per deciliter (MG/DL)Standard Deviation 0.1
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: lg M-6.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Glucose95.8 Milligram per deciliter (MG/DL)Standard Deviation 9.99
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bilirubin-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.163
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bilirubin-0.08 Milligram per deciliter (MG/DL)Standard Deviation 0.192
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CL (fasting)8.0 Milligram per deciliter (MG/DL)Standard Deviation 42.82
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Glucose3.3 Milligram per deciliter (MG/DL)Standard Deviation 14.39
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bilirubin-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.158
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bilirubin-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.158
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: TG (fasting)-8.0 Milligram per deciliter (MG/DL)Standard Deviation 37.31
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Glucose0.5 Milligram per deciliter (MG/DL)Standard Deviation 11.04
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bilirubin-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.122
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bilirubin-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.121
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: TG (fasting)195.2 Milligram per deciliter (MG/DL)Standard Deviation 149.85
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Glucose7.8 Milligram per deciliter (MG/DL)Standard Deviation 13.35
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bilirubin-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.126
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bilirubin0.52 Milligram per deciliter (MG/DL)Standard Deviation 0.204
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: lg M58.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Glucose3.6 Milligram per deciliter (MG/DL)Standard Deviation 10.67
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Calcium-0.37 Milligram per deciliter (MG/DL)Standard Deviation 0.301
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: lg A-25.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CL (fasting)-2.4 Milligram per deciliter (MG/DL)Standard Deviation 23.2
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Glucose11.0 Milligram per deciliter (MG/DL)Standard Deviation 14.61
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: lg A299.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: lg G-40.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Uric Acid0.32 Milligram per deciliter (MG/DL)Standard Deviation 0.785
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Uric Acid0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.997
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Uric Acid-0.48 Milligram per deciliter (MG/DL)Standard Deviation 0.487
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: CL (fasting)-1.3 Milligram per deciliter (MG/DL)Standard Deviation 29.34
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Uric Acid0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.779
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Uric Acid-0.07 Milligram per deciliter (MG/DL)Standard Deviation 0.463
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Uric Acid0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.471
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Glucose17.6 Milligram per deciliter (MG/DL)Standard Deviation 32.65
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Uric Acid0.48 Milligram per deciliter (MG/DL)Standard Deviation 0.933
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Calcium-0.26 Milligram per deciliter (MG/DL)Standard Deviation 0.55
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: lg G-30.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Uric Acid-0.10 Milligram per deciliter (MG/DL)Standard Deviation 0.51
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Calcium-0.38 Milligram per deciliter (MG/DL)Standard Deviation 0.396
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Uric Acid5.58 Milligram per deciliter (MG/DL)Standard Deviation 1.238
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: lg G793.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Calcium9.76 Milligram per deciliter (MG/DL)Standard Deviation 0.301
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Creatinine-0.045 Milligram per deciliter (MG/DL)Standard Deviation 0.3023
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Creatinine0.015 Milligram per deciliter (MG/DL)Standard Deviation 0.2118
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CL (fasting)7.2 Milligram per deciliter (MG/DL)Standard Deviation 40.49
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Creatinine-0.018 Milligram per deciliter (MG/DL)Standard Deviation 0.2525
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Calcium-0.22 Milligram per deciliter (MG/DL)Standard Deviation 0.471
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Creatinine0.002 Milligram per deciliter (MG/DL)Standard Deviation 0.1956
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Glucose7.2 Milligram per deciliter (MG/DL)Standard Deviation 28.03
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CL (fasting)13.0 Milligram per deciliter (MG/DL)Standard Deviation 37.9
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Creatinine-0.024 Milligram per deciliter (MG/DL)Standard Deviation 0.1747
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Creatinine-0.038 Milligram per deciliter (MG/DL)Standard Deviation 0.1512
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: TG (fasting)-42.0 Milligram per deciliter (MG/DL)Standard Deviation 168.16
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: lg A-25.0 Milligram per deciliter (MG/DL)
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Calcium-0.16 Milligram per deciliter (MG/DL)Standard Deviation 0.498
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Creatinine-0.013 Milligram per deciliter (MG/DL)Standard Deviation 0.1317
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Creatinine-0.007 Milligram per deciliter (MG/DL)Standard Deviation 0.1371
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CL (fasting)-5.4 Milligram per deciliter (MG/DL)Standard Deviation 33.06
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Calcium-0.30 Milligram per deciliter (MG/DL)Standard Deviation 0.66
PlaceboChange From Baseline in Bilirubin, Direct Bilirubin, Blood Urea Nitrogen, Creatinine, Uric Acid, Calcium, Phosphate, Glucose, Cholesterol, Triglycerides, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Creatinine1.105 Milligram per deciliter (MG/DL)Standard Deviation 0.3136
Secondary

Change From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ET

Time frame: Baseline, 1 and 4 H post-dose on Day 1; pre-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 168, 224 and 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112-1.78 Beats per minuteStandard Deviation 1.559
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 1400.50 Beats per minuteStandard Deviation 2.606
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 12.28 Beats per minuteStandard Deviation 2.752
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 1403.67 Beats per minuteStandard Deviation 5.578
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1402.61 Beats per minuteStandard Deviation 11.432
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET-0.61 Beats per minuteStandard Deviation 5.031
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28-1.78 Beats per minuteStandard Deviation 2.562
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1-0.33 Beats per minuteStandard Deviation 3.026
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 560.39 Beats per minuteStandard Deviation 4.096
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 1682.22 Beats per minuteStandard Deviation 5.419
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 840.22 Beats per minuteStandard Deviation 3.41
RN6G 5 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline64.94 Beats per minuteStandard Deviation 9.318
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline63.17 Beats per minuteStandard Deviation 7.327
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28-0.17 Beats per minuteStandard Deviation 3.475
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET-0.67 Beats per minuteStandard Deviation 4.279
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 1405.11 Beats per minuteStandard Deviation 6.869
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 1121.33 Beats per minuteStandard Deviation 4.58
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 1402.89 Beats per minuteStandard Deviation 5.556
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 1682.00 Beats per minuteStandard Deviation 1.687
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 840.50 Beats per minuteStandard Deviation 3.378
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 561.17 Beats per minuteStandard Deviation 1.81
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1401.17 Beats per minuteStandard Deviation 3.65
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 12.11 Beats per minuteStandard Deviation 5.188
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET-2.50 Beats per minuteStandard Deviation 4.451
RN6G 10 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1-1.67 Beats per minuteStandard Deviation 4.142
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140-3.61 Beats per minuteStandard Deviation 5.752
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline66.06 Beats per minuteStandard Deviation 7.295
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1-5.44 Beats per minuteStandard Deviation 6.527
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1-1.72 Beats per minuteStandard Deviation 8.045
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28-4.39 Beats per minuteStandard Deviation 5.463
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56-4.89 Beats per minuteStandard Deviation 7.29
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84-3.72 Beats per minuteStandard Deviation 6.191
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112-1.89 Beats per minuteStandard Deviation 3.959
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140-1.39 Beats per minuteStandard Deviation 6.591
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140-5.22 Beats per minuteStandard Deviation 6.649
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168-3.56 Beats per minuteStandard Deviation 7.745
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET1.11 Beats per minuteStandard Deviation 7.067
RN6G 15 mg/kgChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET0.94 Beats per minuteStandard Deviation 6.22
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 844.00 Beats per minuteStandard Deviation 12.243
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 1400.47 Beats per minuteStandard Deviation 12.613
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56-1.11 Beats per minuteStandard Deviation 4.617
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28-3.78 Beats per minuteStandard Deviation 5.496
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline65.44 Beats per minuteStandard Deviation 7.556
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 1682.20 Beats per minuteStandard Deviation 5.316
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 14.00 Beats per minuteStandard Deviation 7.226
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 12.72 Beats per minuteStandard Deviation 10.603
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET3.08 Beats per minuteStandard Deviation 9.094
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET-3.44 Beats per minuteStandard Deviation 5.73
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140-2.13 Beats per minuteStandard Deviation 10.038
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 1400.93 Beats per minuteStandard Deviation 3.919
PlaceboChange From Baseline in Heart Rate at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 1123.00 Beats per minuteStandard Deviation 6.342
Secondary

Change From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Following parameters were analyzed for laboratory examination: Aspartate Aminotransferase (AMT), Creatine Kinase (CK), Alanine Aminotransferase (ALT), Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase (LD), Alkaline Phosphatase (AP).

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AST-3.3 international units per liter (IU/L)Standard Deviation 4.27
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CK-0.5 international units per liter (IU/L)Standard Deviation 79.89
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CK-15.3 international units per liter (IU/L)Standard Deviation 12.6
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: ALT-2.0 international units per liter (IU/L)Standard Deviation 4.52
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CK-32.5 international units per liter (IU/L)Standard Deviation 34.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CK-16.7 international units per liter (IU/L)Standard Deviation 28.79
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: LD-3.0 international units per liter (IU/L)Standard Deviation 30.42
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: ALT-3.0 international units per liter (IU/L)Standard Deviation 4.15
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CK-29.3 international units per liter (IU/L)Standard Deviation 24.47
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: GGT-3.3 international units per liter (IU/L)Standard Deviation 3.33
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CK15.0 international units per liter (IU/L)Standard Deviation 43.26
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AP63.5 international units per liter (IU/L)Standard Deviation 20.34
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: ALT8.2 international units per liter (IU/L)Standard Deviation 25.13
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: ALT17.0 international units per liter (IU/L)Standard Deviation 4
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: ALT-1.8 international units per liter (IU/L)Standard Deviation 4.07
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: ALT-0.3 international units per liter (IU/L)Standard Deviation 5.13
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: ALT1.8 international units per liter (IU/L)Standard Deviation 3.54
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AP-1.3 international units per liter (IU/L)Standard Deviation 3.72
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: LD-11.3 international units per liter (IU/L)Standard Deviation 9.4
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: GGT-5.0 international units per liter (IU/L)Standard Deviation 4.52
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AP-2.3 international units per liter (IU/L)Standard Deviation 6.56
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AP-2.3 international units per liter (IU/L)Standard Deviation 8.62
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AST0.2 international units per liter (IU/L)Standard Deviation 5.81
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: GGT-4.5 international units per liter (IU/L)Standard Deviation 5.01
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AP-1.7 international units per liter (IU/L)Standard Deviation 7.17
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: LD-15.7 international units per liter (IU/L)Standard Deviation 13.06
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AP-1.0 international units per liter (IU/L)Standard Deviation 12.12
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: LD-18.0 international units per liter (IU/L)Standard Deviation 6.9
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: GGT-2.2 international units per liter (IU/L)Standard Deviation 6.88
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AP-1.3 international units per liter (IU/L)Standard Deviation 8.36
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AST22.2 international units per liter (IU/L)Standard Deviation 3.13
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AST-1.2 international units per liter (IU/L)Standard Deviation 8.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: GGT-2.0 international units per liter (IU/L)Standard Deviation 4.05
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AST1.3 international units per liter (IU/L)Standard Deviation 3.93
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: LD-17.3 international units per liter (IU/L)Standard Deviation 9.65
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AST-3.5 international units per liter (IU/L)Standard Deviation 2.95
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AST-3.2 international units per liter (IU/L)Standard Deviation 2.64
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: ALT1.0 international units per liter (IU/L)Standard Deviation 3.69
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: GGT-2.3 international units per liter (IU/L)Standard Deviation 3.39
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AST0.3 international units per liter (IU/L)Standard Deviation 4.18
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: LD174.5 international units per liter (IU/L)Standard Deviation 13.4
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: LD-7.5 international units per liter (IU/L)Standard Deviation 18.56
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: GGT-2.7 international units per liter (IU/L)Standard Deviation 2.58
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CK97.2 international units per liter (IU/L)Standard Deviation 40.32
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AP3.3 international units per liter (IU/L)Standard Deviation 9.95
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: GGT22.0 international units per liter (IU/L)Standard Deviation 6.78
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: LD5.7 international units per liter (IU/L)Standard Deviation 27.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CK-26.3 international units per liter (IU/L)Standard Deviation 26.07
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: LD-6.5 international units per liter (IU/L)Standard Deviation 17.56
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: LD-6.0 international units per liter (IU/L)Standard Deviation 13.11
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AP-0.5 international units per liter (IU/L)Standard Deviation 10.84
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: AP-5.8 international units per liter (IU/L)Standard Deviation 14.8
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: GGT-0.8 international units per liter (IU/L)Standard Deviation 4.75
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AST-0.7 international units per liter (IU/L)Standard Deviation 4.27
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AP-6.5 international units per liter (IU/L)Standard Deviation 10.8
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AST-0.5 international units per liter (IU/L)Standard Deviation 2.35
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CK-4.2 international units per liter (IU/L)Standard Deviation 12.48
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AST2.0 international units per liter (IU/L)Standard Deviation 1.67
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: ALT-1.2 international units per liter (IU/L)Standard Deviation 3.54
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: GGT-0.3 international units per liter (IU/L)Standard Deviation 3.93
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CK1.0 international units per liter (IU/L)Standard Deviation 18.22
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: GGT-1.5 international units per liter (IU/L)Standard Deviation 3.39
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: AST-0.5 international units per liter (IU/L)Standard Deviation 1.87
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AP-4.2 international units per liter (IU/L)Standard Deviation 10.61
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CK7.5 international units per liter (IU/L)Standard Deviation 18.73
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: LD-5.2 international units per liter (IU/L)Standard Deviation 15.56
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: ALT-1.8 international units per liter (IU/L)Standard Deviation 3.49
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: LD0.0 international units per liter (IU/L)Standard Deviation 17.42
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CK7.7 international units per liter (IU/L)Standard Deviation 19.71
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: ALT0.3 international units per liter (IU/L)Standard Deviation 1.97
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AST21.2 international units per liter (IU/L)Standard Deviation 1.6
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: LD-10.0 international units per liter (IU/L)Standard Deviation 7.69
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CK16.3 international units per liter (IU/L)Standard Deviation 45.35
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: GGT-0.7 international units per liter (IU/L)Standard Deviation 2.34
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: ALT2.2 international units per liter (IU/L)Standard Deviation 2.48
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: GGT-2.3 international units per liter (IU/L)Standard Deviation 4.32
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CK19.0 international units per liter (IU/L)Standard Deviation 29.14
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AST-1.0 international units per liter (IU/L)Standard Deviation 1.41
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: LD174.7 international units per liter (IU/L)Standard Deviation 25.11
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: CK61.8 international units per liter (IU/L)Standard Deviation 134
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AP72.5 international units per liter (IU/L)Standard Deviation 22.65
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: ALT-1.2 international units per liter (IU/L)Standard Deviation 2.4
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CK0.7 international units per liter (IU/L)Standard Deviation 15.06
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: ALT19.5 international units per liter (IU/L)Standard Deviation 1.64
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: LD-14.5 international units per liter (IU/L)Standard Deviation 9.89
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CK104.8 international units per liter (IU/L)Standard Deviation 74.79
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AST0.0 international units per liter (IU/L)Standard Deviation 0.89
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: ALT0.3 international units per liter (IU/L)Standard Deviation 2.66
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: GGT-2.3 international units per liter (IU/L)Standard Deviation 5.01
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: ALT0.8 international units per liter (IU/L)Standard Deviation 1.6
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: GGT21.5 international units per liter (IU/L)Standard Deviation 8.29
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: GGT-1.3 international units per liter (IU/L)Standard Deviation 3.27
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AP-4.0 international units per liter (IU/L)Standard Deviation 4.43
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: ALT-1.0 international units per liter (IU/L)Standard Deviation 3.46
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AST-0.2 international units per liter (IU/L)Standard Deviation 2.48
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: LD-14.0 international units per liter (IU/L)Standard Deviation 21.95
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AP-4.7 international units per liter (IU/L)Standard Deviation 3.98
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: LD-3.5 international units per liter (IU/L)Standard Deviation 17.93
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: GGT-2.2 international units per liter (IU/L)Standard Deviation 4.71
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AP-6.0 international units per liter (IU/L)Standard Deviation 9.32
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AP-0.8 international units per liter (IU/L)Standard Deviation 6.31
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AST-0.3 international units per liter (IU/L)Standard Deviation 3.14
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: GGT-1.2 international units per liter (IU/L)Standard Deviation 2.48
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AST-5.8 international units per liter (IU/L)Standard Deviation 11.61
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AST-5.2 international units per liter (IU/L)Standard Deviation 9.58
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: LD-1.7 international units per liter (IU/L)Standard Deviation 13.69
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: LD-0.8 international units per liter (IU/L)Standard Deviation 12.72
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: LD-1.0 international units per liter (IU/L)Standard Deviation 15.48
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: LD-2.8 international units per liter (IU/L)Standard Deviation 13.51
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: LD4.8 international units per liter (IU/L)Standard Deviation 18.63
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: LD7.2 international units per liter (IU/L)Standard Deviation 19.22
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AP59.3 international units per liter (IU/L)Standard Deviation 12.72
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AP-6.8 international units per liter (IU/L)Standard Deviation 2.5
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AP-5.3 international units per liter (IU/L)Standard Deviation 9.87
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AP-7.7 international units per liter (IU/L)Standard Deviation 9.67
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AP-6.5 international units per liter (IU/L)Standard Deviation 8.24
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AP-6.5 international units per liter (IU/L)Standard Deviation 8.98
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AP-5.8 international units per liter (IU/L)Standard Deviation 11.25
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AST25.5 international units per liter (IU/L)Standard Deviation 11.38
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AST-6.8 international units per liter (IU/L)Standard Deviation 12.26
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AST-3.7 international units per liter (IU/L)Standard Deviation 10.05
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AST-4.3 international units per liter (IU/L)Standard Deviation 11.02
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AST-6.2 international units per liter (IU/L)Standard Deviation 9.26
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AST-3.8 international units per liter (IU/L)Standard Deviation 11.34
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: AST-3.8 international units per liter (IU/L)Standard Deviation 9.77
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AP-6.2 international units per liter (IU/L)Standard Deviation 10.94
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: AP-3.3 international units per liter (IU/L)Standard Deviation 11.52
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: LD-1.2 international units per liter (IU/L)Standard Deviation 13.51
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CK80.0 international units per liter (IU/L)Standard Deviation 20.21
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CK-7.3 international units per liter (IU/L)Standard Deviation 24.1
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CK12.0 international units per liter (IU/L)Standard Deviation 11.45
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CK7.5 international units per liter (IU/L)Standard Deviation 26.77
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CK2.8 international units per liter (IU/L)Standard Deviation 13.1
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CK0.5 international units per liter (IU/L)Standard Deviation 29.92
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CK21.7 international units per liter (IU/L)Standard Deviation 59.27
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CK77.8 international units per liter (IU/L)Standard Deviation 148.91
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: CK19.0 international units per liter (IU/L)Standard Deviation 31.69
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: ALT24.3 international units per liter (IU/L)Standard Deviation 14.14
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: ALT-11.3 international units per liter (IU/L)Standard Deviation 14.24
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: ALT-6.2 international units per liter (IU/L)Standard Deviation 13.7
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: ALT-6.8 international units per liter (IU/L)Standard Deviation 14.13
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: ALT-7.2 international units per liter (IU/L)Standard Deviation 14.5
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: ALT-6.5 international units per liter (IU/L)Standard Deviation 10.54
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: ALT-8.7 international units per liter (IU/L)Standard Deviation 13.81
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: ALT-6.7 international units per liter (IU/L)Standard Deviation 13.28
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: ALT-6.8 international units per liter (IU/L)Standard Deviation 12.8
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: GGT17.3 international units per liter (IU/L)Standard Deviation 7.37
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: GGT-1.8 international units per liter (IU/L)Standard Deviation 2.06
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: GGT0.5 international units per liter (IU/L)Standard Deviation 2.59
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: GGT-0.7 international units per liter (IU/L)Standard Deviation 4.8
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: GGT-0.2 international units per liter (IU/L)Standard Deviation 2.04
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: GGT-1.3 international units per liter (IU/L)Standard Deviation 2.73
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: GGT0.2 international units per liter (IU/L)Standard Deviation 2.56
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: GGT0.5 international units per liter (IU/L)Standard Deviation 1.97
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: LD166.7 international units per liter (IU/L)Standard Deviation 19.65
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: LD-8.0 international units per liter (IU/L)Standard Deviation 15.47
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: LD0.2 international units per liter (IU/L)Standard Deviation 18.35
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: ALT0.8 international units per liter (IU/L)Standard Deviation 4.55
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: CK9.2 international units per liter (IU/L)Standard Deviation 18.69
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: CK67.5 international units per liter (IU/L)Standard Deviation 26.91
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: LD-4.3 international units per liter (IU/L)Standard Deviation 20.26
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: ALT0.3 international units per liter (IU/L)Standard Deviation 3.44
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: AP9.3 international units per liter (IU/L)Standard Deviation 18.71
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: GGT31.5 international units per liter (IU/L)Standard Deviation 61.07
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: ALT13.8 international units per liter (IU/L)Standard Deviation 25.33
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AP8.8 international units per liter (IU/L)Standard Deviation 9.45
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AP3.4 international units per liter (IU/L)Standard Deviation 5.55
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: LD-1.2 international units per liter (IU/L)Standard Deviation 16.57
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: GGT20.0 international units per liter (IU/L)Standard Deviation 10.32
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: AST7.5 international units per liter (IU/L)Standard Deviation 10.47
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: AST1.8 international units per liter (IU/L)Standard Deviation 2.64
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: LD-6.0 international units per liter (IU/L)Standard Deviation 15.87
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: GGT-0.7 international units per liter (IU/L)Standard Deviation 1.21
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: AST0.6 international units per liter (IU/L)Standard Deviation 3.65
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AST2.5 international units per liter (IU/L)Standard Deviation 7.79
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AST-1.0 international units per liter (IU/L)Standard Deviation 4.64
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: GGT-0.8 international units per liter (IU/L)Standard Deviation 1.17
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AST-1.3 international units per liter (IU/L)Standard Deviation 3.2
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AST19.5 international units per liter (IU/L)Standard Deviation 4.55
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: LD172.0 international units per liter (IU/L)Standard Deviation 20.03
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: GGT-2.0 international units per liter (IU/L)Standard Deviation 4.12
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: AP1.4 international units per liter (IU/L)Standard Deviation 4.51
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AP5.8 international units per liter (IU/L)Standard Deviation 5.12
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AST-0.8 international units per liter (IU/L)Standard Deviation 3.86
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: GGT-1.0 international units per liter (IU/L)Standard Deviation 3.39
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: AP0.2 international units per liter (IU/L)Standard Deviation 5.89
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: AP-0.8 international units per liter (IU/L)Standard Deviation 3.31
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: LD3.3 international units per liter (IU/L)Standard Deviation 25.53
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: GGT0.0 international units per liter (IU/L)Standard Deviation 1.41
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: AP-1.7 international units per liter (IU/L)Standard Deviation 3.78
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: AP69.7 international units per liter (IU/L)Standard Deviation 9.73
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: LD1.2 international units per liter (IU/L)Standard Deviation 8.53
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: GGT0.8 international units per liter (IU/L)Standard Deviation 1.92
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: ALT-0.2 international units per liter (IU/L)Standard Deviation 0.98
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: LD-6.5 international units per liter (IU/L)Standard Deviation 38.66
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: ALT3.3 international units per liter (IU/L)Standard Deviation 11.24
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: ALT17.2 international units per liter (IU/L)Standard Deviation 5.27
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: CK9.5 international units per liter (IU/L)Standard Deviation 8.58
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: LD-4.0 international units per liter (IU/L)Standard Deviation 18.61
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: ALT-2.5 international units per liter (IU/L)Standard Deviation 3.32
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: CK7.5 international units per liter (IU/L)Standard Deviation 9.79
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: CK8.8 international units per liter (IU/L)Standard Deviation 16.16
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: AST-2.2 international units per liter (IU/L)Standard Deviation 2.77
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: ALT-2.2 international units per liter (IU/L)Standard Deviation 3.96
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: CK53.0 international units per liter (IU/L)Standard Deviation 106.5
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: CK-2.0 international units per liter (IU/L)Standard Deviation 19.79
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: GGT1.3 international units per liter (IU/L)Standard Deviation 3.98
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: ALT-1.0 international units per liter (IU/L)Standard Deviation 4.06
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: CK3.2 international units per liter (IU/L)Standard Deviation 14.2
PlaceboChange From Baseline in Laboratory Assessments: Aspartate Aminotransferase, Creatine Kinase, Alanine Aminotransferase, Gamma Glutamyl Transferase (GGT), Lactate Dehydrogenase, Alkaline Phosphatase at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: CK8.7 international units per liter (IU/L)Standard Deviation 15.6
Secondary

Change From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140

Time frame: Baseline, Day 28, 56, 84, 112, 140

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: IL-60.00 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: beta IL-10.32 Picogram per milliliter (pg/ml)Standard Deviation 0.776
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: beta IL-10.00 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: IL-60.00 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: beta IL-10.23 Picogram per milliliter (pg/ml)Standard Deviation 0.572
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: IL-61.84 Picogram per milliliter (pg/ml)Standard Deviation 2.855
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: beta IL-10.40 Picogram per milliliter (pg/ml)Standard Deviation 0.98
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: IL-60.00 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: alpha TNF2.943 Picogram per milliliter (pg/ml)Standard Deviation 1.7942
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: alpha TNF1.175 Picogram per milliliter (pg/ml)Standard Deviation 2.017
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: alpha TNF0.590 Picogram per milliliter (pg/ml)Standard Deviation 2.2536
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: beta IL-10.00 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: alpha TNF1.423 Picogram per milliliter (pg/ml)Standard Deviation 1.2367
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: IL-60.90 Picogram per milliliter (pg/ml)Standard Deviation 1.445
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: alpha TNF1.762 Picogram per milliliter (pg/ml)Standard Deviation 1.5999
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: alpha TNF1.512 Picogram per milliliter (pg/ml)Standard Deviation 1.4736
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: beta IL-10.00 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: IL-60.67 Picogram per milliliter (pg/ml)Standard Deviation 1.633
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: IL-61.22 Picogram per milliliter (pg/ml)Standard Deviation 1.354
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: IL-60.90 Picogram per milliliter (pg/ml)Standard Deviation 3.366
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: IL-6-0.05 Picogram per milliliter (pg/ml)Standard Deviation 2.002
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: IL-6-1.22 Picogram per milliliter (pg/ml)Standard Deviation 1.354
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: IL-61.50 Picogram per milliliter (pg/ml)Standard Deviation 2.386
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: IL-6-1.22 Picogram per milliliter (pg/ml)Standard Deviation 1.354
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: IL-60.10 Picogram per milliliter (pg/ml)Standard Deviation 3.186
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: IL-61.23 Picogram per milliliter (pg/ml)Standard Deviation 4.19
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: IL-60.62 Picogram per milliliter (pg/ml)Standard Deviation 1.511
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: IL-63.38 Picogram per milliliter (pg/ml)Standard Deviation 5.754
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: IL-6-0.05 Picogram per milliliter (pg/ml)Standard Deviation 2.247
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: IL-6-0.62 Picogram per milliliter (pg/ml)Standard Deviation 1.511
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: INF (Gamma)0.0 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: beta IL-10.00 Picogram per milliliter (pg/ml)Standard Deviation 0
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: beta IL-10.00 Picogram per milliliter (pg/ml)Standard Deviation 0
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: beta IL-10.00 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: beta IL-10.00 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: beta IL-10.00 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: beta IL-10.00 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: IL-60.52 Picogram per milliliter (pg/ml)Standard Deviation 1.163
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: IL-60.34 Picogram per milliliter (pg/ml)Standard Deviation 0.76
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: IL-60.20 Picogram per milliliter (pg/ml)Standard Deviation 0.4
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: IL-60.50 Picogram per milliliter (pg/ml)Standard Deviation 1
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: IL-60.55 Picogram per milliliter (pg/ml)Standard Deviation 1.168
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: IL-61.63 Picogram per milliliter (pg/ml)Standard Deviation 1.95
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: alpha TNF3.185 Picogram per milliliter (pg/ml)Standard Deviation 1.2657
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: alpha TNF-1.425 Picogram per milliliter (pg/ml)Standard Deviation 1.2233
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: alpha TNF0.790 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: alpha TNF0.520 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: alpha TNF1.140 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 140: alpha TNF1.220 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Baseline: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 28: INF (Gamma)0.0 Picogram per milliliter (pg/ml)Standard Deviation 0
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 56: INF (Gamma)0.0 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 84: INF (Gamma)0.0 Picogram per milliliter (pg/ml)
PlaceboChange From Baseline in Laboratory Assessments: Beta Interleukin-1, Interleukin-6, Alpha Tumor Necrosis Factor, Interferon (Gamma) at Day 28, 56, 84, 112, 140Change at Day 112: INF (Gamma)0.0 Picogram per milliliter (pg/ml)
Secondary

Change From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140

Time frame: Baseline, Day 28, 56, 84, 112, 140

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Baseline: C4D2.692 Microgram per milliliter (mcg/mL)Standard Deviation 1.5264
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 28: C4D1.078 Microgram per milliliter (mcg/mL)Standard Deviation 4.3643
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 56: C4D-1.503 Microgram per milliliter (mcg/mL)Standard Deviation 1.4911
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 84: C4D-0.907 Microgram per milliliter (mcg/mL)Standard Deviation 1.6772
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 112: C4D-0.466 Microgram per milliliter (mcg/mL)Standard Deviation 1.6322
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 140: C4D-0.338 Microgram per milliliter (mcg/mL)Standard Deviation 1.679
PlaceboChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 112: C4D1.060 Microgram per milliliter (mcg/mL)
PlaceboChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Baseline: C4D3.720 Microgram per milliliter (mcg/mL)Standard Deviation 2.291
PlaceboChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 84: C4D1.180 Microgram per milliliter (mcg/mL)
PlaceboChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 28: C4D-1.720 Microgram per milliliter (mcg/mL)Standard Deviation 1.0748
PlaceboChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 140: C4D0.140 Microgram per milliliter (mcg/mL)
PlaceboChange From Baseline in Laboratory Assessments: Cluster of Differentiation 4 (C4D) at Day 28, 56, 84, 112, 140Change at Day 56: C4D-1.320 Microgram per milliliter (mcg/mL)
Secondary

Change From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140

Time frame: Baseline, Day 28, 56, 84, 112, 140

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C5B-9-9.8 Nanogram per milliliter (ng/mL)Standard Deviation 152.15
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C5B-9-36.8 Nanogram per milliliter (ng/mL)Standard Deviation 69.42
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C5B-9-33.5 Nanogram per milliliter (ng/mL)Standard Deviation 83.69
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C3A970.3 Nanogram per milliliter (ng/mL)Standard Deviation 214.77
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C5B-9-78.0 Nanogram per milliliter (ng/mL)Standard Deviation 47.76
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C3A )404.7 Nanogram per milliliter (ng/mL)Standard Deviation 280.7
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C3A380.3 Nanogram per milliliter (ng/mL)Standard Deviation 341.07
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C3A560.2 Nanogram per milliliter (ng/mL)Standard Deviation 1109.51
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C5B-9-35.8 Nanogram per milliliter (ng/mL)Standard Deviation 63.01
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C3A445.2 Nanogram per milliliter (ng/mL)Standard Deviation 465.87
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C3A297.8 Nanogram per milliliter (ng/mL)Standard Deviation 508.62
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C5B-9289.5 Nanogram per milliliter (ng/mL)Standard Deviation 56.64
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C3A447.5 Nanogram per milliliter (ng/mL)Standard Deviation 457.21
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C5B-9199.8 Nanogram per milliliter (ng/mL)Standard Deviation 16.87
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C3A290.2 Nanogram per milliliter (ng/mL)Standard Deviation 414.07
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C5B-911.3 Nanogram per milliliter (ng/mL)Standard Deviation 59.09
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C5B-916.6 Nanogram per milliliter (ng/mL)Standard Deviation 105.2
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C5B-9-26.2 Nanogram per milliliter (ng/mL)Standard Deviation 44.51
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C3A928.0 Nanogram per milliliter (ng/mL)Standard Deviation 228.37
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C3A928.6 Nanogram per milliliter (ng/mL)Standard Deviation 398.79
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C3A246.0 Nanogram per milliliter (ng/mL)Standard Deviation 337.86
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C3A )221.0 Nanogram per milliliter (ng/mL)Standard Deviation 202.67
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C5B-9-10.2 Nanogram per milliliter (ng/mL)Standard Deviation 123.29
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C5B-9-15.3 Nanogram per milliliter (ng/mL)Standard Deviation 36.68
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C5B-9-63.0 Nanogram per milliliter (ng/mL)Standard Deviation 131.56
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C3A1465.8 Nanogram per milliliter (ng/mL)Standard Deviation 352.95
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C3A161.3 Nanogram per milliliter (ng/mL)Standard Deviation 523.83
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C3A )-74.5 Nanogram per milliliter (ng/mL)Standard Deviation 723.41
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C3A-610.3 Nanogram per milliliter (ng/mL)Standard Deviation 425.31
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C3A-129.5 Nanogram per milliliter (ng/mL)Standard Deviation 454.93
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C3A-68.3 Nanogram per milliliter (ng/mL)Standard Deviation 543.15
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C5B-9244.3 Nanogram per milliliter (ng/mL)Standard Deviation 132.87
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C5B-90.0 Nanogram per milliliter (ng/mL)Standard Deviation 50.73
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C5B-934.5 Nanogram per milliliter (ng/mL)Standard Deviation 102.8
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C5B-951.8 Nanogram per milliliter (ng/mL)Standard Deviation 106.84
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C5B-9-13.3 Nanogram per milliliter (ng/mL)Standard Deviation 98.95
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C3A-32.2 Nanogram per milliliter (ng/mL)Standard Deviation 846.33
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C3A746.2 Nanogram per milliliter (ng/mL)Standard Deviation 1686.03
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C3A1813.0 Nanogram per milliliter (ng/mL)Standard Deviation 1060.66
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C5B-94.8 Nanogram per milliliter (ng/mL)Standard Deviation 86.14
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 84: C3A117.0 Nanogram per milliliter (ng/mL)Standard Deviation 826.44
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C3A )-220.6 Nanogram per milliliter (ng/mL)Standard Deviation 231.43
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 140: C5B-9-30.2 Nanogram per milliliter (ng/mL)Standard Deviation 74.25
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 112: C5B-942.6 Nanogram per milliliter (ng/mL)Standard Deviation 99.64
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C5B-9-85.5 Nanogram per milliliter (ng/mL)Standard Deviation 87.54
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Baseline: C5B-9299.7 Nanogram per milliliter (ng/mL)Standard Deviation 154.14
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 28: C3A-305.3 Nanogram per milliliter (ng/mL)Standard Deviation 899.05
PlaceboChange From Baseline in Laboratory Assessments: Component of Complement (C3A, C5B-9) at Day 28, 56, 84, 112, 140Change at Day 56: C5B-9-8.0 Nanogram per milliliter (ng/mL)Standard Deviation 109.9
Secondary

Change From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Following hematology parameters were analyzed for laboratory examination: Hemoglobin, Hematocrit, Red blood cell (RBC) count, Platelet count, WBC count, Total neutrophils (Abs),Eosinophils (Abs),Monocytes (Abs),Basophils (Abs), Lymphocytes (Abs).

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hematocrit-0.25 Percentage of RBCs to total blood volumeStandard Deviation 1.545
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hematocrit-1.47 Percentage of RBCs to total blood volumeStandard Deviation 1.48
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hematocrit0.07 Percentage of RBCs to total blood volumeStandard Deviation 2.272
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hematocrit-0.53 Percentage of RBCs to total blood volumeStandard Deviation 1.458
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hematocrit-1.18 Percentage of RBCs to total blood volumeStandard Deviation 1.161
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hematocrit-0.30 Percentage of RBCs to total blood volumeStandard Deviation 1.611
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hematocrit-0.60 Percentage of RBCs to total blood volumeStandard Deviation 1.797
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hematocrit41.70 Percentage of RBCs to total blood volumeStandard Deviation 3.906
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hematocrit0.08 Percentage of RBCs to total blood volumeStandard Deviation 2.464
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hematocrit41.28 Percentage of RBCs to total blood volumeStandard Deviation 2.436
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hematocrit-0.67 Percentage of RBCs to total blood volumeStandard Deviation 0.864
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hematocrit-1.68 Percentage of RBCs to total blood volumeStandard Deviation 0.823
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hematocrit0.56 Percentage of RBCs to total blood volumeStandard Deviation 1.593
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hematocrit0.53 Percentage of RBCs to total blood volumeStandard Deviation 1.28
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hematocrit0.05 Percentage of RBCs to total blood volumeStandard Deviation 1.294
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hematocrit1.50 Percentage of RBCs to total blood volumeStandard Deviation 1.745
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Hematocrit2.07 Percentage of RBCs to total blood volumeStandard Deviation 3.841
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hematocrit0.90 Percentage of RBCs to total blood volumeStandard Deviation 0.876
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hematocrit-0.34 Percentage of RBCs to total blood volumeStandard Deviation 3.14
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hematocrit-1.28 Percentage of RBCs to total blood volumeStandard Deviation 3.342
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hematocrit-0.78 Percentage of RBCs to total blood volumeStandard Deviation 2.92
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hematocrit-1.20 Percentage of RBCs to total blood volumeStandard Deviation 3.251
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hematocrit40.78 Percentage of RBCs to total blood volumeStandard Deviation 2.927
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Hematocrit0.23 Percentage of RBCs to total blood volumeStandard Deviation 2.007
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hematocrit1.15 Percentage of RBCs to total blood volumeStandard Deviation 2.393
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hematocrit1.25 Percentage of RBCs to total blood volumeStandard Deviation 1.714
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hematocrit-1.35 Percentage of RBCs to total blood volumeStandard Deviation 2.914
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hematocrit-1.26 Percentage of RBCs to total blood volumeStandard Deviation 0.73
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hematocrit-2.18 Percentage of RBCs to total blood volumeStandard Deviation 1.847
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hematocrit-1.85 Percentage of RBCs to total blood volumeStandard Deviation 1.771
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hematocrit0.22 Percentage of RBCs to total blood volumeStandard Deviation 2.845
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hematocrit-1.73 Percentage of RBCs to total blood volumeStandard Deviation 1.866
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hematocrit-1.30 Percentage of RBCs to total blood volumeStandard Deviation 1.687
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hematocrit40.87 Percentage of RBCs to total blood volumeStandard Deviation 5.369
PlaceboChange From Baseline in Laboratory Assessments: Hematocrit at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Hematocrit-1.10 Percentage of RBCs to total blood volumeStandard Deviation 5.412
Secondary

Change From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Monocytes (abs)0.522 10^3 cells/microliterStandard Deviation 0.1622
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Eosinophils (abs)-0.008 10^3 cells/microliterStandard Deviation 0.0685
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Eosinophils (abs)-0.007 10^3 cells/microliterStandard Deviation 0.0547
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: WBC-0.08 10^3 cells/microliterStandard Deviation 1.28
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Platelets13.5 10^3 cells/microliterStandard Deviation 21.19
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Eosinophils (abs)-0.002 10^3 cells/microliterStandard Deviation 0.0898
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Eosinophils (abs)0.012 10^3 cells/microliterStandard Deviation 0.0638
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: WBC0.35 10^3 cells/microliterStandard Deviation 1.693
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Monocytes (abs)-0.023 10^3 cells/microliterStandard Deviation 0.1649
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Eosinophils (abs)0.212 10^3 cells/microliterStandard Deviation 0.1298
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Neutrophils(abs)0.413 10^3 cells/microliterStandard Deviation 1.3356
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Lymphocytes(abs)-0.025 10^3 cells/microliterStandard Deviation 0.3961
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Neutrophils (abs)0.137 10^3 cells/microliterStandard Deviation 0.9677
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Neutrophils (abs)-0.348 10^3 cells/microliterStandard Deviation 1.1549
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Neutrophils (abs)3.508 10^3 cells/microliterStandard Deviation 1.4359
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Lymphocytes (abs)-0.173 10^3 cells/microliterStandard Deviation 0.2486
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Neutrophils (abs)0.043 10^3 cells/microliterStandard Deviation 0.8887
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Neutrophils (abs)0.405 10^3 cells/microliterStandard Deviation 1.3205
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Neutrophils (abs)0.154 10^3 cells/microliterStandard Deviation 0.8442
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Platelets5.2 10^3 cells/microliterStandard Deviation 20.97
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Neutrophils (abs)0.237 10^3 cells/microliterStandard Deviation 1.1972
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Monocytes (abs)-0.020 10^3 cells/microliterStandard Deviation 0.1753
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Lymphocytes (abs)0.012 10^3 cells/microliterStandard Deviation 0.2175
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Lymphocytes (abs)0.023 10^3 cells/microliterStandard Deviation 0.2299
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Platelets4.5 10^3 cells/microliterStandard Deviation 26.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Monocytes (abs)0.000 10^3 cells/microliterStandard Deviation 0.0701
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Lymphocytes (abs)-0.063 10^3 cells/microliterStandard Deviation 0.1973
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Platelets187.5 10^3 cells/microliterStandard Deviation 50.91
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Platelets5.4 10^3 cells/microliterStandard Deviation 9.56
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Platelets-1.0 10^3 cells/microliterStandard Deviation 15.38
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Lymphocytes (abs)-0.042 10^3 cells/microliterStandard Deviation 0.1594
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Lymphocytes (abs)-0.160 10^3 cells/microliterStandard Deviation 0.2853
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Monocytes (abs)-0.005 10^3 cells/microliterStandard Deviation 0.1566
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Lymphocytes (abs)1.470 10^3 cells/microliterStandard Deviation 0.3329
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Basophils (abs)-0.008 10^3 cells/microliterStandard Deviation 0.0147
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: WBC5.75 10^3 cells/microliterStandard Deviation 1.744
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Monocytes (abs)-0.040 10^3 cells/microliterStandard Deviation 0.1185
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Basophils (abs)0.005 10^3 cells/microliterStandard Deviation 0.0266
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Basophils (abs)0.003 10^3 cells/microliterStandard Deviation 0.0137
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: WBC-0.02 10^3 cells/microliterStandard Deviation 1.163
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Monocytes (abs)-0.043 10^3 cells/microliterStandard Deviation 0.1229
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Basophils (abs)0.003 10^3 cells/microliterStandard Deviation 0.0103
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Basophils (abs)0.007 10^3 cells/microliterStandard Deviation 0.0175
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: WBC0.15 10^3 cells/microliterStandard Deviation 1.104
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Platelets-0.6 10^3 cells/microliterStandard Deviation 14.17
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Basophils (abs)0.003 10^3 cells/microliterStandard Deviation 0.0137
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Basophils (abs)0.014 10^3 cells/microliterStandard Deviation 0.0358
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: WBC0.30 10^3 cells/microliterStandard Deviation 1.41
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Platelets1.2 10^3 cells/microliterStandard Deviation 13.55
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Basophils (abs)0.032 10^3 cells/microliterStandard Deviation 0.0133
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Eosinophils(abs)-0.015 10^3 cells/microliterStandard Deviation 0.074
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: WBC0.05 10^3 cells/microliterStandard Deviation 1.048
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Monocytes (abs)-0.034 10^3 cells/microliterStandard Deviation 0.1826
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Eosinophils (abs)-0.042 10^3 cells/microliterStandard Deviation 0.0786
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Eosinophils (abs)0.028 10^3 cells/microliterStandard Deviation 0.0567
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: WBC-0.33 10^3 cells/microliterStandard Deviation 1.414
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Lymphocytes (abs)-0.190 10^3 cells/microliterStandard Deviation 0.2155
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Platelets209.3 10^3 cells/microliterStandard Deviation 39.52
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Platelets-10.7 10^3 cells/microliterStandard Deviation 21.99
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Platelets-14.4 10^3 cells/microliterStandard Deviation 24.27
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Platelets4.0 10^3 cells/microliterStandard Deviation 22.9
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Platelets-3.5 10^3 cells/microliterStandard Deviation 31.05
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Platelets-12.2 10^3 cells/microliterStandard Deviation 16.8
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Platelets-1.2 10^3 cells/microliterStandard Deviation 28.49
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Platelets-5.5 10^3 cells/microliterStandard Deviation 27.29
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Platelets-11.8 10^3 cells/microliterStandard Deviation 30.33
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: WBC6.08 10^3 cells/microliterStandard Deviation 1.023
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: WBC-0.40 10^3 cells/microliterStandard Deviation 0.839
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: WBC-0.42 10^3 cells/microliterStandard Deviation 0.676
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: WBC-0.28 10^3 cells/microliterStandard Deviation 1.326
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: WBC0.32 10^3 cells/microliterStandard Deviation 1.341
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: WBC0.03 10^3 cells/microliterStandard Deviation 1.166
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: WBC-0.13 10^3 cells/microliterStandard Deviation 1.657
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: WBC-0.42 10^3 cells/microliterStandard Deviation 0.882
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: WBC-0.18 10^3 cells/microliterStandard Deviation 1.743
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Neutrophils (abs)3.813 10^3 cells/microliterStandard Deviation 1.1002
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Neutrophils (abs)-0.320 10^3 cells/microliterStandard Deviation 0.7102
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Neutrophils (abs)-0.226 10^3 cells/microliterStandard Deviation 0.7418
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Neutrophils (abs)-0.062 10^3 cells/microliterStandard Deviation 0.9878
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Neutrophils (abs)0.455 10^3 cells/microliterStandard Deviation 1.2804
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Neutrophils (abs)0.260 10^3 cells/microliterStandard Deviation 1.1844
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Neutrophils (abs)0.092 10^3 cells/microliterStandard Deviation 1.5919
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Neutrophils(abs)-0.188 10^3 cells/microliterStandard Deviation 0.7241
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Neutrophils(abs)-0.035 10^3 cells/microliterStandard Deviation 1.3786
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Eosinophils (abs)0.242 10^3 cells/microliterStandard Deviation 0.0823
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Eosinophils (abs)0.020 10^3 cells/microliterStandard Deviation 0.0994
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Eosinophils (abs)0.012 10^3 cells/microliterStandard Deviation 0.1215
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Eosinophils (abs)0.074 10^3 cells/microliterStandard Deviation 0.0832
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Eosinophils (abs)0.053 10^3 cells/microliterStandard Deviation 0.1285
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Eosinophils (abs)-0.005 10^3 cells/microliterStandard Deviation 0.0892
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Eosinophils (abs)0.012 10^3 cells/microliterStandard Deviation 0.0467
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Eosinophils(abs)0.002 10^3 cells/microliterStandard Deviation 0.083
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Eosinophils(abs)-0.010 10^3 cells/microliterStandard Deviation 0.1122
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Basophils (abs)0.048 10^3 cells/microliterStandard Deviation 0.0371
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Basophils (abs)-0.012 10^3 cells/microliterStandard Deviation 0.0549
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Basophils (abs)-0.016 10^3 cells/microliterStandard Deviation 0.0611
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Basophils (abs)-0.014 10^3 cells/microliterStandard Deviation 0.0404
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Basophils (abs)-0.022 10^3 cells/microliterStandard Deviation 0.0422
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Basophils (abs)-0.027 10^3 cells/microliterStandard Deviation 0.0344
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Basophils (abs)-0.025 10^3 cells/microliterStandard Deviation 0.0378
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Basophils (abs)-0.027 10^3 cells/microliterStandard Deviation 0.0294
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Basophils (abs)-0.028 10^3 cells/microliterStandard Deviation 0.0223
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Lymphocytes (abs)1.528 10^3 cells/microliterStandard Deviation 0.3669
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Lymphocytes (abs)-0.088 10^3 cells/microliterStandard Deviation 0.2491
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Lymphocytes (abs)-0.256 10^3 cells/microliterStandard Deviation 0.4282
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Lymphocytes (abs)-0.145 10^3 cells/microliterStandard Deviation 0.3142
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Lymphocytes (abs)-0.188 10^3 cells/microliterStandard Deviation 0.2584
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Lymphocytes (abs)-0.192 10^3 cells/microliterStandard Deviation 0.1985
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Lymphocytes(abs)-0.200 10^3 cells/microliterStandard Deviation 0.1579
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Lymphocytes(abs)-0.128 10^3 cells/microliterStandard Deviation 0.2971
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Monocytes (abs)0.455 10^3 cells/microliterStandard Deviation 0.144
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Monocytes (abs)-0.033 10^3 cells/microliterStandard Deviation 0.0898
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Monocytes (abs)-0.020 10^3 cells/microliterStandard Deviation 0.0265
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Monocytes (abs)-0.022 10^3 cells/microliterStandard Deviation 0.0991
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Monocytes (abs)-0.017 10^3 cells/microliterStandard Deviation 0.1061
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Monocytes (abs)-0.013 10^3 cells/microliterStandard Deviation 0.1058
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Monocytes (abs)-0.017 10^3 cells/microliterStandard Deviation 0.1216
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Monocytes (abs)-0.025 10^3 cells/microliterStandard Deviation 0.1154
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Monocytes (abs)0.012 10^3 cells/microliterStandard Deviation 0.162
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Eosinophils (abs)-0.008 10^3 cells/microliterStandard Deviation 0.0643
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Platelets19.3 10^3 cells/microliterStandard Deviation 30.32
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Basophils (abs)0.008 10^3 cells/microliterStandard Deviation 0.0214
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Lymphocytes (abs)0.023 10^3 cells/microliterStandard Deviation 0.2467
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Eosinophils(abs)-0.057 10^3 cells/microliterStandard Deviation 0.0831
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Platelets5.2 10^3 cells/microliterStandard Deviation 13.52
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Platelets-7.0 10^3 cells/microliterStandard Deviation 22.3
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Lymphocytes (abs)-0.090 10^3 cells/microliterStandard Deviation 0.1452
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: WBC-0.87 10^3 cells/microliterStandard Deviation 1.571
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Platelets9.3 10^3 cells/microliterStandard Deviation 14.49
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Basophils (abs)-0.008 10^3 cells/microliterStandard Deviation 0.0204
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Lymphocytes (abs)-0.303 10^3 cells/microliterStandard Deviation 0.2717
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: WBC-0.35 10^3 cells/microliterStandard Deviation 1.417
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Platelets-2.7 10^3 cells/microliterStandard Deviation 41.86
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Monocytes (abs)-0.177 10^3 cells/microliterStandard Deviation 0.2366
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Lymphocytes (abs)-0.293 10^3 cells/microliterStandard Deviation 0.0907
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: WBC-0.54 10^3 cells/microliterStandard Deviation 0.783
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Monocytes (abs)-0.017 10^3 cells/microliterStandard Deviation 0.1188
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Basophils (abs)0.008 10^3 cells/microliterStandard Deviation 0.0194
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Lymphocytes (abs)-0.192 10^3 cells/microliterStandard Deviation 0.2218
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Eosinophils(abs)-0.010 10^3 cells/microliterStandard Deviation 0.0447
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Monocytes (abs)-0.084 10^3 cells/microliterStandard Deviation 0.0899
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Neutrophils (abs)-0.264 10^3 cells/microliterStandard Deviation 0.4348
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Platelets27.3 10^3 cells/microliterStandard Deviation 55.97
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Neutrophils (abs)-0.007 10^3 cells/microliterStandard Deviation 0.4337
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Monocytes (abs)-0.102 10^3 cells/microliterStandard Deviation 0.07
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Basophils (abs)-0.003 10^3 cells/microliterStandard Deviation 0.0225
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: WBC-0.33 10^3 cells/microliterStandard Deviation 0.463
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Neutrophils (abs)-0.100 10^3 cells/microliterStandard Deviation 0.3685
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: WBC6.17 10^3 cells/microliterStandard Deviation 1.334
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Neutrophils (abs)3.637 10^3 cells/microliterStandard Deviation 0.843
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Lymphocytes(abs)-0.048 10^3 cells/microliterStandard Deviation 0.2303
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Neutrophils (abs)0.218 10^3 cells/microliterStandard Deviation 1.3491
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Platelets198.7 10^3 cells/microliterStandard Deviation 57.3
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Basophils (abs)-0.007 10^3 cells/microliterStandard Deviation 0.0225
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Basophils (abs)0.032 10^3 cells/microliterStandard Deviation 0.0214
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Neutrophils (abs)-0.313 10^3 cells/microliterStandard Deviation 1.3322
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Eosinophils (abs)-0.082 10^3 cells/microliterStandard Deviation 0.0891
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: WBC0.60 10^3 cells/microliterStandard Deviation 2.199
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Platelets-1.0 10^3 cells/microliterStandard Deviation 11.54
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Neutrophils (abs)-0.398 10^3 cells/microliterStandard Deviation 0.3572
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Basophils (abs)0.007 10^3 cells/microliterStandard Deviation 0.0378
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Monocytes (abs)-0.095 10^3 cells/microliterStandard Deviation 0.0517
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Lymphocytes(abs)-0.180 10^3 cells/microliterStandard Deviation 0.36
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Neutrophils(abs)0.088 10^3 cells/microliterStandard Deviation 0.4068
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Monocytes (abs)-0.077 10^3 cells/microliterStandard Deviation 0.0789
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Basophils (abs)-0.012 10^3 cells/microliterStandard Deviation 0.0256
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Neutrophils(abs)0.838 10^3 cells/microliterStandard Deviation 1.8792
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Basophils (abs)0.002 10^3 cells/microliterStandard Deviation 0.0349
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: WBC-0.10 10^3 cells/microliterStandard Deviation 0.395
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Platelets15.5 10^3 cells/microliterStandard Deviation 16.36
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Eosinophils (abs)0.208 10^3 cells/microliterStandard Deviation 0.1338
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Monocytes (abs)-0.203 10^3 cells/microliterStandard Deviation 0.1183
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Lymphocytes (abs)1.748 10^3 cells/microliterStandard Deviation 0.4477
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Monocytes (abs)-0.128 10^3 cells/microliterStandard Deviation 0.0781
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Eosinophils (abs)0.012 10^3 cells/microliterStandard Deviation 0.0676
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Eosinophils (abs)-0.045 10^3 cells/microliterStandard Deviation 0.0547
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: WBC-0.82 10^3 cells/microliterStandard Deviation 0.454
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Monocytes (abs)0.525 10^3 cells/microliterStandard Deviation 0.1169
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Eosinophils (abs)0.017 10^3 cells/microliterStandard Deviation 0.0909
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: WBC-0.07 10^3 cells/microliterStandard Deviation 0.579
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Eosinophils (abs)-0.078 10^3 cells/microliterStandard Deviation 0.0652
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Lymphocytes (abs)-0.198 10^3 cells/microliterStandard Deviation 0.1997
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Lymphocytes (abs)-0.197 10^3 cells/microliterStandard Deviation 0.376
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Eosinophils (abs)0.043 10^3 cells/microliterStandard Deviation 0.0842
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Eosinophils (abs)0.058 10^3 cells/microliterStandard Deviation 0.1003
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: WBC-0.76 10^3 cells/microliterStandard Deviation 1.408
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Monocytes (abs)-0.080 10^3 cells/microliterStandard Deviation 0.0718
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Eosinophils (abs)0.032 10^3 cells/microliterStandard Deviation 0.075
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Eosinophils (abs)0.030 10^3 cells/microliterStandard Deviation 0.0903
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: WBC-1.08 10^3 cells/microliterStandard Deviation 1.721
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Monocytes (abs)-0.127 10^3 cells/microliterStandard Deviation 0.1488
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Eosinophils(abs)0.076 10^3 cells/microliterStandard Deviation 0.1328
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Platelets-3.2 10^3 cells/microliterStandard Deviation 18.85
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Eosinophils(abs)0.075 10^3 cells/microliterStandard Deviation 0.1318
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Basophils (abs)0.030 10^3 cells/microliterStandard Deviation 0.02
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: WBC-1.75 10^3 cells/microliterStandard Deviation 1.26
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Basophils (abs)-0.003 10^3 cells/microliterStandard Deviation 0.0258
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Monocytes (abs)-0.133 10^3 cells/microliterStandard Deviation 0.1402
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Basophils (abs)-0.005 10^3 cells/microliterStandard Deviation 0.0176
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: WBC-1.02 10^3 cells/microliterStandard Deviation 1.88
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Basophils (abs)0.000 10^3 cells/microliterStandard Deviation 0.0216
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Basophils (abs)0.002 10^3 cells/microliterStandard Deviation 0.0217
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: WBC7.40 10^3 cells/microliterStandard Deviation 2.497
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Basophils (abs)0.000 10^3 cells/microliterStandard Deviation 0.0265
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Monocytes (abs)-0.100 10^3 cells/microliterStandard Deviation 0.0702
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Basophils (abs)0.022 10^3 cells/microliterStandard Deviation 0.0363
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Platelets6.0 10^3 cells/microliterStandard Deviation 37.05
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Platelets0.7 10^3 cells/microliterStandard Deviation 17.19
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Basophils (abs)0.012 10^3 cells/microliterStandard Deviation 0.0179
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Basophils (abs)0.010 10^3 cells/microliterStandard Deviation 0.0082
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Lymphocytes (abs)1.598 10^3 cells/microliterStandard Deviation 0.381
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Platelets0.2 10^3 cells/microliterStandard Deviation 24.77
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Monocytes (abs)-0.090 10^3 cells/microliterStandard Deviation 0.062
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Platelets-2.0 10^3 cells/microliterStandard Deviation 35.94
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Lymphocytes (abs)-0.273 10^3 cells/microliterStandard Deviation 0.3223
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Lymphocytes (abs)-0.108 10^3 cells/microliterStandard Deviation 0.0171
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Platelets-2.0 10^3 cells/microliterStandard Deviation 17.72
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Monocytes (abs)-0.080 10^3 cells/microliterStandard Deviation 0.1259
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Lymphocytes (abs)-0.238 10^3 cells/microliterStandard Deviation 0.3872
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Lymphocytes (abs)-0.084 10^3 cells/microliterStandard Deviation 0.4824
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Platelets10.4 10^3 cells/microliterStandard Deviation 29.95
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Monocytes (abs)-0.068 10^3 cells/microliterStandard Deviation 0.1283
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Lymphocytes (abs)-0.152 10^3 cells/microliterStandard Deviation 0.5413
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Neutrophils (abs)-0.730 10^3 cells/microliterStandard Deviation 1.9961
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Neutrophils (abs)-1.342 10^3 cells/microliterStandard Deviation 1.2706
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Neutrophils (abs)5.077 10^3 cells/microliterStandard Deviation 2.3807
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Platelets204.2 10^3 cells/microliterStandard Deviation 51.86
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Neutrophils (abs)-0.925 10^3 cells/microliterStandard Deviation 1.7647
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Neutrophils (abs)-0.502 10^3 cells/microliterStandard Deviation 1.5264
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: WBC-0.98 10^3 cells/microliterStandard Deviation 1.513
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Lymphocytes(abs)0.118 10^3 cells/microliterStandard Deviation 0.3841
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Neutrophils (abs)-0.968 10^3 cells/microliterStandard Deviation 1.641
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Monocytes (abs)-0.065 10^3 cells/microliterStandard Deviation 0.0915
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Neutrophils (abs)-0.020 10^3 cells/microliterStandard Deviation 1.9093
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: WBC-0.82 10^3 cells/microliterStandard Deviation 1.329
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Neutrophils(abs)-0.972 10^3 cells/microliterStandard Deviation 1.1744
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Lymphocytes(abs)-0.180 10^3 cells/microliterStandard Deviation 0.1911
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Neutrophils(abs)-0.815 10^3 cells/microliterStandard Deviation 1.3199
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Platelets9.8 10^3 cells/microliterStandard Deviation 31.96
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Eosinophils (abs)0.162 10^3 cells/microliterStandard Deviation 0.1005
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: WBC-0.16 10^3 cells/microliterStandard Deviation 1.766
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Eosinophils (abs)0.027 10^3 cells/microliterStandard Deviation 0.0871
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Eosinophils (abs)-0.007 10^3 cells/microliterStandard Deviation 0.0628
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: WBC-1.06 10^3 cells/microliterStandard Deviation 1.324
PlaceboChange From Baseline in Laboratory Assessments: Platelets, White Blood Cells (WBCs), Neutrophils (Absolute), Eosinophils (Absolute), Basophils (Absolute), Lymphocytes (Absolute), Monocytes (Absolute) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Monocytes (abs)0.542 10^3 cells/microliterStandard Deviation 0.1569
Secondary

Change From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Albumin-0.12 Gram per deciliter (g/dL)Standard Deviation 0.313
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Protein-0.33 Gram per deciliter (g/dL)Standard Deviation 0.273
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Albumin0.02 Gram per deciliter (g/dL)Standard Deviation 0.098
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Albumin0.08 Gram per deciliter (g/dL)Standard Deviation 0.319
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Albumin-0.10 Gram per deciliter (g/dL)Standard Deviation 0.19
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Protein-0.18 Gram per deciliter (g/dL)Standard Deviation 0.354
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Protein7.07 Gram per deciliter (g/dL)Standard Deviation 0.273
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Albumin4.23 Gram per deciliter (g/dL)Standard Deviation 0.301
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hemoglobin-0.48 Gram per deciliter (g/dL)Standard Deviation 0.293
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hemoglobin-0.18 Gram per deciliter (g/dL)Standard Deviation 0.627
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Protein-0.08 Gram per deciliter (g/dL)Standard Deviation 0.392
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hemoglobin-0.28 Gram per deciliter (g/dL)Standard Deviation 0.471
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hemoglobin-0.03 Gram per deciliter (g/dL)Standard Deviation 0.622
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Protein-0.03 Gram per deciliter (g/dL)Standard Deviation 0.216
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hemoglobin-0.12 Gram per deciliter (g/dL)Standard Deviation 0.585
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hemoglobin-0.36 Gram per deciliter (g/dL)Standard Deviation 0.493
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hemoglobin14.07 Gram per deciliter (g/dL)Standard Deviation 1.392
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Protein-0.25 Gram per deciliter (g/dL)Standard Deviation 0.339
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hemoglobin-0.42 Gram per deciliter (g/dL)Standard Deviation 0.462
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Albumin0.03 Gram per deciliter (g/dL)Standard Deviation 0.175
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Albumin-0.17 Gram per deciliter (g/dL)Standard Deviation 0.175
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Protein-0.28 Gram per deciliter (g/dL)Standard Deviation 0.271
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Protein-0.25 Gram per deciliter (g/dL)Standard Deviation 0.274
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Albumin-0.08 Gram per deciliter (g/dL)Standard Deviation 0.133
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Protein-0.13 Gram per deciliter (g/dL)Standard Deviation 0.25
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Protein6.93 Gram per deciliter (g/dL)Standard Deviation 0.273
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Protein-0.25 Gram per deciliter (g/dL)Standard Deviation 0.302
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Protein-0.25 Gram per deciliter (g/dL)Standard Deviation 0.207
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Protein0.02 Gram per deciliter (g/dL)Standard Deviation 0.293
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Protein-0.02 Gram per deciliter (g/dL)Standard Deviation 0.343
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Protein-0.17 Gram per deciliter (g/dL)Standard Deviation 0.225
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Protein-0.17 Gram per deciliter (g/dL)Standard Deviation 0.383
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Protein-0.03 Gram per deciliter (g/dL)Standard Deviation 0.339
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Albumin4.48 Gram per deciliter (g/dL)Standard Deviation 0.194
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Albumin-0.12 Gram per deciliter (g/dL)Standard Deviation 0.256
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Albumin-0.13 Gram per deciliter (g/dL)Standard Deviation 0.151
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Albumin-0.02 Gram per deciliter (g/dL)Standard Deviation 0.286
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Albumin-0.07 Gram per deciliter (g/dL)Standard Deviation 0.197
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Albumin-0.15 Gram per deciliter (g/dL)Standard Deviation 0.152
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Albumin-0.10 Gram per deciliter (g/dL)Standard Deviation 0.155
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Albumin-0.05 Gram per deciliter (g/dL)Standard Deviation 0.362
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Albumin-0.08 Gram per deciliter (g/dL)Standard Deviation 0.264
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hemoglobin14.28 Gram per deciliter (g/dL)Standard Deviation 0.662
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hemoglobin-0.38 Gram per deciliter (g/dL)Standard Deviation 0.337
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hemoglobin-0.68 Gram per deciliter (g/dL)Standard Deviation 0.356
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hemoglobin0.08 Gram per deciliter (g/dL)Standard Deviation 0.576
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hemoglobin-0.12 Gram per deciliter (g/dL)Standard Deviation 0.714
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hemoglobin-0.10 Gram per deciliter (g/dL)Standard Deviation 0.352
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hemoglobin-0.25 Gram per deciliter (g/dL)Standard Deviation 0.451
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hemoglobin0.00 Gram per deciliter (g/dL)Standard Deviation 0.525
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Hemoglobin0.28 Gram per deciliter (g/dL)Standard Deviation 1.1136
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Protein-0.05 Gram per deciliter (g/dL)Standard Deviation 0.383
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hemoglobin0.15 Gram per deciliter (g/dL)Standard Deviation 0.709
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Albumin-0.02 Gram per deciliter (g/dL)Standard Deviation 0.075
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hemoglobin0.17 Gram per deciliter (g/dL)Standard Deviation 0.308
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Albumin0.02 Gram per deciliter (g/dL)Standard Deviation 0.232
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Protein-0.03 Gram per deciliter (g/dL)Standard Deviation 0.266
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Protein6.97 Gram per deciliter (g/dL)Standard Deviation 0.234
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hemoglobin0.18 Gram per deciliter (g/dL)Standard Deviation 0.523
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Albumin0.02 Gram per deciliter (g/dL)Standard Deviation 0.117
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Albumin0.00 Gram per deciliter (g/dL)Standard Deviation 0.167
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Protein0.02 Gram per deciliter (g/dL)Standard Deviation 0.319
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Protein-0.23 Gram per deciliter (g/dL)Standard Deviation 0.386
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Protein0.03 Gram per deciliter (g/dL)Standard Deviation 0.258
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hemoglobin-0.25 Gram per deciliter (g/dL)Standard Deviation 0.991
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Albumin4.43 Gram per deciliter (g/dL)Standard Deviation 0.121
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Albumin-0.08 Gram per deciliter (g/dL)Standard Deviation 0.16
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hemoglobin13.93 Gram per deciliter (g/dL)Standard Deviation 1.007
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Protein-0.05 Gram per deciliter (g/dL)Standard Deviation 0.259
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Albumin-0.13 Gram per deciliter (g/dL)Standard Deviation 0.31
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Protein0.02 Gram per deciliter (g/dL)Standard Deviation 0.407
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Protein-0.23 Gram per deciliter (g/dL)Standard Deviation 0.207
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hemoglobin-0.33 Gram per deciliter (g/dL)Standard Deviation 0.905
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Albumin0.02 Gram per deciliter (g/dL)Standard Deviation 0.147
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hemoglobin-0.55 Gram per deciliter (g/dL)Standard Deviation 0.819
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Hemoglobin0.05 Gram per deciliter (g/dL)Standard Deviation 0.565
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hemoglobin-0.44 Gram per deciliter (g/dL)Standard Deviation 1.029
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Albumin0.02 Gram per deciliter (g/dL)Standard Deviation 0.183
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Hemoglobin-0.57 Gram per deciliter (g/dL)Standard Deviation 0.468
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Protein-0.36 Gram per deciliter (g/dL)Standard Deviation 0.305
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Albumin-0.08 Gram per deciliter (g/dL)Standard Deviation 0.277
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Albumin-0.14 Gram per deciliter (g/dL)Standard Deviation 0.321
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Protein-0.06 Gram per deciliter (g/dL)Standard Deviation 0.378
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Albumin0.00 Gram per deciliter (g/dL)Standard Deviation 0.354
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Hemoglobin-0.66 Gram per deciliter (g/dL)Standard Deviation 0.581
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Albumin0.12 Gram per deciliter (g/dL)Standard Deviation 0.256
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Protein6.77 Gram per deciliter (g/dL)Standard Deviation 0.225
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Albumin0.13 Gram per deciliter (g/dL)Standard Deviation 0.377
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Protein-0.06 Gram per deciliter (g/dL)Standard Deviation 0.207
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Hemoglobin-0.12 Gram per deciliter (g/dL)Standard Deviation 0.769
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Hemoglobin13.80 Gram per deciliter (g/dL)Standard Deviation 1.669
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Albumin-0.06 Gram per deciliter (g/dL)Standard Deviation 0.152
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Protein-0.10 Gram per deciliter (g/dL)Standard Deviation 0.434
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Hemoglobin-0.58 Gram per deciliter (g/dL)Standard Deviation 0.507
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Hemoglobin-0.58 Gram per deciliter (g/dL)Standard Deviation 0.96
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Protein0.35 Gram per deciliter (g/dL)Standard Deviation 0.404
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Hemoglobin-0.75 Gram per deciliter (g/dL)Standard Deviation 0.387
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Protein0.10 Gram per deciliter (g/dL)Standard Deviation 0.572
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Protein-0.15 Gram per deciliter (g/dL)Standard Deviation 0.266
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Albumin4.28 Gram per deciliter (g/dL)Standard Deviation 0.172
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Protein0.00 Gram per deciliter (g/dL)Standard Deviation 0.529
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Hemoglobin-0.55 Gram per deciliter (g/dL)Standard Deviation 1.473
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Albumin-0.03 Gram per deciliter (g/dL)Standard Deviation 0.175
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Albumin-0.12 Gram per deciliter (g/dL)Standard Deviation 0.331
PlaceboChange From Baseline in Laboratory Assessments: Protein, Albumin, Hemoglobin at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Hemoglobin-0.80 Gram per deciliter (g/dL)Standard Deviation 0.592
Secondary

Change From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Following hematology parameters were analyzed for laboratory examination: Prothrombin Time (PT), Partial Thromboplastin Time.

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT0.20 SecondStandard Deviation 1.259
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-0.55 SecondStandard Deviation 0.362
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT0.10 SecondStandard Deviation 0.758
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-0.25 SecondStandard Deviation 0.327
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT11.82 SecondStandard Deviation 0.556
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT0.47 SecondStandard Deviation 0.7
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-0.32 SecondStandard Deviation 1.326
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-0.67 SecondStandard Deviation 0.931
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PTT31.12 SecondStandard Deviation 3.842
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PTT-1.77 SecondStandard Deviation 4.431
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PTT-4.64 SecondStandard Deviation 7.314
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PTT-3.08 SecondStandard Deviation 4.275
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PTT-0.18 SecondStandard Deviation 6.184
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PTT0.18 SecondStandard Deviation 5.651
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PTT-1.83 SecondStandard Deviation 4.898
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PTT-2.47 SecondStandard Deviation 3.686
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT11.53 SecondStandard Deviation 0.505
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PTT-2.42 SecondStandard Deviation 2.87
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PTT32.57 SecondStandard Deviation 4.457
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT-0.28 SecondStandard Deviation 0.92
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PTT0.44 SecondStandard Deviation 2.235
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PTT0.45 SecondStandard Deviation 2.338
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PTT-0.33 SecondStandard Deviation 1.49
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PTT-0.48 SecondStandard Deviation 3.284
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PTT0.90 SecondStandard Deviation 4.901
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-0.37 SecondStandard Deviation 0.871
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT-0.43 SecondStandard Deviation 0.308
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PTT-2.02 SecondStandard Deviation 1.105
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-0.02 SecondStandard Deviation 0.248
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-0.42 SecondStandard Deviation 0.407
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT0.17 SecondStandard Deviation 0.802
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PTT1.92 SecondStandard Deviation 3.381
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PT-0.05 SecondStandard Deviation 0.75
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-0.12 SecondStandard Deviation 0.676
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PTT2.78 SecondStandard Deviation 8.713
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT0.60 SecondStandard Deviation 1.356
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PTT4.83 SecondStandard Deviation 5.654
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT0.24 SecondStandard Deviation 0.82
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT0.15 SecondStandard Deviation 0.609
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-0.28 SecondStandard Deviation 0.783
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PT-0.73 SecondStandard Deviation 0.528
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PTT31.63 SecondStandard Deviation 6.808
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PTT-3.86 SecondStandard Deviation 5.106
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PTT-1.00 SecondStandard Deviation 7.216
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PTT1.68 SecondStandard Deviation 6.563
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PTT1.73 SecondStandard Deviation 12.794
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PTT1.06 SecondStandard Deviation 5.949
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT11.10 SecondStandard Deviation 1.056
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT0.18 SecondStandard Deviation 0.896
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT0.12 SecondStandard Deviation 0.766
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PTT0.22 SecondStandard Deviation 6.524
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT0.37 SecondStandard Deviation 1.221
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PTT-0.52 SecondStandard Deviation 2.84
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT-1.00 SecondStandard Deviation 1.383
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PTT-0.02 SecondStandard Deviation 1.424
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PT-0.42 SecondStandard Deviation 2.05
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT-0.27 SecondStandard Deviation 2.025
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT11.90 SecondStandard Deviation 1.22
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-0.77 SecondStandard Deviation 1.51
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PTT-2.02 SecondStandard Deviation 2.751
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-0.95 SecondStandard Deviation 1.353
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PTT0.17 SecondStandard Deviation 2.521
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PTT3.95 SecondStandard Deviation 8.973
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-0.58 SecondStandard Deviation 1.143
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PTT-0.52 SecondStandard Deviation 3.801
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-0.80 SecondStandard Deviation 1.037
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PTT31.23 SecondStandard Deviation 5.46
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT-0.26 SecondStandard Deviation 2.019
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PTT0.00 SecondStandard Deviation 2.302
PlaceboChange From Baseline in Laboratory Assessments: Prothrombin Time (PT), Partial Thromboplastin Time at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PTT-0.28 SecondStandard Deviation 2.869
Secondary

Change From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: RBC-0.07 10^6 cells/microliterStandard Deviation 0.207
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: RBC-0.10 10^6 cells/microliterStandard Deviation 0.141
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RBC-0.02 10^6 cells/microliterStandard Deviation 0.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RBC-0.12 10^6 cells/microliterStandard Deviation 0.172
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: RBC0.03 10^6 cells/microliterStandard Deviation 0.207
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: RBC0.02 10^6 cells/microliterStandard Deviation 0.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RBC4.45 10^6 cells/microliterStandard Deviation 0.394
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: RBC-0.03 10^6 cells/microliterStandard Deviation 0.151
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RBC0.10 10^6 cells/microliterStandard Deviation 0.11
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: RBC0.00 10^6 cells/microliterStandard Deviation 0.255
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: RBC-0.05 10^6 cells/microliterStandard Deviation 0.302
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: RBC-0.03 10^6 cells/microliterStandard Deviation 0.207
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RBC-0.03 10^6 cells/microliterStandard Deviation 0.163
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: RBC0.15 10^6 cells/microliterStandard Deviation 0.442
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RBC4.48 10^6 cells/microliterStandard Deviation 0.407
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: RBC-0.07 10^6 cells/microliterStandard Deviation 0.103
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: RBC-0.18 10^6 cells/microliterStandard Deviation 0.11
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: RBC-0.02 10^6 cells/microliterStandard Deviation 0.214
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RBC0.03 10^6 cells/microliterStandard Deviation 0.32
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: RBC0.02 10^6 cells/microliterStandard Deviation 0.098
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: RBC-0.14 10^6 cells/microliterStandard Deviation 0.358
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: RBC-0.13 10^6 cells/microliterStandard Deviation 0.242
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: RBC0.07 10^6 cells/microliterStandard Deviation 0.121
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RBC-0.22 10^6 cells/microliterStandard Deviation 0.319
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RBC4.42 10^6 cells/microliterStandard Deviation 0.417
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: RBC-0.13 10^6 cells/microliterStandard Deviation 0.333
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: RBC4.43 10^6 cells/microliterStandard Deviation 0.677
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: RBC0.00 10^6 cells/microliterStandard Deviation 0.292
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: RBC-0.23 10^6 cells/microliterStandard Deviation 0.443
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: RBC-0.10 10^6 cells/microliterStandard Deviation 0.335
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: RBC-0.22 10^6 cells/microliterStandard Deviation 0.277
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: RBC-0.23 10^6 cells/microliterStandard Deviation 0.126
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: RBC-0.08 10^6 cells/microliterStandard Deviation 0.277
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: RBC-0.15 10^6 cells/microliterStandard Deviation 0.176
PlaceboChange From Baseline in Laboratory Assessments: Red Blood Cells (RBCs) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: RBC-0.10 10^6 cells/microliterStandard Deviation 0.187
Secondary

Change From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Potassium-0.20 Milliequivalent per liter (mEq/L)Standard Deviation 0.276
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bicarbonate-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 2.07
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Chloride-1.3 Milliequivalent per liter (mEq/L)Standard Deviation 3.72
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Chloride-1.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.88
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Magnesium0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.075
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bicarbonate0.3 Milliequivalent per liter (mEq/L)Standard Deviation 2.94
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Chloride-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 3.83
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Sodium-1.3 Milliequivalent per liter (mEq/L)Standard Deviation 4.08
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Chloride-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 2.94
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bicarbonate1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.53
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bicarbonate27.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.55
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bicarbonate0.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.34
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bicarbonate0.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.17
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Sodium0.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.4
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bicarbonate1.5 Milliequivalent per liter (mEq/L)Standard Deviation 1.76
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.098
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Magnesium0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.075
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Sodium-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 2.8
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Potassium4.52 Milliequivalent per liter (mEq/L)Standard Deviation 0.204
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Magnesium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.089
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Potassium-0.18 Milliequivalent per liter (mEq/L)Standard Deviation 0.183
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Sodium140.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.26
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Potassium-0.18 Milliequivalent per liter (mEq/L)Standard Deviation 0.223
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Magnesium-0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.082
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Potassium-0.28 Milliequivalent per liter (mEq/L)Standard Deviation 0.248
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Sodium-0.7 Milliequivalent per liter (mEq/L)Standard Deviation 3.01
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Potassium-0.10 Milliequivalent per liter (mEq/L)Standard Deviation 0.322
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Magnesium0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.052
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Potassium-0.20 Milliequivalent per liter (mEq/L)Standard Deviation 0.253
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Potassium0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.121
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.098
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Magnesium1.72 Milliequivalent per liter (mEq/L)Standard Deviation 0.075
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Sodium-0.7 Milliequivalent per liter (mEq/L)Standard Deviation 3.2
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Chloride103.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.48
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Sodium-2.3 Milliequivalent per liter (mEq/L)Standard Deviation 3.27
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bicarbonate0.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.16
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Chloride-1.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.79
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Chloride-0.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.4
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Sodium0.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.67
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Chloride-1.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.48
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Potassium0.15 Milliequivalent per liter (mEq/L)Standard Deviation 0.394
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Potassium-0.07 Milliequivalent per liter (mEq/L)Standard Deviation 0.266
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Magnesium-0.05 Milliequivalent per liter (mEq/L)Standard Deviation 0.176
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Magnesium-0.05 Milliequivalent per liter (mEq/L)Standard Deviation 0.138
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Bicarbonate0.2 Milliequivalent per liter (mEq/L)Standard Deviation 3.06
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Potassium-0.07 Milliequivalent per liter (mEq/L)Standard Deviation 0.266
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Magnesium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.2
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Potassium0.40 Milliequivalent per liter (mEq/L)Standard Deviation 0.369
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Chloride0.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.25
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Sodium-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 4.46
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bicarbonate-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 1.21
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Sodium1.0 Milliequivalent per liter (mEq/L)Standard Deviation 3.41
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Chloride-0.3 Milliequivalent per liter (mEq/L)Standard Deviation 1.37
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Potassium0.08 Milliequivalent per liter (mEq/L)Standard Deviation 0.248
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bicarbonate-1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.19
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Magnesium-0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.103
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Chloride1.7 Milliequivalent per liter (mEq/L)Standard Deviation 3.5
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Magnesium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.126
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bicarbonate-1.5 Milliequivalent per liter (mEq/L)Standard Deviation 0.84
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Potassium0.10 Milliequivalent per liter (mEq/L)Standard Deviation 0.303
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Chloride1.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.34
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Sodium0.5 Milliequivalent per liter (mEq/L)Standard Deviation 4.14
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Sodium1.3 Milliequivalent per liter (mEq/L)Standard Deviation 3.01
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Chloride1.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.79
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Sodium137.8 Milliequivalent per liter (mEq/L)Standard Deviation 5.88
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bicarbonate-0.5 Milliequivalent per liter (mEq/L)Standard Deviation 1.87
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Chloride100.8 Milliequivalent per liter (mEq/L)Standard Deviation 4.88
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bicarbonate27.3 Milliequivalent per liter (mEq/L)Standard Deviation 1.03
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Magnesium0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.16
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bicarbonate-1.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.07
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Potassium0.08 Milliequivalent per liter (mEq/L)Standard Deviation 0.16
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bicarbonate-0.7 Milliequivalent per liter (mEq/L)Standard Deviation 1.51
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.147
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bicarbonate-0.8 Milliequivalent per liter (mEq/L)Standard Deviation 1.47
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Magnesium1.88 Milliequivalent per liter (mEq/L)Standard Deviation 0.16
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Sodium1.5 Milliequivalent per liter (mEq/L)Standard Deviation 3.83
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Chloride1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.76
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Potassium-0.05 Milliequivalent per liter (mEq/L)Standard Deviation 0.468
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Sodium1.5 Milliequivalent per liter (mEq/L)Standard Deviation 3.15
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Chloride0.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.14
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Magnesium0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.151
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Chloride0.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.66
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Potassium4.40 Milliequivalent per liter (mEq/L)Standard Deviation 0.2
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Sodium0.5 Milliequivalent per liter (mEq/L)Standard Deviation 4.97
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Sodium0.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.41
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bicarbonate-1.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.04
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Sodium140.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.79
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Sodium0.3 Milliequivalent per liter (mEq/L)Standard Deviation 0.96
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Sodium0.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.17
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Sodium0.7 Milliequivalent per liter (mEq/L)Standard Deviation 3.33
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Sodium0.7 Milliequivalent per liter (mEq/L)Standard Deviation 3.39
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Sodium2.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.45
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Sodium3.5 Milliequivalent per liter (mEq/L)Standard Deviation 1.38
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Sodium2.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.07
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Sodium2.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.32
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Potassium4.22 Milliequivalent per liter (mEq/L)Standard Deviation 0.475
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Potassium-0.08 Milliequivalent per liter (mEq/L)Standard Deviation 0.15
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Potassium-0.12 Milliequivalent per liter (mEq/L)Standard Deviation 0.504
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Potassium0.10 Milliequivalent per liter (mEq/L)Standard Deviation 0.438
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Potassium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.49
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Potassium-0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.535
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Potassium0.08 Milliequivalent per liter (mEq/L)Standard Deviation 0.467
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Potassium0.20 Milliequivalent per liter (mEq/L)Standard Deviation 0.329
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Potassium0.38 Milliequivalent per liter (mEq/L)Standard Deviation 0.458
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Chloride102.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.66
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Chloride1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.71
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Chloride0.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.17
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Chloride2.0 Milliequivalent per liter (mEq/L)Standard Deviation 3.03
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Chloride1.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.73
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Chloride0.7 Milliequivalent per liter (mEq/L)Standard Deviation 1.75
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Chloride1.3 Milliequivalent per liter (mEq/L)Standard Deviation 1.03
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Chloride0.3 Milliequivalent per liter (mEq/L)Standard Deviation 1.86
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Chloride0.5 Milliequivalent per liter (mEq/L)Standard Deviation 3.21
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bicarbonate26.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.43
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bicarbonate-1.8 Milliequivalent per liter (mEq/L)Standard Deviation 4.15
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bicarbonate-0.5 Milliequivalent per liter (mEq/L)Standard Deviation 1.87
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bicarbonate-1.5 Milliequivalent per liter (mEq/L)Standard Deviation 3.51
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bicarbonate-0.7 Milliequivalent per liter (mEq/L)Standard Deviation 1.97
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bicarbonate-0.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.42
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bicarbonate0.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.23
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Bicarbonate-1.5 Milliequivalent per liter (mEq/L)Standard Deviation 1.64
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Magnesium1.67 Milliequivalent per liter (mEq/L)Standard Deviation 0.294
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.126
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.133
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Magnesium0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.082
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Magnesium0.05 Milliequivalent per liter (mEq/L)Standard Deviation 0.084
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Magnesium-0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.082
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Magnesium-0.05 Milliequivalent per liter (mEq/L)Standard Deviation 0.055
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Magnesium-0.03 Milliequivalent per liter (mEq/L)Standard Deviation 0.103
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Magnesium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.089
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Chloride0.6 Milliequivalent per liter (mEq/L)Standard Deviation 2.41
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Chloride0.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.56
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Chloride-1.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.4
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Bicarbonate-1.4 Milliequivalent per liter (mEq/L)Standard Deviation 2.07
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Chloride104.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.48
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Potassium-0.25 Milliequivalent per liter (mEq/L)Standard Deviation 0.173
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Magnesium-0.06 Milliequivalent per liter (mEq/L)Standard Deviation 0.055
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Bicarbonate-0.8 Milliequivalent per liter (mEq/L)Standard Deviation 3.43
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Potassium-0.13 Milliequivalent per liter (mEq/L)Standard Deviation 0.484
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Sodium1.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.28
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Bicarbonate-1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.94
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Potassium-0.04 Milliequivalent per liter (mEq/L)Standard Deviation 0.586
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Potassium0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.536
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Sodium0.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.97
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Magnesium1.83 Milliequivalent per liter (mEq/L)Standard Deviation 0.052
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Potassium0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.593
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Potassium-0.16 Milliequivalent per liter (mEq/L)Standard Deviation 0.439
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Sodium141.7 Milliequivalent per liter (mEq/L)Standard Deviation 2.07
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Magnesium-0.10 Milliequivalent per liter (mEq/L)Standard Deviation 0
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Potassium-0.13 Milliequivalent per liter (mEq/L)Standard Deviation 0.367
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Potassium-0.23 Milliequivalent per liter (mEq/L)Standard Deviation 0.427
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.13
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Magnesium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.063
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Potassium4.42 Milliequivalent per liter (mEq/L)Standard Deviation 0.354
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Sodium1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.45
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Sodium-1.8 Milliequivalent per liter (mEq/L)Standard Deviation 3.43
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Magnesium0.00 Milliequivalent per liter (mEq/L)Standard Deviation 0.122
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Sodium-0.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.48
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Sodium0.6 Milliequivalent per liter (mEq/L)Standard Deviation 3.05
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Magnesium-0.10 Milliequivalent per liter (mEq/L)Standard Deviation 0.183
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Bicarbonate-1.5 Milliequivalent per liter (mEq/L)Standard Deviation 2.26
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Magnesium-0.02 Milliequivalent per liter (mEq/L)Standard Deviation 0.084
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Bicarbonate-2.8 Milliequivalent per liter (mEq/L)Standard Deviation 4.12
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Bicarbonate28.0 Milliequivalent per liter (mEq/L)Standard Deviation 1.67
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Chloride-0.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.99
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Sodium1.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.55
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Bicarbonate-2.0 Milliequivalent per liter (mEq/L)Standard Deviation 2.92
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Chloride-1.8 Milliequivalent per liter (mEq/L)Standard Deviation 3.54
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Chloride-0.6 Milliequivalent per liter (mEq/L)Standard Deviation 1.82
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Sodium1.6 Milliequivalent per liter (mEq/L)Standard Deviation 3.13
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Bicarbonate-1.6 Milliequivalent per liter (mEq/L)Standard Deviation 3.51
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Chloride-0.2 Milliequivalent per liter (mEq/L)Standard Deviation 3.11
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Chloride0.8 Milliequivalent per liter (mEq/L)Standard Deviation 2.39
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Magnesium-0.07 Milliequivalent per liter (mEq/L)Standard Deviation 0.121
PlaceboChange From Baseline in Laboratory Assessments: Sodium, Potassium, Chloride, Bicarbonate, Magnesium at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Bicarbonate-1.2 Milliequivalent per liter (mEq/L)Standard Deviation 2.17
Secondary

Change From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Urine pH is a method for evaluating urine acidity measured on a 10-point scale ranging from 0 (most acidic) to 9 (most alkaline). A lower pH means more acidity.

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Urine pH0.00 units on a scaleStandard Deviation 0.447
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Urine pH-0.08 units on a scaleStandard Deviation 0.492
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Urine pH0.08 units on a scaleStandard Deviation 0.585
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Urine pH-0.08 units on a scaleStandard Deviation 0.376
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Urine pH-0.17 units on a scaleStandard Deviation 0.258
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Urine pH-0.17 units on a scaleStandard Deviation 0.408
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Urine pH-0.25 units on a scaleStandard Deviation 0.274
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Urine pH6.33 units on a scaleStandard Deviation 0.408
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Urine pH0.00 units on a scaleStandard Deviation 0.316
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Urine pH5.92 units on a scaleStandard Deviation 0.376
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Urine pH0.42 units on a scaleStandard Deviation 0.376
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Urine pH0.17 units on a scaleStandard Deviation 0.408
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Urine pH0.00 units on a scaleStandard Deviation 0.447
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Urine pH0.50 units on a scaleStandard Deviation 0.548
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Urine pH0.30 units on a scaleStandard Deviation 0.671
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Urine pH0.25 units on a scaleStandard Deviation 0.689
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Urine pH0.33 units on a scaleStandard Deviation 0.408
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Urine pH0.08 units on a scaleStandard Deviation 0.204
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Urine pH0.17 units on a scaleStandard Deviation 0.408
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Urine pH0.30 units on a scaleStandard Deviation 0.447
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Urine pH0.25 units on a scaleStandard Deviation 0.524
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Urine pH0.17 units on a scaleStandard Deviation 0.516
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Urine pH6.00 units on a scaleStandard Deviation 0
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Urine pH0.25 units on a scaleStandard Deviation 0.418
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Urine pH0.75 units on a scaleStandard Deviation 0.935
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Urine pH0.25 units on a scaleStandard Deviation 0.524
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: Urine pH0.08 units on a scaleStandard Deviation 0.585
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: Urine pH0.00 units on a scaleStandard Deviation 0.354
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: Urine pH-0.20 units on a scaleStandard Deviation 0.57
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: Urine pH0.20 units on a scaleStandard Deviation 0.274
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: Urine pH-0.17 units on a scaleStandard Deviation 0.258
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: Urine pH-0.08 units on a scaleStandard Deviation 0.492
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: Urine pH0.00 units on a scaleStandard Deviation 0.5
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: Urine pH6.00 units on a scaleStandard Deviation 0.316
PlaceboChange From Baseline in Laboratory Assessments: Urine pH at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: Urine pH-0.13 units on a scaleStandard Deviation 0.479
Secondary

Change From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Urine specific gravity is a measure of the ratio of the density of urine to the density of water.

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: USG-0.0010 ratioStandard Deviation 0.0094
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: USG-0.0018 ratioStandard Deviation 0.00741
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: USG-0.0013 ratioStandard Deviation 0.00266
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: USG-0.0010 ratioStandard Deviation 0.00654
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: USG0.0008 ratioStandard Deviation 0.00884
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: USG-0.0018 ratioStandard Deviation 0.0095
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: USG1.0197 ratioStandard Deviation 0.00565
RN6G 5 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: USG-0.0002 ratioStandard Deviation 0.00462
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: USG-0.0020 ratioStandard Deviation 0.00447
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: USG1.0150 ratioStandard Deviation 0.00529
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: USG0.0012 ratioStandard Deviation 0.00462
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: USG-0.0003 ratioStandard Deviation 0.00787
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: USG-0.0008 ratioStandard Deviation 0.00376
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: USG-0.0005 ratioStandard Deviation 0.00625
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: USG-0.0012 ratioStandard Deviation 0.00559
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: USG-0.0003 ratioStandard Deviation 0.00497
RN6G 10 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: USG-0.0028 ratioStandard Deviation 0.00768
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: USG0.0045 ratioStandard Deviation 0.00568
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: USG0.0047 ratioStandard Deviation 0.0068
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: USG1.0138 ratioStandard Deviation 0.00343
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: USG0.0058 ratioStandard Deviation 0.00591
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: USG0.0020 ratioStandard Deviation 0.00636
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: USG0.0022 ratioStandard Deviation 0.00293
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: USG0.0038 ratioStandard Deviation 0.00366
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: USG-0.0002 ratioStandard Deviation 0.00293
RN6G 15 mg/kgChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: USG0.0015 ratioStandard Deviation 0.0065
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: USG-0.0020 ratioStandard Deviation 0.00474
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: USG-0.0022 ratioStandard Deviation 0.00527
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: USG0.0002 ratioStandard Deviation 0.00277
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: USG-0.0022 ratioStandard Deviation 0.00492
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: USG1.0242 ratioStandard Deviation 0.00615
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: USG-0.0010 ratioStandard Deviation 0.00566
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: USG-0.0024 ratioStandard Deviation 0.00493
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: USG-0.0025 ratioStandard Deviation 0.00259
PlaceboChange From Baseline in Laboratory Assessments: Urine Specific Gravity at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: USG-0.0043 ratioStandard Deviation 0.00383
Secondary

Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET

Time frame: Baseline, Day 1 (1 hour , 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 847687.9 Picogram per milliliter (pg/ml)Standard Deviation 915.03
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 146047.9 Picogram per milliliter (pg/ml)Standard Deviation 751.77
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 14015889.6 Picogram per milliliter (pg/ml)Standard Deviation 1923.62
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7510751.3 Picogram per milliliter (pg/ml)Standard Deviation 796.75
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 566352.9 Picogram per milliliter (pg/ml)Standard Deviation 513.41
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 194626.3 Picogram per milliliter (pg/ml)Standard Deviation 506.1
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 11939.6 Picogram per milliliter (pg/ml)Standard Deviation 185.16
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4510302.9 Picogram per milliliter (pg/ml)Standard Deviation 2886.26
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 282809.6 Picogram per milliliter (pg/ml)Standard Deviation 534.82
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 16811557.9 Picogram per milliliter (pg/ml)Standard Deviation 2152.82
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 14013922.9 Picogram per milliliter (pg/ml)Standard Deviation 2470.45
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 14012626.3 Picogram per milliliter (pg/ml)Standard Deviation 2294.39
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 13159.6 Picogram per milliliter (pg/ml)Standard Deviation 510.52
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 11271.3 Picogram per milliliter (pg/ml)Standard Deviation 131.35
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14010402.9 Picogram per milliliter (pg/ml)Standard Deviation 1699.34
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline160.4 Picogram per milliliter (pg/ml)Standard Deviation 36.33
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 210071.3 Picogram per milliliter (pg/ml)Standard Deviation 1097.81
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2243534.6 Picogram per milliliter (pg/ml)Standard Deviation 1383.04
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 13115272.9 Picogram per milliliter (pg/ml)Standard Deviation 2939.43
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1128517.9 Picogram per milliliter (pg/ml)Standard Deviation 1608.78
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 712089.6 Picogram per milliliter (pg/ml)Standard Deviation 2224.22
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14120889.6 Picogram per milliliter (pg/ml)Standard Deviation 2456.19
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 10312239.6 Picogram per milliliter (pg/ml)Standard Deviation 1315.07
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 13126550.3 Picogram per milliliter (pg/ml)Standard Deviation 5860.63
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline199.7 Picogram per milliliter (pg/ml)Standard Deviation 24.19
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 11306.4 Picogram per milliliter (pg/ml)Standard Deviation 184.77
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 12082.4 Picogram per milliliter (pg/ml)Standard Deviation 457.09
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 13290.3 Picogram per milliliter (pg/ml)Standard Deviation 525.32
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 210256.8 Picogram per milliliter (pg/ml)Standard Deviation 1125.2
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 718817.0 Picogram per milliliter (pg/ml)Standard Deviation 4600.38
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1416450.3 Picogram per milliliter (pg/ml)Standard Deviation 4571.75
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1912467.0 Picogram per milliliter (pg/ml)Standard Deviation 3360.84
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 289117.0 Picogram per milliliter (pg/ml)Standard Deviation 2492.73
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4518746.0 Picogram per milliliter (pg/ml)Standard Deviation 4221.27
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5614645.3 Picogram per milliliter (pg/ml)Standard Deviation 5174.94
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7524750.3 Picogram per milliliter (pg/ml)Standard Deviation 5951.71
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 8420800.3 Picogram per milliliter (pg/ml)Standard Deviation 6538.53
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 10325900.3 Picogram per milliliter (pg/ml)Standard Deviation 6385.93
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 11223517.0 Picogram per milliliter (pg/ml)Standard Deviation 6359.32
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14020192.0 Picogram per milliliter (pg/ml)Standard Deviation 10768.73
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 14025550.3 Picogram per milliliter (pg/ml)Standard Deviation 6073.42
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 14026717.0 Picogram per milliliter (pg/ml)Standard Deviation 5581.26
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 14025283.7 Picogram per milliliter (pg/ml)Standard Deviation 5234.95
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14131733.7 Picogram per milliliter (pg/ml)Standard Deviation 6395.71
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 15425050.3 Picogram per milliliter (pg/ml)Standard Deviation 5480.9
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 16821517.0 Picogram per milliliter (pg/ml)Standard Deviation 5926.14
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2248518.7 Picogram per milliliter (pg/ml)Standard Deviation 2946.68
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET2483.7 Picogram per milliliter (pg/ml)Standard Deviation 1124.28
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline209.2 Picogram per milliliter (pg/ml)Standard Deviation 13.26
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 14036114.8 Picogram per milliliter (pg/ml)Standard Deviation 6268.68
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 13137614.8 Picogram per milliliter (pg/ml)Standard Deviation 8703.34
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 10329170.8 Picogram per milliliter (pg/ml)Standard Deviation 5936.75
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET3340.8 Picogram per milliliter (pg/ml)Standard Deviation 994.48
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 14036750.8 Picogram per milliliter (pg/ml)Standard Deviation 14910.47
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 13202.3 Picogram per milliliter (pg/ml)Standard Deviation 730.89
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 11548.8 Picogram per milliliter (pg/ml)Standard Deviation 398.99
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 22414190.8 Picogram per milliliter (pg/ml)Standard Deviation 3337.13
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 16836750.8 Picogram per milliliter (pg/ml)Standard Deviation 5023.07
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14139990.8 Picogram per milliliter (pg/ml)Standard Deviation 8261.8
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2815410.8 Picogram per milliliter (pg/ml)Standard Deviation 3844.36
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14033910.8 Picogram per milliliter (pg/ml)Standard Deviation 4820.26
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1917990.8 Picogram per milliliter (pg/ml)Standard Deviation 4568.62
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 11228250.8 Picogram per milliliter (pg/ml)Standard Deviation 2534.65
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4524150.8 Picogram per milliliter (pg/ml)Standard Deviation 1138.42
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 724150.8 Picogram per milliliter (pg/ml)Standard Deviation 3178.81
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 211164.8 Picogram per milliliter (pg/ml)Standard Deviation 563.89
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 14034470.8 Picogram per milliliter (pg/ml)Standard Deviation 7089.1
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5620630.8 Picogram per milliliter (pg/ml)Standard Deviation 3400.87
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 8423270.8 Picogram per milliliter (pg/ml)Standard Deviation 1691.32
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1419050.8 Picogram per milliliter (pg/ml)Standard Deviation 3495.78
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 15447310.8 Picogram per milliliter (pg/ml)Standard Deviation 2244.59
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7526910.8 Picogram per milliliter (pg/ml)Standard Deviation 1110.6
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 12264.8 Picogram per milliliter (pg/ml)Standard Deviation 438.4
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 75-33.0 Picogram per milliliter (pg/ml)Standard Deviation 24.37
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154-35.8 Picogram per milliliter (pg/ml)Standard Deviation 37.98
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 84-15.6 Picogram per milliliter (pg/ml)Standard Deviation 61.32
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline224.3 Picogram per milliliter (pg/ml)Standard Deviation 61.26
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 103-15.6 Picogram per milliliter (pg/ml)Standard Deviation 36.92
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2-5.5 Picogram per milliliter (pg/ml)Standard Deviation 21.94
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET26.8 Picogram per milliliter (pg/ml)Standard Deviation 87.01
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 112-18.6 Picogram per milliliter (pg/ml)Standard Deviation 35.53
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 14.2 Picogram per milliliter (pg/ml)Standard Deviation 27.8
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1317.0 Picogram per milliliter (pg/ml)Standard Deviation 56.04
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14026.8 Picogram per milliliter (pg/ml)Standard Deviation 102.19
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 1-0.7 Picogram per milliliter (pg/ml)Standard Deviation 27.1
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 168-20.4 Picogram per milliliter (pg/ml)Standard Deviation 52.83
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 140-9.0 Picogram per milliliter (pg/ml)Standard Deviation 41.35
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140-31.0 Picogram per milliliter (pg/ml)Standard Deviation 27.6
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 1-3.7 Picogram per milliliter (pg/ml)Standard Deviation 21.1
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140-27.4 Picogram per milliliter (pg/ml)Standard Deviation 38.63
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 198.2 Picogram per milliliter (pg/ml)Standard Deviation 27.46
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 28-3.0 Picogram per milliliter (pg/ml)Standard Deviation 17.44
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 141-24.2 Picogram per milliliter (pg/ml)Standard Deviation 40.38
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 45-7.7 Picogram per milliliter (pg/ml)Standard Deviation 46.88
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14-6.5 Picogram per milliliter (pg/ml)Standard Deviation 13.91
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 22415.3 Picogram per milliliter (pg/ml)Standard Deviation 66.79
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 56-16.8 Picogram per milliliter (pg/ml)Standard Deviation 46.67
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-40) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7-2.8 Picogram per milliliter (pg/ml)Standard Deviation 16.02
Secondary

Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET

Time frame: Baseline, Day 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2248.6 picogram per milliliter (pg/ml)Standard Deviation 9.82
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 16839.5 picogram per milliliter (pg/ml)Standard Deviation 4.78
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline34.0 picogram per milliliter (pg/ml)Standard Deviation 5.61
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 165.3 picogram per milliliter (pg/ml)Standard Deviation 15.08
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 184.6 picogram per milliliter (pg/ml)Standard Deviation 21.5
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 1100.0 picogram per milliliter (pg/ml)Standard Deviation 18.5
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 288.6 picogram per milliliter (pg/ml)Standard Deviation 32.58
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 742.1 picogram per milliliter (pg/ml)Standard Deviation 16.79
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1418.7 picogram per milliliter (pg/ml)Standard Deviation 9.18
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1913.9 picogram per milliliter (pg/ml)Standard Deviation 5.23
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 284.8 picogram per milliliter (pg/ml)Standard Deviation 3.31
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4531.3 picogram per milliliter (pg/ml)Standard Deviation 7.24
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5618.0 picogram per milliliter (pg/ml)Standard Deviation 7.94
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7528.9 picogram per milliliter (pg/ml)Standard Deviation 11.25
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 8425.6 picogram per milliliter (pg/ml)Standard Deviation 3.6
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 10341.9 picogram per milliliter (pg/ml)Standard Deviation 6.37
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 11226.2 picogram per milliliter (pg/ml)Standard Deviation 8.53
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 13156.3 picogram per milliliter (pg/ml)Standard Deviation 11.71
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14037.2 picogram per milliliter (pg/ml)Standard Deviation 8.51
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 14087.8 picogram per milliliter (pg/ml)Standard Deviation 10.7
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140113.2 picogram per milliliter (pg/ml)Standard Deviation 19.82
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140132.3 picogram per milliliter (pg/ml)Standard Deviation 12.73
RN6G 5 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 141120.0 picogram per milliliter (pg/ml)Standard Deviation 15.08
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140209.2 picogram per milliliter (pg/ml)Standard Deviation 51.64
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14080.2 picogram per milliliter (pg/ml)Standard Deviation 59.94
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 777.4 picogram per milliliter (pg/ml)Standard Deviation 26.92
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 16872.7 picogram per milliliter (pg/ml)Standard Deviation 50.7
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 224-1.8 picogram per milliliter (pg/ml)Standard Deviation 41.26
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 288.4 picogram per milliliter (pg/ml)Standard Deviation 28.46
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET-3.6 picogram per milliliter (pg/ml)Standard Deviation 40.36
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline67.3 picogram per milliliter (pg/ml)Standard Deviation 36.14
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 140177.5 picogram per milliliter (pg/ml)Standard Deviation 67.55
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 172.4 picogram per milliliter (pg/ml)Standard Deviation 14.51
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140243.7 picogram per milliliter (pg/ml)Standard Deviation 58.08
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 1126.8 picogram per milliliter (pg/ml)Standard Deviation 36.79
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4550.9 picogram per milliliter (pg/ml)Standard Deviation 31.77
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 1179.5 picogram per milliliter (pg/ml)Standard Deviation 34.06
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2194.8 picogram per milliliter (pg/ml)Standard Deviation 48.89
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5656.6 picogram per milliliter (pg/ml)Standard Deviation 61.02
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1442.4 picogram per milliliter (pg/ml)Standard Deviation 43.12
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7578.0 picogram per milliliter (pg/ml)Standard Deviation 51.53
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 8456.3 picogram per milliliter (pg/ml)Standard Deviation 54.71
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 141280.2 picogram per milliliter (pg/ml)Standard Deviation 81.8
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 10394.4 picogram per milliliter (pg/ml)Standard Deviation 49.79
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1933.2 picogram per milliliter (pg/ml)Standard Deviation 34.62
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 11288.2 picogram per milliliter (pg/ml)Standard Deviation 58.68
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 131115.0 picogram per milliliter (pg/ml)Standard Deviation 68.5
RN6G 10 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154113.4 picogram per milliliter (pg/ml)Standard Deviation 72.67
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1971.2 picogram per milliliter (pg/ml)Standard Deviation 13.06
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140360.9 picogram per milliliter (pg/ml)Standard Deviation 66.62
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 140136.3 picogram per milliliter (pg/ml)Standard Deviation 9.43
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 103141.1 picogram per milliliter (pg/ml)Standard Deviation 47.02
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 56101.3 picogram per milliliter (pg/ml)Standard Deviation 25.8
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140292.9 picogram per milliliter (pg/ml)Standard Deviation 57.03
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 22445.6 picogram per milliliter (pg/ml)Standard Deviation 14.6
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 1262.6 picogram per milliliter (pg/ml)Standard Deviation 113.24
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 141404.7 picogram per milliliter (pg/ml)Standard Deviation 84.86
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET4.8 picogram per milliliter (pg/ml)Standard Deviation 5.31
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2868.3 picogram per milliliter (pg/ml)Standard Deviation 29.29
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154229.5 picogram per milliliter (pg/ml)Standard Deviation 29.57
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 75144.5 picogram per milliliter (pg/ml)Standard Deviation 29.38
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline46.9 picogram per milliliter (pg/ml)Standard Deviation 8.62
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7144.1 picogram per milliliter (pg/ml)Standard Deviation 35.08
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1475.9 picogram per milliliter (pg/ml)Standard Deviation 19.03
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2328.4 picogram per milliliter (pg/ml)Standard Deviation 99.74
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 1154.9 picogram per milliliter (pg/ml)Standard Deviation 49.51
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 131180.1 picogram per milliliter (pg/ml)Standard Deviation 18.23
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 140257.7 picogram per milliliter (pg/ml)Standard Deviation 63.99
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 84104.1 picogram per milliliter (pg/ml)Standard Deviation 21.92
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 1193.9 picogram per milliliter (pg/ml)Standard Deviation 65.55
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 168168.9 picogram per milliliter (pg/ml)Standard Deviation 34.85
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 45123.1 picogram per milliliter (pg/ml)Standard Deviation 23.36
RN6G 15 mg/kgChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 112124.9 picogram per milliliter (pg/ml)Standard Deviation 39.52
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 141-26.1 picogram per milliliter (pg/ml)Standard Deviation 24.22
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H post-dose Day 14.0 picogram per milliliter (pg/ml)Standard Deviation 5.75
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2-13.3 picogram per milliliter (pg/ml)Standard Deviation 26.69
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 73.9 picogram per milliliter (pg/ml)Standard Deviation 32
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 149.1 picogram per milliliter (pg/ml)Standard Deviation 22.03
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140-28.7 picogram per milliliter (pg/ml)Standard Deviation 31.64
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 198.4 picogram per milliliter (pg/ml)Standard Deviation 22.71
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 168-21.9 picogram per milliliter (pg/ml)Standard Deviation 27.63
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 28-4.3 picogram per milliliter (pg/ml)Standard Deviation 11.73
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 45-12.6 picogram per milliliter (pg/ml)Standard Deviation 25.16
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 56-15.9 picogram per milliliter (pg/ml)Standard Deviation 28.84
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140-10.5 picogram per milliliter (pg/ml)Standard Deviation 39.49
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 75-22.3 picogram per milliliter (pg/ml)Standard Deviation 27.87
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154-29.3 picogram per milliliter (pg/ml)Standard Deviation 25.98
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 84-14.7 picogram per milliliter (pg/ml)Standard Deviation 26.98
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 103-17.8 picogram per milliliter (pg/ml)Standard Deviation 28.09
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 112-18.8 picogram per milliliter (pg/ml)Standard Deviation 22.91
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 131-19.9 picogram per milliliter (pg/ml)Standard Deviation 24.25
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 140-10.9 picogram per milliliter (pg/ml)Standard Deviation 43.12
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 224-8.5 picogram per milliliter (pg/ml)Standard Deviation 42.38
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET-35.9 picogram per milliliter (pg/ml)Standard Deviation 26.66
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline61.4 picogram per milliliter (pg/ml)Standard Deviation 31.71
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 1-7.7 picogram per milliliter (pg/ml)Standard Deviation 16.71
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H post-dose Day 1-4.0 picogram per milliliter (pg/ml)Standard Deviation 19.86
PlaceboChange From Baseline in Plasma Amyloid (A) Beta (1-42) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 140-21.7 picogram per milliliter (pg/ml)Standard Deviation 25.89
Secondary

Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET

Amyloid (A) Beta (1-X) is a primary activator of complement in Alzheimer's disease (AD).

Time frame: Baseline, Day 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 13162226.8 Picogram per milliliter (pg/ml)Standard Deviation 17554.96
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline371.8 Picogram per milliliter (pg/ml)Standard Deviation 284.73
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1425303.0 Picogram per milliliter (pg/ml)Standard Deviation 4293.92
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 8429386.3 Picogram per milliliter (pg/ml)Standard Deviation 3246.3
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 13340.5 Picogram per milliliter (pg/ml)Standard Deviation 386.71
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 10350269.8 Picogram per milliliter (pg/ml)Standard Deviation 7129.73
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1917782.7 Picogram per milliliter (pg/ml)Standard Deviation 4264.51
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 14046295.7 Picogram per milliliter (pg/ml)Standard Deviation 7585.69
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 14049017.8 Picogram per milliliter (pg/ml)Standard Deviation 6793.71
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14127212.1 Picogram per milliliter (pg/ml)Standard Deviation 12018.62
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 288777.5 Picogram per milliliter (pg/ml)Standard Deviation 1441.65
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 22420950.3 Picogram per milliliter (pg/ml)Standard Deviation 6951.3
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 233804.2 Picogram per milliliter (pg/ml)Standard Deviation 5420.83
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4H post-dose Day 17850.0 Picogram per milliliter (pg/ml)Standard Deviation 1490.33
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4541329.3 Picogram per milliliter (pg/ml)Standard Deviation 12376.68
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 11234071.5 Picogram per milliliter (pg/ml)Standard Deviation 4062.24
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 16852558.0 Picogram per milliliter (pg/ml)Standard Deviation 6374.13
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 14051102.8 Picogram per milliliter (pg/ml)Standard Deviation 6552.83
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5623723.0 Picogram per milliliter (pg/ml)Standard Deviation 4080.35
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 750329.3 Picogram per milliliter (pg/ml)Standard Deviation 9389.75
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2H post-dose Day 15118.7 Picogram per milliliter (pg/ml)Standard Deviation 709
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 14041991.0 Picogram per milliliter (pg/ml)Standard Deviation 7209.04
RN6G 5 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 7542393.7 Picogram per milliliter (pg/ml)Standard Deviation 7739.27
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5670846.5 Picogram per milliliter (pg/ml)Standard Deviation 24378.68
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140102384.7 Picogram per milliliter (pg/ml)Standard Deviation 17624.73
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14136042.0 Picogram per milliliter (pg/ml)Standard Deviation 25934.3
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2H post-dose Day 14821.2 Picogram per milliliter (pg/ml)Standard Deviation 1114.32
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 8489908.2 Picogram per milliliter (pg/ml)Standard Deviation 28896.82
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 14098349.2 Picogram per milliliter (pg/ml)Standard Deviation 20226.44
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 103114474.3 Picogram per milliliter (pg/ml)Standard Deviation 28268.9
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 131124417.0 Picogram per milliliter (pg/ml)Standard Deviation 26689.05
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4H post-dose Day 16992.7 Picogram per milliliter (pg/ml)Standard Deviation 1716.83
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 140102548.2 Picogram per milliliter (pg/ml)Standard Deviation 22902.22
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline1596.8 Picogram per milliliter (pg/ml)Standard Deviation 2794.08
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 168103651.8 Picogram per milliliter (pg/ml)Standard Deviation 27880.97
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 233566.0 Picogram per milliliter (pg/ml)Standard Deviation 4698.42
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 788678.7 Picogram per milliliter (pg/ml)Standard Deviation 22431.39
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET13550.8 Picogram per milliliter (pg/ml)Standard Deviation 5901.76
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154141033.8 Picogram per milliliter (pg/ml)Standard Deviation 22685.63
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1469611.3 Picogram per milliliter (pg/ml)Standard Deviation 21077.31
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 75121176.2 Picogram per milliliter (pg/ml)Standard Deviation 34652.27
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1954407.7 Picogram per milliliter (pg/ml)Standard Deviation 15467.03
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 13205.5 Picogram per milliliter (pg/ml)Standard Deviation 856.06
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2835848.3 Picogram per milliliter (pg/ml)Standard Deviation 9540.26
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 112107243.5 Picogram per milliliter (pg/ml)Standard Deviation 28813.61
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140101938.3 Picogram per milliliter (pg/ml)Standard Deviation 21440.86
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 4587735.4 Picogram per milliliter (pg/ml)Standard Deviation 19304.46
RN6G 10 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 22435489.0 Picogram per milliliter (pg/ml)Standard Deviation 11571.26
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154190913.6 Picogram per milliliter (pg/ml)Standard Deviation 29331.01
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline200.0 Picogram per milliliter (pg/ml)Standard Deviation 0
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 13947.2 Picogram per milliliter (pg/ml)Standard Deviation 1822.39
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2H post-dose Day 15610.8 Picogram per milliliter (pg/ml)Standard Deviation 2544.7
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4H post-dose Day 17874.3 Picogram per milliliter (pg/ml)Standard Deviation 2158.56
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 237862.0 Picogram per milliliter (pg/ml)Standard Deviation 1069.86
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 794017.0 Picogram per milliliter (pg/ml)Standard Deviation 7060.55
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1480138.0 Picogram per milliliter (pg/ml)Standard Deviation 13795.55
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 1971190.6 Picogram per milliliter (pg/ml)Standard Deviation 7553.42
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2857701.0 Picogram per milliliter (pg/ml)Standard Deviation 14705.1
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 45110278.0 Picogram per milliliter (pg/ml)Standard Deviation 20296.92
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 5698343.8 Picogram per milliliter (pg/ml)Standard Deviation 21336.44
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 75149272.0 Picogram per milliliter (pg/ml)Standard Deviation 23898.1
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 84120091.6 Picogram per milliliter (pg/ml)Standard Deviation 5895.1
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 103157448.0 Picogram per milliliter (pg/ml)Standard Deviation 33235.41
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 112140917.6 Picogram per milliliter (pg/ml)Standard Deviation 17498.78
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 131168767.8 Picogram per milliliter (pg/ml)Standard Deviation 7272.93
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 140154350.0 Picogram per milliliter (pg/ml)Standard Deviation 9459.75
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 140140246.0 Picogram per milliliter (pg/ml)Standard Deviation 15770.21
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140136109.5 Picogram per milliliter (pg/ml)Standard Deviation 12883.65
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140153793.0 Picogram per milliliter (pg/ml)Standard Deviation 15312.09
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14180464.2 Picogram per milliliter (pg/ml)Standard Deviation 11546.49
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 168161691.4 Picogram per milliliter (pg/ml)Standard Deviation 21292.74
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 22457692.0 Picogram per milliliter (pg/ml)Standard Deviation 16310.16
RN6G 15 mg/kgChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET12127.2 Picogram per milliliter (pg/ml)Standard Deviation 3196.16
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 56-36.3 Picogram per milliliter (pg/ml)Standard Deviation 305.27
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1H post-dose Day 10.3 Picogram per milliliter (pg/ml)Standard Deviation 83.39
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2 H Post-dose Day 140-137.3 Picogram per milliliter (pg/ml)Standard Deviation 135.93
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 45-6.5 Picogram per milliliter (pg/ml)Standard Deviation 209.72
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 28-69.7 Picogram per milliliter (pg/ml)Standard Deviation 239.14
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at day 304/ET-164.3 Picogram per milliliter (pg/ml)Standard Deviation 167.57
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4 H Post-dose Day 140-144.2 Picogram per milliliter (pg/ml)Standard Deviation 158.04
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 19-62.5 Picogram per milliliter (pg/ml)Standard Deviation 106.16
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 14-66.2 Picogram per milliliter (pg/ml)Standard Deviation 103.72
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 224-110.3 Picogram per milliliter (pg/ml)Standard Deviation 138.97
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 141-11.0 Picogram per milliliter (pg/ml)Standard Deviation 30.66
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 716.8 Picogram per milliliter (pg/ml)Standard Deviation 52.82
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 103116.6 Picogram per milliliter (pg/ml)Standard Deviation 296.52
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 154-103.5 Picogram per milliliter (pg/ml)Standard Deviation 85.83
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 2-9.8 Picogram per milliliter (pg/ml)Standard Deviation 132.42
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 4H post-dose Day 11.7 Picogram per milliliter (pg/ml)Standard Deviation 225.19
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETBaseline386.5 Picogram per milliliter (pg/ml)Standard Deviation 174.33
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 131-61.6 Picogram per milliliter (pg/ml)Standard Deviation 131.01
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 168-64.6 Picogram per milliliter (pg/ml)Standard Deviation 132.4
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at pre-dose Day 140-3.4 Picogram per milliliter (pg/ml)Standard Deviation 92.42
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 112214.4 Picogram per milliliter (pg/ml)Standard Deviation 342.45
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 84122.2 Picogram per milliliter (pg/ml)Standard Deviation 362.01
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 2H post-dose Day 145.3 Picogram per milliliter (pg/ml)Standard Deviation 125.22
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at 1 H post-dose Day 140-25.0 Picogram per milliliter (pg/ml)Standard Deviation 80.53
PlaceboChange From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETChange at Day 75205.6 Picogram per milliliter (pg/ml)Standard Deviation 302.4
Secondary

Change From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Time frame: Baseline, Day 28, 56, 84, 112, 140, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT-INR0.006 RatioStandard Deviation 0.0586
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-INR-0.027 RatioStandard Deviation 0.1078
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT-INR0.014 RatioStandard Deviation 0.1001
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-INR-0.022 RatioStandard Deviation 0.0256
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-INR-0.047 RatioStandard Deviation 0.0288
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-INR-0.058 RatioStandard Deviation 0.0776
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT-INR0.037 RatioStandard Deviation 0.0535
RN6G 5 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT-INR0.995 RatioStandard Deviation 0.0455
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT-INR-0.008 RatioStandard Deviation 0.0488
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT-INR0.972 RatioStandard Deviation 0.0436
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-INR-0.003 RatioStandard Deviation 0.0234
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT-INR-0.027 RatioStandard Deviation 0.0755
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-INR0.004 RatioStandard Deviation 0.0522
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT-INR0.042 RatioStandard Deviation 0.0697
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-INR-0.005 RatioStandard Deviation 0.0912
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-INR0.047 RatioStandard Deviation 0.0344
RN6G 10 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PT-INR0.085 RatioStandard Deviation 0.0599
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT-INR0.096 RatioStandard Deviation 0.0623
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT-INR0.140 RatioStandard Deviation 0.1231
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-INR0.064 RatioStandard Deviation 0.1199
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT-INR0.106 RatioStandard Deviation 0.0669
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-INR0.098 RatioStandard Deviation 0.0519
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT-INR0.933 RatioStandard Deviation 0.0871
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PT-INR0.055 RatioStandard Deviation 0.0481
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-INR0.060 RatioStandard Deviation 0.0651
RN6G 15 mg/kgChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-INR0.117 RatioStandard Deviation 0.1076
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 56: PT-INR0.000 RatioStandard Deviation 0.1802
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: PT-INR-0.050 RatioStandard Deviation 0.1077
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 112: PT-INR-0.062 RatioStandard Deviation 0.1284
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 84: PT-INR-0.060 RatioStandard Deviation 0.1374
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: PT-INR-0.018 RatioStandard Deviation 0.1148
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 28: PT-INR-0.050 RatioStandard Deviation 0.0925
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 140: PT-INR-0.006 RatioStandard Deviation 0.1757
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: PT-INR1.017 RatioStandard Deviation 0.1167
PlaceboChange From Baseline in Prothrombin Time (PT) International Normalized Ratio (INR) at Day 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: PT-INR0.050 RatioStandard Deviation 0.1927
Secondary

Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse Rate

Time frame: Baseline, 1 and 4 H post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET

Population: Safety analysis set included all randomized participants who received any amount of study drug. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateBaseline64.2 Beats per minuteStandard Deviation 6.4
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 561.2 Beats per minuteStandard Deviation 2.99
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 112-0.8 Beats per minuteStandard Deviation 4.02
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose day 563.0 Beats per minuteStandard Deviation 4.69
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 751.5 Beats per minuteStandard Deviation 4.64
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1032.2 Beats per minuteStandard Deviation 2.04
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 842.3 Beats per minuteStandard Deviation 3.83
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1H post-dose Day 11.7 Beats per minuteStandard Deviation 2.66
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 84-0.3 Beats per minuteStandard Deviation 5.89
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post dose Day 1411.0 Beats per minuteStandard Deviation 3.22
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1 H post-dose Day 140-0.5 Beats per minuteStandard Deviation 4.37
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post-dose Day 13.5 Beats per minuteStandard Deviation 6.25
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 224/ET-1.2 Beats per minuteStandard Deviation 6.94
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post-dose Day 20.8 Beats per minuteStandard Deviation 2.71
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 74.5 Beats per minuteStandard Deviation 3.67
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1681.7 Beats per minuteStandard Deviation 1.86
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 1402.5 Beats per minuteStandard Deviation 3.99
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 141.2 Beats per minuteStandard Deviation 2.04
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 192.5 Beats per minuteStandard Deviation 5.92
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1311.8 Beats per minuteStandard Deviation 4.07
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 280.2 Beats per minuteStandard Deviation 5.53
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 286.5 Beats per minuteStandard Deviation 10.15
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post dose Day 140.3.2 Beats per minuteStandard Deviation 4.83
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 1121.8 Beats per minuteStandard Deviation 2.86
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 453.5 Beats per minuteStandard Deviation 2.17
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1549.2 Beats per minuteStandard Deviation 3.82
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 304/ET1.2 Beats per minuteStandard Deviation 5.88
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post-dose Day 21.5 Beats per minuteStandard Deviation 1.97
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 1121.5 Beats per minuteStandard Deviation 3.33
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 224/ET0.3 Beats per minuteStandard Deviation 5.01
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 561.5 Beats per minuteStandard Deviation 4.37
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateBaseline62.8 Beats per minuteStandard Deviation 4.4
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 1402.8 Beats per minuteStandard Deviation 4.07
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 452.3 Beats per minuteStandard Deviation 4.03
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose day 562.3 Beats per minuteStandard Deviation 4.13
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post dose Day 1418.7 Beats per minuteStandard Deviation 3.88
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1032.5 Beats per minuteStandard Deviation 4.09
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 73.3 Beats per minuteStandard Deviation 3.08
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 755.5 Beats per minuteStandard Deviation 6.19
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1 H post-dose Day 1400.8 Beats per minuteStandard Deviation 5.53
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 282.2 Beats per minuteStandard Deviation 2.56
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 282.3 Beats per minuteStandard Deviation 5.32
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 844.0 Beats per minuteStandard Deviation 3.1
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1317.2 Beats per minuteStandard Deviation 7.55
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 841.8 Beats per minuteStandard Deviation 4.31
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 168-0.5 Beats per minuteStandard Deviation 4.89
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1H post-dose Day 1-1.8 Beats per minuteStandard Deviation 4.4
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 144.3 Beats per minuteStandard Deviation 7.39
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post dose Day 140.4.0 Beats per minuteStandard Deviation 8.94
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 1123.3 Beats per minuteStandard Deviation 5.05
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post-dose Day 11.2 Beats per minuteStandard Deviation 5.81
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 197.8 Beats per minuteStandard Deviation 7.6
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 140-0.8 Beats per minuteStandard Deviation 4.79
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1540.5 Beats per minuteStandard Deviation 8.73
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 168-6.8 Beats per minuteStandard Deviation 5.42
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 224/ET-0.7 Beats per minuteStandard Deviation 5.99
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 304/ET-0.2 Beats per minuteStandard Deviation 2.56
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateBaseline66.5 Beats per minuteStandard Deviation 6.53
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1H post-dose Day 1-4.2 Beats per minuteStandard Deviation 5.46
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post-dose Day 1-2.3 Beats per minuteStandard Deviation 7.5
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post-dose Day 2-2.0 Beats per minuteStandard Deviation 3.74
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 7-4.2 Beats per minuteStandard Deviation 5.42
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 140.3 Beats per minuteStandard Deviation 4.59
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 190.0 Beats per minuteStandard Deviation 2.45
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 28-1.5 Beats per minuteStandard Deviation 5.72
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 28-2.8 Beats per minuteStandard Deviation 4.32
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 455.2 Beats per minuteStandard Deviation 7.26
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 56-3.7 Beats per minuteStandard Deviation 5.13
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose day 561.6 Beats per minuteStandard Deviation 10.14
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 758.0 Beats per minuteStandard Deviation 8.12
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 84-1.8 Beats per minuteStandard Deviation 4.17
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 84-2.7 Beats per minuteStandard Deviation 7.76
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1031.3 Beats per minuteStandard Deviation 1.63
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 112-0.2 Beats per minuteStandard Deviation 4.26
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 112-2.2 Beats per minuteStandard Deviation 3.19
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1312.8 Beats per minuteStandard Deviation 13.07
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1 H post-dose Day 140-4.5 Beats per minuteStandard Deviation 6.83
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post dose Day 140.-2.8 Beats per minuteStandard Deviation 6.91
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post dose Day 141-2.0 Beats per minuteStandard Deviation 6.1
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 45-3.0 Beats per minuteStandard Deviation 5.73
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post dose Day 1416.4 Beats per minuteStandard Deviation 4.77
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 1120.2 Beats per minuteStandard Deviation 5.02
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 280.3 Beats per minuteStandard Deviation 12.04
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 28-1.2 Beats per minuteStandard Deviation 2.71
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post dose Day 140.-1.0 Beats per minuteStandard Deviation 10.2
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 112-1.6 Beats per minuteStandard Deviation 0.89
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 191.0 Beats per minuteStandard Deviation 5.76
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 146.0 Beats per minuteStandard Deviation 6.93
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1684.8 Beats per minuteStandard Deviation 7.56
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1311.8 Beats per minuteStandard Deviation 6.94
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 74.2 Beats per minuteStandard Deviation 5.95
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 24 H post-dose Day 23.8 Beats per minuteStandard Deviation 6.4
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4 H post-dose Day 14.0 Beats per minuteStandard Deviation 7.77
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 1403.2 Beats per minuteStandard Deviation 3.27
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1H post-dose Day 11.0 Beats per minuteStandard Deviation 8.83
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateBaseline66.7 Beats per minuteStandard Deviation 5.01
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 15413.5 Beats per minuteStandard Deviation 5
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 1 H post-dose Day 140-3.2 Beats per minuteStandard Deviation 9.09
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 842.2 Beats per minuteStandard Deviation 7.09
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 304/ET2.0 Beats per minuteStandard Deviation 5.66
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose Day 844.2 Beats per minuteStandard Deviation 5.12
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 756.8 Beats per minuteStandard Deviation 8.9
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at 4-8 H post-dose day 566.0 Beats per minuteStandard Deviation 9.08
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 224/ET0.5 Beats per minuteStandard Deviation 4.55
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at Day 1036.0 Beats per minuteStandard Deviation 5.29
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Pulse RateChange at pre-dose Day 562.0 Beats per minuteStandard Deviation 5.51
Secondary

Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood Pressure

Time frame: Baseline, 1 and 4 hour (H) post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET

Population: Safety analysis set included all randomized participants who received any amount of study drug. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: DBP-4.3 millimeter of mercury (mmHg)Standard Deviation 10.15
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Pre-dose Day 84: SBP3.2 millimeter of mercury (mmHg)Standard Deviation 15.05
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 7.45
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: DBP-1.7 millimeter of mercury (mmHg)Standard Deviation 7.84
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: DBP-2.7 millimeter of mercury (mmHg)Standard Deviation 8.36
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8H post-dose Day 84: SBP0.0 millimeter of mercury (mmHg)Standard Deviation 9.63
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: DBP1.0 millimeter of mercury (mmHg)Standard Deviation 5.33
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: SBP5.0 millimeter of mercury (mmHg)Standard Deviation 11.22
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: DBP-1.3 millimeter of mercury (mmHg)Standard Deviation 3.01
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: SBP2.0 millimeter of mercury (mmHg)Standard Deviation 13.08
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: DBP-4.7 millimeter of mercury (mmHg)Standard Deviation 4.13
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: SBP-6.0 millimeter of mercury (mmHg)Standard Deviation 9.96
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: SBP5.8 millimeter of mercury (mmHg)Standard Deviation 24.04
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: SBP-2.0 millimeter of mercury (mmHg)Standard Deviation 12.65
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: DBP0.8 millimeter of mercury (mmHg)Standard Deviation 5
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: DBP-1.0 millimeter of mercury (mmHg)Standard Deviation 11.51
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112:DBP-1.3 millimeter of mercury (mmHg)Standard Deviation 8.16
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112: SBP-4.7 millimeter of mercury (mmHg)Standard Deviation 8.26
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28: SBP7.7 millimeter of mercury (mmHg)Standard Deviation 10.61
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: DBP-2.2 millimeter of mercury (mmHg)Standard Deviation 6.88
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: SBP-6.0 millimeter of mercury (mmHg)Standard Deviation 11.1
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: SBP4.3 millimeter of mercury (mmHg)Standard Deviation 13.11
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: SBP1.8 millimeter of mercury (mmHg)Standard Deviation 15.83
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: SBP7.3 millimeter of mercury (mmHg)Standard Deviation 22.08
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: DBP-1.8 millimeter of mercury (mmHg)Standard Deviation 8.35
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: SBP-5.3 millimeter of mercury (mmHg)Standard Deviation 15.78
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: DBP-6.3 millimeter of mercury (mmHg)Standard Deviation 8.24
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: SBP3.7 millimeter of mercury (mmHg)Standard Deviation 6.62
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: SBP7.7 millimeter of mercury (mmHg)Standard Deviation 11.83
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: DBP-0.8 millimeter of mercury (mmHg)Standard Deviation 8.5
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: DBP-1.3 millimeter of mercury (mmHg)Standard Deviation 6.02
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: DBP-5.0 millimeter of mercury (mmHg)Standard Deviation 5.76
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: SBP-0.7 millimeter of mercury (mmHg)Standard Deviation 11.64
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: SBP5.0 millimeter of mercury (mmHg)Standard Deviation 15.48
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28:DBP0.7 millimeter of mercury (mmHg)Standard Deviation 6.53
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: SBP1.0 millimeter of mercury (mmHg)Standard Deviation 8.56
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: DBP-2.7 millimeter of mercury (mmHg)Standard Deviation 7.87
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: SBP2.0 millimeter of mercury (mmHg)Standard Deviation 15.13
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 84:DBP-6.7 millimeter of mercury (mmHg)Standard Deviation 7.97
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: DBP78.7 millimeter of mercury (mmHg)Standard Deviation 7.55
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: SBP4.8 millimeter of mercury (mmHg)Standard Deviation 10.82
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: DBP-1.7 millimeter of mercury (mmHg)Standard Deviation 11.48
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1H post-dose Day 1: SBP11.3 millimeter of mercury (mmHg)Standard Deviation 10.71
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 1: DBP-0.3 millimeter of mercury (mmHg)Standard Deviation 7.09
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: DBP-0.3 millimeter of mercury (mmHg)Standard Deviation 6.12
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: SBP-0.7 millimeter of mercury (mmHg)Standard Deviation 19.34
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 84: DBP-0.7 millimeter of mercury (mmHg)Standard Deviation 8.45
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: DBP-3.7 millimeter of mercury (mmHg)Standard Deviation 11.48
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: DBP1.7 millimeter of mercury (mmHg)Standard Deviation 5.99
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: SBP128.0 millimeter of mercury (mmHg)Standard Deviation 10.58
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 1: DBP3.5 millimeter of mercury (mmHg)Standard Deviation 9.38
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: DBP1.0 millimeter of mercury (mmHg)Standard Deviation 8
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: DBP-1.5 millimeter of mercury (mmHg)Standard Deviation 8.09
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 154: SBP-2.7 millimeter of mercury (mmHg)Standard Deviation 8.8
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: DBP2.2 millimeter of mercury (mmHg)Standard Deviation 12.04
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: DBP-0.7 millimeter of mercury (mmHg)Standard Deviation 5.32
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: SBP-2.5 millimeter of mercury (mmHg)Standard Deviation 10.43
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: DBP4.7 millimeter of mercury (mmHg)Standard Deviation 8.26
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: SBP-6.2 millimeter of mercury (mmHg)Standard Deviation 9.43
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: DBP3.7 millimeter of mercury (mmHg)Standard Deviation 9.91
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: SBP-6.7 millimeter of mercury (mmHg)Standard Deviation 16.44
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: DBP-1.2 millimeter of mercury (mmHg)Standard Deviation 6.59
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: DBP-2.2 millimeter of mercury (mmHg)Standard Deviation 8.95
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: DBP-3.2 millimeter of mercury (mmHg)Standard Deviation 10.01
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28:DBP0.0 millimeter of mercury (mmHg)Standard Deviation 12.9
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: SBP-8.8 millimeter of mercury (mmHg)Standard Deviation 10.09
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: DBP5.8 millimeter of mercury (mmHg)Standard Deviation 11.74
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1H post-dose Day 1: SBP-5.7 millimeter of mercury (mmHg)Standard Deviation 16.56
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: SBP-0.8 millimeter of mercury (mmHg)Standard Deviation 11.18
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: DBP0.3 millimeter of mercury (mmHg)Standard Deviation 10.98
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: DBP3.3 millimeter of mercury (mmHg)Standard Deviation 9.2
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: DBP-0.5 millimeter of mercury (mmHg)Standard Deviation 11.93
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28: SBP-5.5 millimeter of mercury (mmHg)Standard Deviation 12.29
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: SBP0.3 millimeter of mercury (mmHg)Standard Deviation 12.31
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: DBP4.2 millimeter of mercury (mmHg)Standard Deviation 10.82
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 9.61
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: SBP-1.7 millimeter of mercury (mmHg)Standard Deviation 7.34
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 17.42
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: DBP2.5 millimeter of mercury (mmHg)Standard Deviation 11.2
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: SBP-1.8 millimeter of mercury (mmHg)Standard Deviation 16.57
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Pre-dose Day 84: SBP-0.8 millimeter of mercury (mmHg)Standard Deviation 8.91
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: DBP0.0 millimeter of mercury (mmHg)Standard Deviation 11.51
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: DBP-1.7 millimeter of mercury (mmHg)Standard Deviation 8.48
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8H post-dose Day 84: SBP-7.0 millimeter of mercury (mmHg)Standard Deviation 12.62
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 11.29
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: SBP-10.7 millimeter of mercury (mmHg)Standard Deviation 18.53
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112:DBP0.0 millimeter of mercury (mmHg)Standard Deviation 10.73
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: SBP-1.2 millimeter of mercury (mmHg)Standard Deviation 17.28
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: SBP128.7 millimeter of mercury (mmHg)Standard Deviation 18.05
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112: SBP-2.7 millimeter of mercury (mmHg)Standard Deviation 10.25
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: DBP3.3 millimeter of mercury (mmHg)Standard Deviation 10.8
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: SBP0.2 millimeter of mercury (mmHg)Standard Deviation 12.59
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: SBP-2.3 millimeter of mercury (mmHg)Standard Deviation 16.42
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: SBP-5.3 millimeter of mercury (mmHg)Standard Deviation 15.47
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: DBP0.3 millimeter of mercury (mmHg)Standard Deviation 12.23
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: SBP4.7 millimeter of mercury (mmHg)Standard Deviation 14.88
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 304/ET: DBP1.3 millimeter of mercury (mmHg)Standard Deviation 11.57
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 12.75
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 154: DBP2.5 millimeter of mercury (mmHg)Standard Deviation 8.85
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 84:DBP-3.0 millimeter of mercury (mmHg)Standard Deviation 8.07
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 304/ET: SBP-1.7 millimeter of mercury (mmHg)Standard Deviation 9.07
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: DBP75.0 millimeter of mercury (mmHg)Standard Deviation 10.56
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: SBP-1.5 millimeter of mercury (mmHg)Standard Deviation 9.29
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 84: DBP0.8 millimeter of mercury (mmHg)Standard Deviation 14.76
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: SBP-11.8 millimeter of mercury (mmHg)Standard Deviation 7.96
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: SBP127.3 millimeter of mercury (mmHg)Standard Deviation 7.37
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1H post-dose Day 1: SBP3.8 millimeter of mercury (mmHg)Standard Deviation 11.7
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: SBP2.2 millimeter of mercury (mmHg)Standard Deviation 9.64
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: SBP-5.0 millimeter of mercury (mmHg)Standard Deviation 8.29
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: SBP-1.5 millimeter of mercury (mmHg)Standard Deviation 7.74
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: SBP-7.2 millimeter of mercury (mmHg)Standard Deviation 11.84
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: SBP-8.6 millimeter of mercury (mmHg)Standard Deviation 8.35
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 11.76
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28: SBP3.6 millimeter of mercury (mmHg)Standard Deviation 11.8
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: SBP-1.6 millimeter of mercury (mmHg)Standard Deviation 23.42
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: SBP-4.5 millimeter of mercury (mmHg)Standard Deviation 14.71
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: SBP-0.2 millimeter of mercury (mmHg)Standard Deviation 11.58
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: SBP1.8 millimeter of mercury (mmHg)Standard Deviation 15.88
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Pre-dose Day 84: SBP-0.3 millimeter of mercury (mmHg)Standard Deviation 15.88
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8H post-dose Day 84: SBP3.8 millimeter of mercury (mmHg)Standard Deviation 10.3
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: SBP5.5 millimeter of mercury (mmHg)Standard Deviation 8.62
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: SBP-0.5 millimeter of mercury (mmHg)Standard Deviation 10.35
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112: SBP-1.7 millimeter of mercury (mmHg)Standard Deviation 11.64
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: SBP1.0 millimeter of mercury (mmHg)Standard Deviation 9.75
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: SBP-2.8 millimeter of mercury (mmHg)Standard Deviation 8.16
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: SBP-3.0 millimeter of mercury (mmHg)Standard Deviation 12.81
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: SBP-1.0 millimeter of mercury (mmHg)Standard Deviation 13.71
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 304/ET: SBP0.5 millimeter of mercury (mmHg)Standard Deviation 18.57
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: DBP80.3 millimeter of mercury (mmHg)Standard Deviation 7.74
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 1: DBP3.0 millimeter of mercury (mmHg)Standard Deviation 8.44
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: DBP0.2 millimeter of mercury (mmHg)Standard Deviation 8.01
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: DBP-4.7 millimeter of mercury (mmHg)Standard Deviation 8.8
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: DBP-2.7 millimeter of mercury (mmHg)Standard Deviation 9.44
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: DBP-3.7 millimeter of mercury (mmHg)Standard Deviation 10.63
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: DBP-5.4 millimeter of mercury (mmHg)Standard Deviation 4.45
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: DBP-2.8 millimeter of mercury (mmHg)Standard Deviation 11.72
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28:DBP2.6 millimeter of mercury (mmHg)Standard Deviation 4.22
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: DBP-4.6 millimeter of mercury (mmHg)Standard Deviation 11.99
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: DBP-1.0 millimeter of mercury (mmHg)Standard Deviation 5.06
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: DBP1.4 millimeter of mercury (mmHg)Standard Deviation 7.2
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: SBP-3.3 millimeter of mercury (mmHg)Standard Deviation 8.57
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: SBP-0.7 millimeter of mercury (mmHg)Standard Deviation 3.33
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 154: SBP-6.7 millimeter of mercury (mmHg)Standard Deviation 8.24
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: DBP-4.6 millimeter of mercury (mmHg)Standard Deviation 5.59
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 84: DBP-1.2 millimeter of mercury (mmHg)Standard Deviation 11.39
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 84:DBP0.5 millimeter of mercury (mmHg)Standard Deviation 10.25
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: DBP2.2 millimeter of mercury (mmHg)Standard Deviation 7.96
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: DBP-2.3 millimeter of mercury (mmHg)Standard Deviation 5.01
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112:DBP-1.0 millimeter of mercury (mmHg)Standard Deviation 6.93
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: DBP-3.4 millimeter of mercury (mmHg)Standard Deviation 8.99
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: DBP1.0 millimeter of mercury (mmHg)Standard Deviation 14.52
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: DBP-1.3 millimeter of mercury (mmHg)Standard Deviation 10.19
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: DBP-6.5 millimeter of mercury (mmHg)Standard Deviation 8.24
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: DBP-4.5 millimeter of mercury (mmHg)Standard Deviation 7.09
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 154: DBP-5.5 millimeter of mercury (mmHg)Standard Deviation 5.79
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: DBP-4.8 millimeter of mercury (mmHg)Standard Deviation 7
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: DBP-3.0 millimeter of mercury (mmHg)Standard Deviation 4.52
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 304/ET: DBP1.2 millimeter of mercury (mmHg)Standard Deviation 16.41
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 1: DBP-3.3 millimeter of mercury (mmHg)Standard Deviation 7.26
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: DBP76.7 millimeter of mercury (mmHg)Standard Deviation 5.99
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: SBP-4.0 millimeter of mercury (mmHg)Standard Deviation 4.15
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 84: DBP2.2 millimeter of mercury (mmHg)Standard Deviation 7.66
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 304/ET: SBP2.3 millimeter of mercury (mmHg)Standard Deviation 15.52
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: SBP5.4 millimeter of mercury (mmHg)Standard Deviation 20.51
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: DBP-0.5 millimeter of mercury (mmHg)Standard Deviation 5.96
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 84:DBP-2.0 millimeter of mercury (mmHg)Standard Deviation 6.67
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 224/ET: SBP5.5 millimeter of mercury (mmHg)Standard Deviation 9.93
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: SBP2.6 millimeter of mercury (mmHg)Standard Deviation 8.56
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 154: DBP-4.0 millimeter of mercury (mmHg)Standard Deviation 4.97
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: DBP3.4 millimeter of mercury (mmHg)Standard Deviation 4.04
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: SBP12.2 millimeter of mercury (mmHg)Standard Deviation 13.2
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112: SBP7.4 millimeter of mercury (mmHg)Standard Deviation 14.62
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: SBP0.8 millimeter of mercury (mmHg)Standard Deviation 4.62
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: DBP4.4 millimeter of mercury (mmHg)Standard Deviation 4.39
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 112: SBP12.8 millimeter of mercury (mmHg)Standard Deviation 8.87
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 103: SBP11.4 millimeter of mercury (mmHg)Standard Deviation 12.03
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: SBP2.7 millimeter of mercury (mmHg)Standard Deviation 12.55
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 112:DBP1.0 millimeter of mercury (mmHg)Standard Deviation 7.55
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8H post-dose Day 84: SBP7.0 millimeter of mercury (mmHg)Standard Deviation 13.58
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Pre-dose Day 84: SBP10.0 millimeter of mercury (mmHg)Standard Deviation 9.67
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: SBP5.2 millimeter of mercury (mmHg)Standard Deviation 11.12
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 131: DBP0.0 millimeter of mercury (mmHg)Standard Deviation 5.34
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: SBP6.0 millimeter of mercury (mmHg)Standard Deviation 11.77
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: SBP8.2 millimeter of mercury (mmHg)Standard Deviation 17.48
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 168: DBP1.0 millimeter of mercury (mmHg)Standard Deviation 5.92
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 140: DBP-0.4 millimeter of mercury (mmHg)Standard Deviation 5.32
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: SBP3.2 millimeter of mercury (mmHg)Standard Deviation 9.52
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: SBP4.3 millimeter of mercury (mmHg)Standard Deviation 7.12
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1H post-dose Day 1: SBP2.5 millimeter of mercury (mmHg)Standard Deviation 6.38
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 1 H post-dose Day 140: DBP-2.2 millimeter of mercury (mmHg)Standard Deviation 6.22
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28: SBP7.3 millimeter of mercury (mmHg)Standard Deviation 18.69
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: SBP-0.3 millimeter of mercury (mmHg)Standard Deviation 9.56
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureBaseline: SBP125.3 millimeter of mercury (mmHg)Standard Deviation 12.19
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: DBP-2.2 millimeter of mercury (mmHg)Standard Deviation 5.22
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose day 56: DBP-3.0 millimeter of mercury (mmHg)Standard Deviation 6.44
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 56: DBP2.3 millimeter of mercury (mmHg)Standard Deviation 8.73
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 45: DBP-2.0 millimeter of mercury (mmHg)Standard Deviation 10.97
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4-8 H post-dose Day 28:DBP-4.5 millimeter of mercury (mmHg)Standard Deviation 7.15
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at pre-dose Day 28: DBP-4.8 millimeter of mercury (mmHg)Standard Deviation 8.16
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: DBP-3.7 millimeter of mercury (mmHg)Standard Deviation 6.83
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: DBP-1.3 millimeter of mercury (mmHg)Standard Deviation 6.06
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 19: SBP-1.3 millimeter of mercury (mmHg)Standard Deviation 3.2
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post dose Day 140: SBP12.4 millimeter of mercury (mmHg)Standard Deviation 7.44
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 7: DBP-2.3 millimeter of mercury (mmHg)Standard Deviation 6.47
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post-dose Day 2: DBP-2.2 millimeter of mercury (mmHg)Standard Deviation 8.82
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 14: SBP2.8 millimeter of mercury (mmHg)Standard Deviation 7.49
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: SBP10.2 millimeter of mercury (mmHg)Standard Deviation 11.99
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 4 H post-dose Day 1: DBP-4.3 millimeter of mercury (mmHg)Standard Deviation 4.03
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 304/ET: DBP2.8 millimeter of mercury (mmHg)Standard Deviation 4.99
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 154: SBP0.3 millimeter of mercury (mmHg)Standard Deviation 7.41
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at 24 H post dose Day 141: DBP0.6 millimeter of mercury (mmHg)Standard Deviation 6.73
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Systolic and Diastolic Blood PressureChange at Day 75: DBP-1.2 millimeter of mercury (mmHg)Standard Deviation 6.53
Secondary

Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Temperature

Time frame: Baseline, 1 and 4 H post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET

Population: Safety analysis set included all randomized participants who received any amount of study drug. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post dose Day 1410.00 Degree CelsiusStandard Deviation 0.21
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 75-0.15 Degree CelsiusStandard Deviation 0.437
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose day 560.22 Degree CelsiusStandard Deviation 0.313
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 280.18 Degree CelsiusStandard Deviation 0.204
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post dose Day 1400.23 Degree CelsiusStandard Deviation 0.197
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 560.05 Degree CelsiusStandard Deviation 0.476
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 450.13 Degree CelsiusStandard Deviation 0.413
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 280.28 Degree CelsiusStandard Deviation 0.172
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post-dose Day 10.18 Degree CelsiusStandard Deviation 0.571
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1680.27 Degree CelsiusStandard Deviation 0.459
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1 H post-dose Day 1400.02 Degree CelsiusStandard Deviation 0.496
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 1400.10 Degree CelsiusStandard Deviation 0.352
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post-dose Day 20.22 Degree CelsiusStandard Deviation 0.204
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureBaseline36.40 Degree CelsiusStandard Deviation 0.228
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1310.18 Degree CelsiusStandard Deviation 0.387
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 1120.03 Degree CelsiusStandard Deviation 0.437
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 70.15 Degree CelsiusStandard Deviation 0.226
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1H post-dose Day 10.30 Degree CelsiusStandard Deviation 0.405
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 112-0.08 Degree CelsiusStandard Deviation 0.512
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1030.05 Degree CelsiusStandard Deviation 0.394
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 140.37 Degree CelsiusStandard Deviation 0.35
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 224/ET0.03 Degree CelsiusStandard Deviation 0.446
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 84-0.13 Degree CelsiusStandard Deviation 0.665
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 84-0.03 Degree CelsiusStandard Deviation 0.216
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 190.43 Degree CelsiusStandard Deviation 0.234
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post-dose Day 20.12 Degree CelsiusStandard Deviation 0.232
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureBaseline36.72 Degree CelsiusStandard Deviation 0.256
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1H post-dose Day 10.10 Degree CelsiusStandard Deviation 0.253
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post-dose Day 10.08 Degree CelsiusStandard Deviation 0.133
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 70.05 Degree CelsiusStandard Deviation 0.315
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 14-0.03 Degree CelsiusStandard Deviation 0.327
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 19-0.12 Degree CelsiusStandard Deviation 0.271
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 28-0.10 Degree CelsiusStandard Deviation 0.283
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 280.15 Degree CelsiusStandard Deviation 0.339
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 450.12 Degree CelsiusStandard Deviation 0.483
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 560.08 Degree CelsiusStandard Deviation 0.366
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose day 560.13 Degree CelsiusStandard Deviation 0.273
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 750.07 Degree CelsiusStandard Deviation 0.333
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 84-0.03 Degree CelsiusStandard Deviation 0.32
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 840.00 Degree CelsiusStandard Deviation 0.167
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 103-0.08 Degree CelsiusStandard Deviation 0.462
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 1120.12 Degree CelsiusStandard Deviation 0.279
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 1120.12 Degree CelsiusStandard Deviation 0.387
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1310.02 Degree CelsiusStandard Deviation 0.458
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 140-0.05 Degree CelsiusStandard Deviation 0.432
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1 H post-dose Day 1400.08 Degree CelsiusStandard Deviation 0.407
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post dose Day 1400.05 Degree CelsiusStandard Deviation 0.428
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post dose Day 1410.08 Degree CelsiusStandard Deviation 0.248
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1540.07 Degree CelsiusStandard Deviation 0.266
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 168-0.12 Degree CelsiusStandard Deviation 0.293
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 224/ET0.07 Degree CelsiusStandard Deviation 0.234
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 304/ET-0.10 Degree CelsiusStandard Deviation 0.283
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 7-0.40 Degree CelsiusStandard Deviation 0.405
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 840.02 Degree CelsiusStandard Deviation 0.147
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 140.08 Degree CelsiusStandard Deviation 0.117
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 154-0.25 Degree CelsiusStandard Deviation 0.414
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 840.03 Degree CelsiusStandard Deviation 0.103
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 103-0.10 Degree CelsiusStandard Deviation 0.219
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 112-0.15 Degree CelsiusStandard Deviation 0.274
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 112-0.22 Degree CelsiusStandard Deviation 0.293
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post-dose Day 2-0.32 Degree CelsiusStandard Deviation 0.371
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 168-0.18 Degree CelsiusStandard Deviation 0.264
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 131-0.14 Degree CelsiusStandard Deviation 0.288
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 140-0.07 Degree CelsiusStandard Deviation 0.207
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post-dose Day 10.03 Degree CelsiusStandard Deviation 0.207
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureBaseline36.87 Degree CelsiusStandard Deviation 0.082
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1 H post-dose Day 140-0.03 Degree CelsiusStandard Deviation 0.197
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 304/ET-0.10 Degree CelsiusStandard Deviation 0.167
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post dose Day 140-0.12 Degree CelsiusStandard Deviation 0.248
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 280.00 Degree CelsiusStandard Deviation 0.158
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1H post-dose Day 1-0.10 Degree CelsiusStandard Deviation 0.19
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 45-0.06 Degree CelsiusStandard Deviation 0.195
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 28-0.02 Degree CelsiusStandard Deviation 0.172
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 224/ET-0.07 Degree CelsiusStandard Deviation 0.288
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 560.03 Degree CelsiusStandard Deviation 0.175
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post dose Day 141-0.18 Degree CelsiusStandard Deviation 0.183
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose day 560.12 Degree CelsiusStandard Deviation 0.084
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 190.04 Degree CelsiusStandard Deviation 0.288
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 75-0.06 Degree CelsiusStandard Deviation 0.279
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 140-0.02 Degree CelsiusStandard Deviation 0.311
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 224/ET0.03 Degree CelsiusStandard Deviation 0.472
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 560.07 Degree CelsiusStandard Deviation 0.35
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 84-0.10 Degree CelsiusStandard Deviation 0.4
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 19-0.02 Degree CelsiusStandard Deviation 0.183
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 450.03 Degree CelsiusStandard Deviation 0.516
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1 H post-dose Day 140-0.30 Degree CelsiusStandard Deviation 0.224
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 840.10 Degree CelsiusStandard Deviation 0.274
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 70.00 Degree CelsiusStandard Deviation 0.276
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1540.00 Degree CelsiusStandard Deviation 0.141
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 1H post-dose Day 10.08 Degree CelsiusStandard Deviation 0.183
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 103-0.06 Degree CelsiusStandard Deviation 0.251
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 140.05 Degree CelsiusStandard Deviation 0.243
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureBaseline36.72 Degree CelsiusStandard Deviation 0.397
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 75-0.28 Degree CelsiusStandard Deviation 0.383
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 112-0.20 Degree CelsiusStandard Deviation 0.292
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post-dose Day 2-0.08 Degree CelsiusStandard Deviation 0.515
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 304/ET-0.08 Degree CelsiusStandard Deviation 0.15
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 24 H post dose Day 141-0.14 Degree CelsiusStandard Deviation 0.365
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 1120.06 Degree CelsiusStandard Deviation 0.336
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post dose Day 140-0.14 Degree CelsiusStandard Deviation 0.27
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose day 560.00 Degree CelsiusStandard Deviation 0.436
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4-8 H post-dose Day 280.03 Degree CelsiusStandard Deviation 0.186
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 131-0.04 Degree CelsiusStandard Deviation 0.261
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at 4 H post-dose Day 10.17 Degree CelsiusStandard Deviation 0.327
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at Day 1680.12 Degree CelsiusStandard Deviation 0.192
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: TemperatureChange at pre-dose Day 28-0.17 Degree CelsiusStandard Deviation 0.294
Secondary

Change From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: Weight

Time frame: Baseline, 1 and 4 H post-dose on Day 1; 24 H post-dose on Days 2 and 141; pre-dose and 4 - 8 H post-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 7, 14, 19, 45, 75, 103;131, 141, 154 168, 224 and 304/ET

Population: Safety analysis set included all randomized participants who received any amount of study drug. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 103-0.60 KilogramStandard Deviation 4.787
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1401.06 KilogramStandard Deviation 0.833
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1120.67 KilogramStandard Deviation 1.118
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 280.46 KilogramStandard Deviation 0.749
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1311.35 KilogramStandard Deviation 1.354
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 224/ ET0.85 KilogramStandard Deviation 0.976
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 450.71 KilogramStandard Deviation 1.654
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightBaseline81.74 KilogramStandard Deviation 9.975
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 560.72 KilogramStandard Deviation 1.425
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 190.25 KilogramStandard Deviation 0.709
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1681.74 KilogramStandard Deviation 2.723
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 750.60 KilogramStandard Deviation 1.464
RN6G 5 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 840.63 KilogramStandard Deviation 1.538
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 45-0.49 KilogramStandard Deviation 2.298
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 19-0.05 KilogramStandard Deviation 1.588
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 168-1.35 KilogramStandard Deviation 4.393
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 103-0.75 KilogramStandard Deviation 3.213
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 224/ ET-1.97 KilogramStandard Deviation 4.284
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 154-3.78 KilogramStandard Deviation 8.246
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 56-0.99 KilogramStandard Deviation 2.371
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1120.05 KilogramStandard Deviation 3.638
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 140-0.36 KilogramStandard Deviation 4.233
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 131-0.43 KilogramStandard Deviation 4.197
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 84-0.54 KilogramStandard Deviation 3.194
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 28-0.12 KilogramStandard Deviation 2.098
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 304/ET0.71 KilogramStandard Deviation 6.545
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightBaseline85.85 KilogramStandard Deviation 8.443
RN6G 10 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 75-0.46 KilogramStandard Deviation 3.267
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 450.52 KilogramStandard Deviation 0.899
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightBaseline78.58 KilogramStandard Deviation 12.497
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 190.09 KilogramStandard Deviation 1.33
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 280.02 KilogramStandard Deviation 1.172
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 56-1.21 KilogramStandard Deviation 2.942
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 750.48 KilogramStandard Deviation 0.883
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 84-0.16 KilogramStandard Deviation 0.943
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1030.22 KilogramStandard Deviation 1.249
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 112-0.05 KilogramStandard Deviation 0.731
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 131-0.08 KilogramStandard Deviation 0.646
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 140-0.46 KilogramStandard Deviation 1.248
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 154-0.57 KilogramStandard Deviation 1.301
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 168-0.84 KilogramStandard Deviation 1.237
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 224/ ET1.49 KilogramStandard Deviation 4.376
RN6G 15 mg/kgChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 304/ET3.04 KilogramStandard Deviation 4.327
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1401.37 KilogramStandard Deviation 1.708
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 750.98 KilogramStandard Deviation 0.641
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 224/ ET1.42 KilogramStandard Deviation 1.679
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1541.03 KilogramStandard Deviation 1.464
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 560.52 KilogramStandard Deviation 0.616
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 450.36 KilogramStandard Deviation 1.219
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightBaseline80.14 KilogramStandard Deviation 21.43
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1681.26 KilogramStandard Deviation 1.312
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 280.29 KilogramStandard Deviation 0.661
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1121.43 KilogramStandard Deviation 1.097
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 190.93 KilogramStandard Deviation 0.945
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1311.67 KilogramStandard Deviation 1.159
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 1031.23 KilogramStandard Deviation 1.49
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 840.99 KilogramStandard Deviation 1.05
PlaceboChange From Baseline in Vital Signs at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET: WeightChange at Day 304/ET0.60 KilogramStandard Deviation 0.678
Secondary

Change From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ET

QT interval corrected using the Fridericia formula (QTcF) \>=500 msec; Maximum Change from Baseline in QTcF at Borderline \>=30 msec to \<60 msec and Prolonged \>=60 msec.

Time frame: Baseline, 1 and 4 H post-dose on Day 1; pre-dose on Days 28, 56, 84, 112; pre-dose and 1, 4 H post-dose on Day 140; Day 168, 224 and 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcF-5.22 Millisecond (msec)Standard Deviation 8.005
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcF-2.67 Millisecond (msec)Standard Deviation 7.598
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcF1.50 Millisecond (msec)Standard Deviation 14.898
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcF-3.17 Millisecond (msec)Standard Deviation 7.001
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcF-2.28 Millisecond (msec)Standard Deviation 9.488
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcF-4.39 Millisecond (msec)Standard Deviation 6.533
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcF-4.72 Millisecond (msec)Standard Deviation 15.874
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcF0.56 Millisecond (msec)Standard Deviation 8.035
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcF-2.22 Millisecond (msec)Standard Deviation 13.404
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcF-8.56 Millisecond (msec)Standard Deviation 16.363
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcF-1.39 Millisecond (msec)Standard Deviation 10.438
RN6G 5 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcF414.22 Millisecond (msec)Standard Deviation 13.474
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcF427.89 Millisecond (msec)Standard Deviation 21.462
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcF-12.06 Millisecond (msec)Standard Deviation 14.565
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcF-11.22 Millisecond (msec)Standard Deviation 11.485
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcF-3.28 Millisecond (msec)Standard Deviation 8.51
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcF-5.89 Millisecond (msec)Standard Deviation 10.681
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcF-0.11 Millisecond (msec)Standard Deviation 8.614
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcF-1.22 Millisecond (msec)Standard Deviation 12.523
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcF-9.72 Millisecond (msec)Standard Deviation 14.22
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcF-6.06 Millisecond (msec)Standard Deviation 9.799
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcF-15.83 Millisecond (msec)Standard Deviation 36.907
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcF-8.78 Millisecond (msec)Standard Deviation 13.48
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QTcF-6.72 Millisecond (msec)Standard Deviation 14.685
RN6G 10 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcF-1.50 Millisecond (msec)Standard Deviation 4.732
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcF12.72 Millisecond (msec)Standard Deviation 8.172
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcF420.56 Millisecond (msec)Standard Deviation 20.579
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcF3.06 Millisecond (msec)Standard Deviation 8.762
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcF1.50 Millisecond (msec)Standard Deviation 13.328
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcF1.78 Millisecond (msec)Standard Deviation 15.022
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcF7.11 Millisecond (msec)Standard Deviation 19.452
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcF6.11 Millisecond (msec)Standard Deviation 20.435
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcF0.78 Millisecond (msec)Standard Deviation 8.275
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcF8.61 Millisecond (msec)Standard Deviation 7.672
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcF10.61 Millisecond (msec)Standard Deviation 11.174
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcF7.94 Millisecond (msec)Standard Deviation 18.671
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcF1.94 Millisecond (msec)Standard Deviation 16.996
RN6G 15 mg/kgChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QTcF-7.39 Millisecond (msec)Standard Deviation 21.754
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 84: QTcF19.00 Millisecond (msec)Standard Deviation 24.226
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post dose Day 140: QTcF11.60 Millisecond (msec)Standard Deviation 19.991
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 56: QTcF6.44 Millisecond (msec)Standard Deviation 15.93
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 28: QTcF-2.06 Millisecond (msec)Standard Deviation 8.41
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETBaseline: QTcF412.06 Millisecond (msec)Standard Deviation 20.201
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 168: QTcF8.40 Millisecond (msec)Standard Deviation 21.483
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 4 H post-dose Day 1: QTcF9.50 Millisecond (msec)Standard Deviation 28.659
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 1: QTcF3.86 Millisecond (msec)Standard Deviation 13.329
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 304/ET: QTcF11.50 Millisecond (msec)Standard Deviation 18.165
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at Day 224/ET: QTcF10.94 Millisecond (msec)Standard Deviation 17.055
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at 1 H post-dose Day 140: QTcF14.13 Millisecond (msec)Standard Deviation 15.604
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 140: QTcF8.87 Millisecond (msec)Standard Deviation 23.092
PlaceboChange From Electrocardiogram (ECG): QTcF Interval (Fridericia's Correction) at Day 1, 28, 56, 84, 112, 140, 168, 224, 304/ETChange at pre-dose Day 112: QTcF25.80 Millisecond (msec)Standard Deviation 39.012
Secondary

Maximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 168, 336 hours on Day 1 and 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (GEOMETRIC_MEAN)Dispersion
RN6G 5 mg/kgMaximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Day 1142.9 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 12
RN6G 5 mg/kgMaximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Day 140185.1 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 16
RN6G 10 mg/kgMaximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Day 140439.8 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 15
RN6G 10 mg/kgMaximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Day 1283.4 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 18
RN6G 15 mg/kgMaximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Day 1524.1 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 66
RN6G 15 mg/kgMaximum Observed Plasma Concentration (Cmax) of RN6G (PF-04382923)Day 140691.7 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 12
Secondary

Mean Residence Time (MRT) of RN6G (PF-04382923)

The mean total time drug resides in the body.

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureValue (MEAN)Dispersion
RN6G 5 mg/kgMean Residence Time (MRT) of RN6G (PF-04382923)818.1 HourStandard Deviation 182.15
RN6G 10 mg/kgMean Residence Time (MRT) of RN6G (PF-04382923)1274 HourStandard Deviation 352.28
RN6G 15 mg/kgMean Residence Time (MRT) of RN6G (PF-04382923)1121 HourStandard Deviation 135.38
Secondary

Minimum Observed Plasma Trough Concentration (Cmin) of RN6G (PF-04382923)

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureValue (GEOMETRIC_MEAN)Dispersion
RN6G 5 mg/kgMinimum Observed Plasma Trough Concentration (Cmin) of RN6G (PF-04382923)38.43 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 40
RN6G 10 mg/kgMinimum Observed Plasma Trough Concentration (Cmin) of RN6G (PF-04382923)119.7 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 23
RN6G 15 mg/kgMinimum Observed Plasma Trough Concentration (Cmin) of RN6G (PF-04382923)201.5 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 27
Secondary

Percent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET

Time frame: Day 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 193048.1 percent changeStandard Deviation 934.03
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 11283.4 percent changeStandard Deviation 428.98
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1125736.6 percent changeStandard Deviation 2367.32
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 1406750.1 percent changeStandard Deviation 1605.57
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 281836.7 percent changeStandard Deviation 528.74
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 1409035.4 percent changeStandard Deviation 2212.53
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 78153.4 percent changeStandard Deviation 3691.2
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14113778.6 percent changeStandard Deviation 4413.73
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 456632.8 percent changeStandard Deviation 2095.25
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 26536.9 percent changeStandard Deviation 1533.6
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 12129.1 percent changeStandard Deviation 971.74
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 1408274.4 percent changeStandard Deviation 2373.14
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 564104.0 percent changeStandard Deviation 781.38
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1687539.0 percent changeStandard Deviation 2097.66
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 144001.5 percent changeStandard Deviation 1313.42
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 14010332.3 percent changeStandard Deviation 2454.3
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 757033.1 percent changeStandard Deviation 1783.12
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1319742.8 percent changeStandard Deviation 1628.75
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1838.8 percent changeStandard Deviation 262.62
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1038033.3 percent changeStandard Deviation 2202.15
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 845034.2 percent changeStandard Deviation 1396.44
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2242277.4 percent changeStandard Deviation 870.42
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET1263.2 percent changeStandard Deviation 640.49
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 14013326.7 percent changeStandard Deviation 1838.41
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8410287.0 percent changeStandard Deviation 2294.92
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 10312858.0 percent changeStandard Deviation 1914.67
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 14012713.5 percent changeStandard Deviation 2035.1
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11211719.8 percent changeStandard Deviation 2354.18
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 25332.4 percent changeStandard Deviation 437.02
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 13113197.8 percent changeStandard Deviation 1567.68
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 1409991.6 percent changeStandard Deviation 4745.47
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 16810766.1 percent changeStandard Deviation 2561.52
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 79483.1 percent changeStandard Deviation 2136.77
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 11051.5 percent changeStandard Deviation 230.65
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 148124.3 percent changeStandard Deviation 1400.09
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 15412461.9 percent changeStandard Deviation 1481.16
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 196169.0 percent changeStandard Deviation 996.4
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1660.9 percent changeStandard Deviation 101.2
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14115838.7 percent changeStandard Deviation 2208.15
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 284501.8 percent changeStandard Deviation 758.64
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2244228.9 percent changeStandard Deviation 1141.96
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 459614.6 percent changeStandard Deviation 1371.1
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 14012606.4 percent changeStandard Deviation 1626.29
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 567229.3 percent changeStandard Deviation 1982.4
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 11649.8 percent changeStandard Deviation 190.06
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7512296.0 percent changeStandard Deviation 1777.75
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 149132.2 percent changeStandard Deviation 1770.33
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1752.8 percent changeStandard Deviation 247.2
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 11082.6 percent changeStandard Deviation 225.11
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 11509.3 percent changeStandard Deviation 255.86
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 25328.4 percent changeStandard Deviation 422.35
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 711658.5 percent changeStandard Deviation 2346.26
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 198606.3 percent changeStandard Deviation 2099.47
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 287485.9 percent changeStandard Deviation 2422.75
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 4511600.4 percent changeStandard Deviation 1173.09
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 569938.9 percent changeStandard Deviation 2032.57
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7512933.0 percent changeStandard Deviation 1384.7
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8411153.8 percent changeStandard Deviation 978.44
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 10314043.1 percent changeStandard Deviation 3217.61
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11213528.7 percent changeStandard Deviation 1209.21
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 13117840.0 percent changeStandard Deviation 3578.16
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 14016216.1 percent changeStandard Deviation 2105.17
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 14016473.9 percent changeStandard Deviation 3063.74
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 14017173.8 percent changeStandard Deviation 2625.79
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 14017656.9 percent changeStandard Deviation 7083.3
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14119190.4 percent changeStandard Deviation 4117.8
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 15422722.9 percent changeStandard Deviation 2317.53
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 16817703.0 percent changeStandard Deviation 3291.42
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2246880.8 percent changeStandard Deviation 2087.34
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET1603.7 percent changeStandard Deviation 481.43
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 13.2 percent changeStandard Deviation 12.13
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 140-11.2 percent changeStandard Deviation 9.09
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 56-2.8 percent changeStandard Deviation 23.72
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 451.0 percent changeStandard Deviation 22.07
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 11.8 percent changeStandard Deviation 12.92
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 140-9.6 percent changeStandard Deviation 13.47
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 28-0.7 percent changeStandard Deviation 8.35
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 196.5 percent changeStandard Deviation 15.76
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET10.9 percent changeStandard Deviation 32.02
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 141-7.8 percent changeStandard Deviation 15.61
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14-2.1 percent changeStandard Deviation 5.38
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 22414.5 percent changeStandard Deviation 35.7
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 154-12.7 percent changeStandard Deviation 13.89
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7-1.0 percent changeStandard Deviation 7.54
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2-0.4 percent changeStandard Deviation 10.07
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1314.9 percent changeStandard Deviation 23.25
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 10.4 percent changeStandard Deviation 9.79
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 14016.6 percent changeStandard Deviation 51.02
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 112-6.4 percent changeStandard Deviation 15.2
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 103-4.5 percent changeStandard Deviation 16.16
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 168-5.3 percent changeStandard Deviation 22.33
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 140-1.5 percent changeStandard Deviation 18.15
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 84-3.5 percent changeStandard Deviation 28.74
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-40) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 75-12.5 percent changeStandard Deviation 9.43
Secondary

Percent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET

Time frame: Day 1 (1 hour, 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1943.0 percent changeStandard Deviation 20.81
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 1257.8 percent changeStandard Deviation 101.75
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11283.2 percent changeStandard Deviation 46.16
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 140111.1 percent changeStandard Deviation 25.89
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2815.9 percent changeStandard Deviation 14.37
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 140337.7 percent changeStandard Deviation 67.82
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7129.8 percent changeStandard Deviation 71.07
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 141360.6 percent changeStandard Deviation 70.15
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 4592.5 percent changeStandard Deviation 17.6
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2278.1 percent changeStandard Deviation 163.6
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 1306.4 percent changeStandard Deviation 111.88
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 140264.4 percent changeStandard Deviation 55.03
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 5655.8 percent changeStandard Deviation 34.06
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 168119.7 percent changeStandard Deviation 30.44
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1459.7 percent changeStandard Deviation 38.36
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 140397.0 percent changeStandard Deviation 70.71
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7587.8 percent changeStandard Deviation 38.89
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 131168.4 percent changeStandard Deviation 41.44
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1199.0 percent changeStandard Deviation 74.28
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 103128.9 percent changeStandard Deviation 42.92
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8477.0 percent changeStandard Deviation 16.8
RN6G 5 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 22429.7 percent changeStandard Deviation 37.85
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET15.4 percent changeStandard Deviation 66.96
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 140394.6 percent changeStandard Deviation 196.64
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 84146.3 percent changeStandard Deviation 146.97
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 103207.3 percent changeStandard Deviation 159.23
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 140345.7 percent changeStandard Deviation 201.63
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 112207.4 percent changeStandard Deviation 176.39
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2461.6 percent changeStandard Deviation 175.95
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 131249.0 percent changeStandard Deviation 204.05
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 140185.8 percent changeStandard Deviation 164.1
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 168176.4 percent changeStandard Deviation 159.42
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7164.3 percent changeStandard Deviation 114.69
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 1254.3 percent changeStandard Deviation 104.05
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14121.1 percent changeStandard Deviation 132.7
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 154241.5 percent changeStandard Deviation 196.56
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1987.2 percent changeStandard Deviation 92.62
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1163.7 percent changeStandard Deviation 102.35
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 141539.2 percent changeStandard Deviation 291.07
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2836.5 percent changeStandard Deviation 57.79
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 22427.1 percent changeStandard Deviation 74.59
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 45118.9 percent changeStandard Deviation 116.56
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 140459.8 percent changeStandard Deviation 234.24
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 56102.2 percent changeStandard Deviation 74.51
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 1341.8 percent changeStandard Deviation 174.55
RN6G 10 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 75172.1 percent changeStandard Deviation 141.94
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14163.7 percent changeStandard Deviation 37.92
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1340.2 percent changeStandard Deviation 133.1
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 1412.7 percent changeStandard Deviation 98.9
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 1545.8 percent changeStandard Deviation 131.45
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2708.5 percent changeStandard Deviation 200.76
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7306.5 percent changeStandard Deviation 45.29
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 19153.3 percent changeStandard Deviation 25.6
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 28157.6 percent changeStandard Deviation 103.15
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 45267.5 percent changeStandard Deviation 59.75
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 56220.4 percent changeStandard Deviation 62.44
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 75314.3 percent changeStandard Deviation 75.17
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 84224.2 percent changeStandard Deviation 40.97
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 103315.3 percent changeStandard Deviation 127.45
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 112275.2 percent changeStandard Deviation 92.55
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 131393.6 percent changeStandard Deviation 66.08
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 140297.3 percent changeStandard Deviation 48.94
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 140553.7 percent changeStandard Deviation 122.06
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 140637.8 percent changeStandard Deviation 146.28
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 140781.5 percent changeStandard Deviation 165.36
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 141889.4 percent changeStandard Deviation 267.61
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 154506.2 percent changeStandard Deviation 142.03
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 168366.6 percent changeStandard Deviation 91.33
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 224102.6 percent changeStandard Deviation 41.52
RN6G 15 mg/kgPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET11.0 percent changeStandard Deviation 12.78
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H post-dose Day 110.4 percent changeStandard Deviation 12.86
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 140-28.8 percent changeStandard Deviation 33.79
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 56-10.7 percent changeStandard Deviation 36.98
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 45-7.7 percent changeStandard Deviation 30.53
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 10.5 percent changeStandard Deviation 23.12
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 140-4.9 percent changeStandard Deviation 53.65
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 28-2.6 percent changeStandard Deviation 18.74
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1920.9 percent changeStandard Deviation 49.01
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET-38.8 percent changeStandard Deviation 22.12
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 141-31.3 percent changeStandard Deviation 20.95
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1421.2 percent changeStandard Deviation 47.33
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2248.2 percent changeStandard Deviation 68.87
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 154-32.3 percent changeStandard Deviation 22.75
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 719.6 percent changeStandard Deviation 58.46
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2-9.8 percent changeStandard Deviation 31.29
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 131-21.1 percent changeStandard Deviation 25.48
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 1-7.0 percent changeStandard Deviation 20.63
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 1400.2 percent changeStandard Deviation 68.99
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 112-20.2 percent changeStandard Deviation 21.83
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 103-16.7 percent changeStandard Deviation 29.36
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 168-22.8 percent changeStandard Deviation 27.34
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 140-24.0 percent changeStandard Deviation 24.14
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 84-12.4 percent changeStandard Deviation 34.64
PlaceboPercent Change From Baseline in Plasma Amyloid (A) Beta (1-42) Concentrations at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 75-23.6 percent changeStandard Deviation 27.01
Secondary

Percent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ET

Time frame: Day 1 (1 hour , 2 hours, 4 hours post dose), 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140 (predose, 1 hour, 2 hours, 4 hours post dose), 141, 154, 168, 224, 304/ET

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Number Analyzed signifies number of participants evaluated for given time point.

ArmMeasureGroupValue (MEAN)Dispersion
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 196096.9 Percent changeStandard Deviation 2660.58
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 11835.9 Percent changeStandard Deviation 859.97
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11212401.6 Percent changeStandard Deviation 5938.63
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 14016323.4 Percent changeStandard Deviation 6890.74
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 283168.7 Percent changeStandard Deviation 1297.49
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 14017418.4 Percent changeStandard Deviation 7204.24
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 717643.7 Percent changeStandard Deviation 7989.43
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14127212.1 Percent changeStandard Deviation 12018.62
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 4514458.4 Percent changeStandard Deviation 7747.84
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 211999.3 Percent changeStandard Deviation 5344.01
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercentage change at 4 H post-dose Day 12899.5 Percent changeStandard Deviation 1575.11
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 14015067.2 Percent changeStandard Deviation 6922.6
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 568156.5 Percent changeStandard Deviation 3005.78
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 16819415.4 Percent changeStandard Deviation 9203.47
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 148930.3 Percent changeStandard Deviation 3978.36
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 14018171.1 Percent changeStandard Deviation 7481.91
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7514815.6 Percent changeStandard Deviation 6477.51
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 13120902.9 Percent changeStandard Deviation 8509.92
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 11194.4 Percent changeStandard Deviation 541.02
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 10317482.8 Percent changeStandard Deviation 6740.53
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8410497.3 Percent changeStandard Deviation 4494.06
RN6G 5 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2247954.0 Percent changeStandard Deviation 5003.96
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET3182.9 Percent changeStandard Deviation 2499.39
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 14027192.5 Percent changeStandard Deviation 19768.55
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8421128.7 Percent changeStandard Deviation 14305.48
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 10328726.4 Percent changeStandard Deviation 20620.23
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 14025462.2 Percent changeStandard Deviation 18562.61
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11226653.1 Percent changeStandard Deviation 19128.49
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 29771.3 Percent changeStandard Deviation 6115.66
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 13131839.9 Percent changeStandard Deviation 22850.11
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 14026584.4 Percent changeStandard Deviation 19667.93
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 16826639.1 Percent changeStandard Deviation 19545.03
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 722214.1 Percent changeStandard Deviation 16132.62
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 11682.9 Percent changeStandard Deviation 1332.55
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1416692.0 Percent changeStandard Deviation 11490.17
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 15437731.7 Percent changeStandard Deviation 28276.18
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1913136.7 Percent changeStandard Deviation 9098.67
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 11032.9 Percent changeStandard Deviation 860.01
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14136042.0 Percent changeStandard Deviation 25934.3
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 288714.5 Percent changeStandard Deviation 5831.88
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2249003.9 Percent changeStandard Deviation 7319.06
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 4525626.3 Percent changeStandard Deviation 16350.32
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 14026342.6 Percent changeStandard Deviation 19070.4
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 5616396.4 Percent changeStandard Deviation 11269.8
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercentage change at 4 H post-dose Day 12044.5 Percent changeStandard Deviation 1595.93
RN6G 10 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7529483.6 Percent changeStandard Deviation 20874.07
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1440069.0 Percent changeStandard Deviation 6897.78
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 11973.6 Percent changeStandard Deviation 911.19
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 12805.4 Percent changeStandard Deviation 1272.35
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercentage change at 4 H post-dose Day 13937.1 Percent changeStandard Deviation 1079.28
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 218931.0 Percent changeStandard Deviation 534.93
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 747008.5 Percent changeStandard Deviation 3530.28
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 1935595.3 Percent changeStandard Deviation 3776.71
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 2828850.5 Percent changeStandard Deviation 7352.55
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 4555139.0 Percent changeStandard Deviation 10148.46
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 5649171.9 Percent changeStandard Deviation 10668.22
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7574636.0 Percent changeStandard Deviation 11949.05
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8460045.8 Percent changeStandard Deviation 2947.55
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 10378724.0 Percent changeStandard Deviation 16617.7
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11270458.8 Percent changeStandard Deviation 8749.39
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 13184383.9 Percent changeStandard Deviation 3636.46
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 14077175.0 Percent changeStandard Deviation 4729.87
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 14070123.0 Percent changeStandard Deviation 7885.1
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 14068054.8 Percent changeStandard Deviation 6441.82
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 14076896.5 Percent changeStandard Deviation 7656.04
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14180464.2 Percent changeStandard Deviation 11546.49
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 15495456.8 Percent changeStandard Deviation 14665.51
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 16880845.7 Percent changeStandard Deviation 10646.37
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 22428846.0 Percent changeStandard Deviation 8155.08
RN6G 15 mg/kgPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET6063.6 Percent changeStandard Deviation 1598.08
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercentage change at 4 H post-dose Day 114.5 Percent changeStandard Deviation 61.22
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H Post dose Day 140-25.9 Percent changeStandard Deviation 21.26
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 5620.9 Percent changeStandard Deviation 120.63
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 4519.0 Percent changeStandard Deviation 84.63
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 2 H post-dose Day 117.7 Percent changeStandard Deviation 37.96
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 4 H Post dose Day 140-29.4 Percent changeStandard Deviation 24.61
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 28-3.3 Percent changeStandard Deviation 72.57
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 19-13.2 Percent changeStandard Deviation 18.08
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 304 / ET-31.6 Percent changeStandard Deviation 27.03
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 141-11.0 Percent changeStandard Deviation 30.66
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 14-12.4 Percent changeStandard Deviation 20.1
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 224-22.2 Percent changeStandard Deviation 27.76
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 154-21.2 Percent changeStandard Deviation 14.56
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 73.1 Percent changeStandard Deviation 13.89
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 24.3 Percent changeStandard Deviation 29.32
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 131-6.5 Percent changeStandard Deviation 28.29
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H post-dose Day 13.8 Percent changeStandard Deviation 21.25
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Pre-dose Day 1406.8 Percent changeStandard Deviation 25.29
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 11275.8 Percent changeStandard Deviation 138.85
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 10348.2 Percent changeStandard Deviation 120.26
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 168-10.1 Percent changeStandard Deviation 29.15
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at 1 H Post dose Day 140-2.3 Percent changeStandard Deviation 23.04
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 8451.2 Percent changeStandard Deviation 124.25
PlaceboPercent Change From Baseline in Plasma Total Amyloid (A) Beta (1-X) Concentration at Day 1, 2, 7, 14, 19, 28, 45, 56, 75, 84, 103, 112, 131, 140, 141, 154, 168, 224, 304/ETPercent change at Day 7572.3 Percent changeStandard Deviation 122.02
Secondary

Plasma Concentration (Css) at Steady State of RN6G (PF-04382923)

Css is the concentration of the drug at the state when the amount of drug administered is equal to the amount of drug eliminated.

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureValue (GEOMETRIC_MEAN)Dispersion
RN6G 5 mg/kgPlasma Concentration (Css) at Steady State of RN6G (PF-04382923)74.75 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 20
RN6G 10 mg/kgPlasma Concentration (Css) at Steady State of RN6G (PF-04382923)208.7 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 14
RN6G 15 mg/kgPlasma Concentration (Css) at Steady State of RN6G (PF-04382923)317.2 Microgram per milliliter (mcg/mL)Geometric Coefficient of Variation 16
Secondary

Plasma Decay Half-Life (t1/2) of RN6G (PF-04382923)

Plasma decay half-life is the time measured for the plasma concentration to decrease by one half.

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureValue (MEAN)Dispersion
RN6G 5 mg/kgPlasma Decay Half-Life (t1/2) of RN6G (PF-04382923)25.14 HourStandard Deviation 5.0774
RN6G 10 mg/kgPlasma Decay Half-Life (t1/2) of RN6G (PF-04382923)42.00 HourStandard Deviation 6.6321
RN6G 15 mg/kgPlasma Decay Half-Life (t1/2) of RN6G (PF-04382923)38.10 HourStandard Deviation 4.9738
Secondary

Systemic Clearance (CL) of RN6G (PF-04382923)

CL is a quantitative measure of the rate at which a drug substance is removed from the body.

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: All randomized participants who met the inclusion criteria and received any amount of study drug were included. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureValue (GEOMETRIC_MEAN)Dispersion
RN6G 5 mg/kgSystemic Clearance (CL) of RN6G (PF-04382923)0.09954 Milliliter per hour per kilogramGeometric Coefficient of Variation 20
RN6G 10 mg/kgSystemic Clearance (CL) of RN6G (PF-04382923)0.07129 Milliliter per hour per kilogramGeometric Coefficient of Variation 14
RN6G 15 mg/kgSystemic Clearance (CL) of RN6G (PF-04382923)0.07036 Milliliter per hour per kilogramGeometric Coefficient of Variation 16
Secondary

Time to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 168, 336 hours on Day 1 and 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (MEDIAN)
RN6G 5 mg/kgTime to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Day 1401.77 Hour
RN6G 5 mg/kgTime to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Day 11.49 Hour
RN6G 10 mg/kgTime to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Day 12.06 Hour
RN6G 10 mg/kgTime to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Day 1402.05 Hour
RN6G 15 mg/kgTime to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Day 12.17 Hour
RN6G 15 mg/kgTime to Reach Maximum Observed Plasma Concentration (Tmax) of RN6G (PF-04382923)Day 1401.32 Hour
Secondary

Volume of Distribution at Steady State (Vss) of RN6G (PF-04382923)

Volume of distribution is defined as the theoretical volume in which the total amount of drug would need to be uniformly distributed to produce the desired blood concentration of a drug. Steady state volume of distribution (Vss) is the apparent volume of distribution at steady-state.

Time frame: Pre-dose: 0 hour on Day 1, 28, 56, 84,112,140; Post-dose: 1, 2, 4, 24, 336, 672, 1992, 3936 hours on Day 140

Population: Analysis population included all randomized participants who met the inclusion criteria and received any amount of study drug. Here Overall Number of participants Analyzed signifies number of participants evaluable for this outcome measure.

ArmMeasureValue (GEOMETRIC_MEAN)Dispersion
RN6G 5 mg/kgVolume of Distribution at Steady State (Vss) of RN6G (PF-04382923)79.52 Milliliter per kilogram (mL/kg)Geometric Coefficient of Variation 23
RN6G 10 mg/kgVolume of Distribution at Steady State (Vss) of RN6G (PF-04382923)88.04 Milliliter per kilogram (mL/kg)Geometric Coefficient of Variation 26
RN6G 15 mg/kgVolume of Distribution at Steady State (Vss) of RN6G (PF-04382923)78.45 Milliliter per kilogram (mL/kg)Geometric Coefficient of Variation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026